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-The point is not to resist the flow. You go up when you’re supposed to go up and down 
when you’re supposed to go down. When you’re supposed to go up, find the highest tower 
and climb to the top. When you’re supposed to go down, find the deepest well and go 
down to the bottom. When there’s no flow, stay still. If you resist the flow, everything 
dries up. If everything dries up, the world is darkness. 
-Haruki Murakami,  
The Wind-Up Bird Chronicle 
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ABSTRACT 
 Cinnamic acids and their derivatives are building blocks for cyclobutanes in many 
natural products. In nature, dimerization of these derivatives is thought to occur through a 
[2+2] photocycloaddition. Experimentally, efficient dimerization of these substrates using 
UV irradiation has predominantly been achieved in the solid state and is thought to be a 
result of stringent requirements for distance and orientation of the participating olefins. In 
the following pages a new strategy is presented which achieves [2+2] dimerization of these 
substrates in solution through the use of a bis-thiourea catalyst that induces proximity via 
hydrogen bonding while exploiting novel flow technology.  
Using these platforms, we demonstrate the ability to perform the [2+2] 
photocycloaddition on a variety of electron rich and poor cinnamates to yield two major 
truxinic ester products in good yields and regioselectivity. The methodology is also readily 
scalable to a decagram scale and has enabled access to large quantities of a variety of 
truxinic ester products.  Using a liquid-liquid slug flow strategy greatly accelerated 
reactivity by nearly four-fold in most cases and has allowed for an expansion of the 
substrate scope to include historically unreactive substrates such as cinnamamide dimers. 
  viii 
This rate increase is attributed to improved mixing and an organic thin film known to occur 
within these systems.  
More recently, this flow methodology has been further developed to enable access 
to various heterodimers similar to those found in various bioactive natural products in a 
simple and efficient manner by using a cinnamic acid monomer in combination with an 
excess of cinnamic ester or amide monomer. The heterodimer can be easily separated from 
the homodimers and unreacted ester or amide monomers through an acid-base workup.  
Finally, to demonstrate the utility of these methodologies for biological exploration, 
a small library of truxinic amides was synthesized and underwent biological testing in 
breast cancer cell lines. Single dose inhibition data showed promising anti-cancer activity. 
Lastly, this methodology has also been applied to the synthesis of two interesting bioactive 
natural products, eucommicin A and piperarborenine D in an efficient modular fashion in 
both cases. These syntheses open the doors to future SAR studies which have yet to be 
performed on these and most truxinic and truxillic acid derived natural products.   
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CHAPTER ONE: Comprehensive Review of Truxinic and Truxillic Acid Derived 
Natural Products 
Section One: Introduction 
 
 Truxinic and truxillic acids, esters, and amides are found throughout nature and 
have been shown to showcase a variety of interesting biological activities including anti-
diabetic, anti-cancer, anti-infective, and analgesic properties.1,2,3,4 Despite this wide array 
of biological activities, synthesis of these natural products (NPs) has been largely 
unexplored, in part due to a lack of methodology available to effectively access the 
molecules. The most direct way to construct the hallmark cyclobutane core of these NPs is 
the [2+2] photocycloaddition of cinnamic acid derived substrates, however, this reaction 
has historically suffered from poor practicality, substrate scope, and selectivity.  
Recently, there has been a surge in the development of synthetic methods to access 
the cyclobutane core in these types of NPs most notably from the groups of Ramamurthy,5 
Sivaguru,6 Yoon,7 Bach,8,9  and Beeler.10,11 Given these advances, it seems fitting to update 
and consolidate what is known of these unique NPs. The following pages give a 
comprehensive overview of truxinic and truxillic acid derived NPs which will be viewed 
as being composed of one or two cinnamic acid derivatives engaged in a [2+2] 
cycloaddition. For clarification, common nomenclature associated with truxinic and 
truxillic acid dimers is provided in Figure 1.  Emphasis will also be placed on reviewing 
the biosynthesis of these NPs as well as the synthetic methods and strategies available to 
accessing the core scaffolds.  
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Figure 1. Common nomenclature and terminology associated with truxinic and truxillic acid dimers 
 
Section Two: Truxinic and Truxillic Acids in Plant Cell Walls 
 
One of the earliest accounts of truxinic and truxillic acid derived NPs was described 
by the groups of Balza and Towers in 1990 wherein they isolated 12 substituted truxinic 
and truxillic acid homodimers  and heterodimers from the cell walls of grass Cynadon 
dactylon.12 The homo and heterodimers (3-5) were shown to be composed of ferulic acid 
(1a) and p-coumaric acid (1b) and the most commonly observed stereochemistry was 
confirmed to be the α truxillic acid form (Scheme 1). Cell wall extracts were treated with 
sodium hydroxide to provide the observed dimers leading the authors to suggest that the 
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dimers were formed in the cell wall from two ester-linked ferulic acid (1a) and coumaric 
acid (1b) monomers.  Formation of these dimers in the cell wall was postulated to promote 
crosslinking of wall polysaccharides, thus protecting the cell from biodegradation.  
 
Scheme 1. Truxinic and truxillic acids in plant cell walls of Cynadon dactylon 
 
 A follow-up study by Morrison and coworkers investigated this phenomenon by 
studying the dimerization of various phenolic acids including: ferulic acid (1a), p-coumaric 
(1b), sinapic acid (2b), cinnamic acid, and caffeic acid (2c) (Scheme 1).13 The acids were 
irradiated individually or in pairs and analyzed by GC-MS. In all cases one head-to-tail and 
one head-to-head dimer was observed with the head to tail dimer being the major dimer, 
except when sinapic acid was used alone or in combination with another acid, when only 
a single head-to-tail was observed. In addition to NMR spectroscopy, fragmentation 
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patterns of the trimethylsilylated derivatives observed by GC-MS were used to confirm the 
stereochemistry of the head to tail dimer. More specifically, the head to tail dimer showed 
a 5-fold increase in the formation of the ions, [M-90]+ and [M-207]+, corresponding to a 
McLafferty rearrangement compared with the head to head dimer (Scheme 2).  
 
Scheme 2. McLafferty rearrangement for determination of stereochemistry on GCMS 
 
 Mechanistically, it was suggested by Hanley, et. al. that dimerization of cinnamic 
acid monomers  within the plant cell wall could occur via free radicals similar to the 
building of lignan or 5-0-5-dehydrodimers of ferulic acid. 14 However, prolonged exposure 
of monomers linked by simple diols of varying lengths to peroxidase enzyme did not yield 
dimeric products.  On the other hand, exposure of these diol-linked monomers to UV light 
did yield cyclobutane dimers. Although length of the diol linker proved to be of crucial 
importance, an observation consistent with seminal studies by Schmidt and coworkers 
regarding the dimerization of cinnamic acids in the solid-state, which will be discussed in 
a later section. 
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Section Three: Dimeric Truxinic and Truxillic Ester-based Natural Products 
 
 Truxillines are NPs composed of a core unsubstituted truxinic or truxillic acid 
moiety conjugated to a tropane fragment (Figure 2). Truxillines showcasing 10 different 
stereochemical variants are found in most illicit cocaine samples coming from South 
America with the α (6) and β (7) representing the major cyclobutane diastereomers.15 The 
biological activities of α and β-truxillines were studied and found to have no anaesthetic 
activity but were established to be strong heart toxins.16 Similar natural products mooniine 
A (8) and mooniine B (9), differing only by substitution on the tropane fragment, have been 
isolated from Hovea galbulimima (Figure 2).17 Related to the mooniines is grahamine (10), 
also known as schizanthus, an unsymmetrical tropane alkaloid isolated from the aerial parts 
of Scizanthus grahamii. 18  β-Truxinic catapol ester (11) another NP with a core 
unsubstituted truxinic acid fragment was isolated from Premma subscandens (Figure 2).19  
 
Figure 2. Truxinic and truxillic acid based natural products 
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 Phenolic moieties from core cyclobutane dimers of p-coumaric acid, caffeic acid 
and ferulic acid are also commonly observed among truxinic and truxillic acid derived NPs 
(Figure 3). Alkaloid LC7 (12) with a core ferulic acid dimer was isolated upon 
reexamination of the leaf and seed extracts of Lupinus cosentinii.20 A similar truxillic ester 
known as thesine (13) with a core p-coumaric acid dimer isolated from Thesium 
minkwizianum was shown to have extremely toxic properties in mice. 21,22 ,23  Another 
ferulic acid derived β-truxinic dimer esterified to a sucrose moiety (14) was isolated from 
oat grains (Avena sateva).24 Sagerinic acid (15) is a truxinic ester derived from a caffeic 
acid µ dimer isolated from Salvia officinalis suspected to be the product of a photochemical 
cyclization of monomeric rosmarinic acid.25  
 
Figure 3. Truxinic and Truxillic ester NPs derived from phenolic cinnamic acid monomers 
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The simple methyl ester dimer of caffeic acid with δ stereochemistry around the 
cyclobutane ring (16) was recently isolated from the leaves of Andrographis lineata and 
was shown to have anti-diabetic activity (Figure 3). This exact NP was also isolated earlier 
from the extracts of Vitex quinata and was tested against MC-7 breast cancer cell lines but 
found to be inactive.26 A similar NP with the variation of an ethyl ester in place of one of 
the methyl esters (17) isolated from Elephantopus scaper was found to be cytotoxic against 
HepG2 cancer cell lines with an IC50 of 50-60 µM.
27 This NP was also shown to have anti-
inflammatory and anti AIDS activity. Finally, a mono-methyl variation of this δ caffeic 
acid dimer (18) was also isolated recently from Lysimachia clethroides in addition to 
flavonol glycosides (Figure 3).28 L. clethroides is a traditional Chinese medicine used in 
many provinces in China to treat throat ache, edema, and menoschesis.29 These compounds 
were evaluated for their in vitro inhibitory activity against aldose reductase due to a 
previous disclosure of the inhibition of aldose reductase by acylated flavonols and 
displayed moderate inhibitory activity of 2-8 µM.30  Aldose reductase is an important 
enzyme contributing to cataract induction in diabetic patients, a major cause of blindness.31  
 Eucommicin A (19), a truxinic ester NP with a core β-caffeic acid dimer 
conjugated to quinic acid fragments recently isolated from Eucommia ulmoides was found 
to have anti-cancer stem cell activity with an IC50 of 55 μM (Figure 3).32 Cancer stem cells 
(CSC) are undifferentiated cancer cell precursors found in tumors that have been recently 
been characterized and found to be associated with recurrence of cancer. Thus, therapies 
to eliminate CSC are considered to be crucial to completely curing the disease.33 
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Arguably the most famous and studied of the truxillic/ truxinic ester NPs is 
incarvillateine (20), and its derivative (21), isolated from Incarvillea sinesis, a commonly 
used traditional Chinese remedy to treat pain and rheumatism (Figure 4).34 Incarvillateine 
has been shown to possess novel non opioid analgesic and sedative activities.35 The core 
scaffold is comprised of an α-truxillic acid dimer of ferulic acid.  To date there have been 
three total syntheses of this natural product and one study investigating the structure 
activity relationship of analogues. These studies will be discussed in greater depth in later 
sections of this chapter. Derivatives of incarvillateine, methoxyincarvilateine 22 and the 
N-oxides 23 and 24 have also been isolated from extracts of I. sinesis. 36 Incarvillateine E 
(25), a heterodimeric version possessing 3 incarvilline moieties was subsequently isolated 
from the aerial parts of I. sinesis. 37 
 
Figure 4. Incarvillateine and its derivatives 
 
 Stachysetin (26) is a truxinic ester found in the herb Stachys aegyptiaca with a core 
p-coumaric acid dimer conjugated to a flavonoid glycoside (Figure 5).38 This NP was 
originally suspected by the isolation chemists to be an artifact arising from exposure to 
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daylight during the extraction process causing two monomers of apigenin to 
photodimerize. However, this theory was not supported by chromatography of methanolic 
extracts prepared in the absence of light, which still revealed the presence of 26. A similar 
truxinic diester of flavonoid diglycoside was isolated from the leaves of Monochaetum 
multiflorum and named monochaetin (27) (Figure 5).39 Also related to these flavonoid 
derived truxinic esters are the daglesiosides I and II (28 and 29), isolated from the needles 
of green Douglas fir- Pseudotsuga menziesii (Figure 5). 40  These represent the first 
flavonoid truxinoylmonoglucosides. They were isolated along with dagleosides III (30) 
which represents the undimerized di-p-coumaryl dagleoside I and dagleosied IV (31), an 
undimerized di-cinnamoyl derivative. P. menziessii along with various other species of the 
genus Pseudotsuga have been used in traditional medicine as antirheumatic, analgesic, 
diaphoretic, and diuretic agents.41  
 
Figure 5. Flavonoid truxinic esters and derivatives 
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Dagleosides I and III (28, 30) were evaluated for cytotoxic activity along with other 
flavonoids against HL-60, HeLa, and MDA-MB468 cancer cell lines with human skin 
fibroblast cells as a non-neoplastic control. 42  They displayed the greatest cytotoxicity 
against all examined cell lines, exerting the highest toxicity towards HL-60 cell lines with 
IC50 values of 8.5 µg/ L and 6 µg/ L, respectively. Dagleoside III also exhibited a two-fold 
more potent activity towards MDA-MB468 and three fold more towards HeLA cells. Both 
dagleoside I and III exhibited comparatively lower activity towards the control fibroblast 
cells.  
 
Section Four:  Dimeric Truxinic and Truxillic Amide-based Natural Products 
 
(+)-Santiaguine (32), an α-truxillic amide, as well as the racemic santiaguine were 
isolated from Adenocarpus complicates, subspecies aureus (Figure 6).43 This NP, 32, has 
also been isolated from A. mannii,44 A. foliosus,45 A. intermedius, and A. parvifolius.46, 47, 
48, 49 Other related NPs 33 and 34 were also isolated from A. foliosus.50 51 Another related 
natural product, hoveine (35), isolated from Hovea linearis and Galbulimima was found to 
have cardiovascular activity (Figure 6).52 53 
 
Figure 6. (+)-Santiaguine and related NPs 
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One of the largest genera of basal angiosperms, the genus Piper, includes more than 
1000 species, and has provided several cyclobutane-containing alkaloids (Figure 7).54 
Piper species are typically shrubs, herbs and lianas in lowland wet forests in tropical 
locations.55 The dipiperamides A-E (35 - 39) were isolated from the white pepper Piper 
nigrum. All five compounds were shown to inhibit the activity of CYP3A4 with 
submicromolar IC50’s. 56,57 A recent synthesis, discussed in more detail in a later section, 
resulted in reassignment of the structure of dipiperamide A (35) to that of B (36). The 
proposed structure of dipiperamide B (36) has yet to be confirmed.  An extremely similar 
group of NPs known as the nigramides, also isolated from the roots of P. nigrum, constitute 
a class of 15 NPs which includes four cyclobutane containing members, nigramides P, Q, 
R and S (40 - 43) (Figure 7).58  
Another related group of NPs also isolated from the fruits of P. nigrum are the 
pipercyclobutanamides A (45) and B (44) (Figure 7).59  However, after a recent total 
synthesis of the proposed structure of pipercyclobutanamide A (45), the structure was 
revised to 46 as will be discussed in a later section. It is noteworthy to mention that many 
of the NPs mentioned from these classes contain one or more olefin moieties directly 
attached to the cyclobutane ring and thus can be thought of being formed from the [2+2] 
photocycloaddition of the diene or triene precursors rather than the cinnamic acid derived 
precursor. Although some of these NPs may or may not still contain at least one cinnamic 
acid derived fragment, for the purposes of comprehensiveness, they have all been included 
in this section.  
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Figure 7. Truxinic and truxillic amide and imide NPs from the genus Piper 
 
In 2008, two new related NPs were isolated from the fruits of Piper chaba, widely 
distributed in Southeast Asia, and named piperchabamides G (48) and H (47) (Figure 7).60 
In traditional Thai medicine, the fruits of this plant, commonly called ‘Dee Plee’, have been 
used as anti-flatulent, expectorant, antitussive, antifungal, uterus-contracting agent, 
sedative-hypnotic, appetizer and counter irritant.61 These compounds were shown to have 
hepatoprotective properties through the inhibition of D-GaIN/tumor necrosis factor-α 
(TNF-α) induced death of hepatocytes with IC50’s of 4 and 11 μM respectively. The 
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structure of piperchabamide G was later revised to 49 after a synthesis of the proposed 
structure was successfully completed. This study will be discussed in a later section.  
Various truxillic imide NPs, including piplartine-dimer A (50), piperarborenine A 
(51) and B (52), and piperarboresine (53) were isolated from the stem of P. aborescens 
with piplartine-dimer A (50) also being found in P. rugosum, and P. tuberculatum (Figure 
8).62, 63, 64, 65, 66, 67 Later, three more truxillic and truxinic imides, piperarborenines C, D, and 
E (54-56) were isolated from P. aborescens. Piperarborenine C along with the monomer, 
methyl trans-3,4,5-trimethoxycinnamate, were shown to possess antiplatelet aggregation 
activity in vitro. 68 Piperarborenines C-E were also found to be cytotoxic with IC50 values 
of <4 μg/ mL against HT-29, P-388, and A549 cancer cell lines in vitro. The structure of 
piperarborenine D (56) was originally misassigned and the structure was later revised to 
56 following a total synthesis of the proposed structure by Baran and coworkers, which 
will be discussed in a later section. Pyrrolidinamide dimers 57 and 58 were isolated from 
the leaves and stem of P. peepuloides (Figure 8).69 Similar piperidinamide dimers 59 and 
60 were isolated from the leaves and immature buds of P. peepuloides.70  
Figure 8. Piperaborenine and related NPs 
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Caracasandiamide (61), its derivative (62), and imide (63) were isolated from the 
Venezuelan plant Verbesina caracasana and were shown to have hypotensive activity 
(Figure 9). 71  Both compounds have been synthesized and their structures and 
pharmacological activity confirmed. 72  Intravenous administration of caracasandiamide 
affected both the central respiratory and cardiovascular systems by stimulating breathing, 
increasing inotropism and peripheral vascular resistance. Interestingly, at higher doses it 
depressed breathing and caused arterial hypotension through reduced peripheral vascular 
resistance. Possible explanations for these observations included reduced activation of 
vascular α1 and α2 adrenoreceptors paired with increased activation of β2 adrenoreceptors 
and muscarinic cholinergic receptors. The previously isolated and synthesized monomeric 
version, known as caracasamide (64), which was shown to have less favorable therapeutic 
profile compared with caracasandiamide due to its display of negative side effects such as 
reflex tachycardia 73 
 
Figure 9. Truxinic amide and imide NPs isolated from the plant Verbesina caracasana 
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 Section Five: Miscellaneous Truxinic and Truxillic Acid Related Natural 
Products 
 
 
A small group of NPs and their derivatives, classified as miscellaneous truxinic and 
truxillic acid NPs for the purposes of this review, contain only one cinnamic acid derived 
fragment. Retrosynthetically compounds 65 and 66 can be thought of as being composed 
of a cinnamamide precursor (Scheme 3). These compounds were however isolated in vitro 
and were identified as the product of a dimerization and photoisomerization of gilvocarcin 
V an antitumor agent produced by Streptomyces friseoflavus with thymidyl residue on 
DNA.74  Another DNA photoadduct (68) is derived from the photodimerization of 8-
methoxypsoralen (67), a known DNA intercalator with 1,3 dimethyl thymine followed by 
a lactone opening to furnish the acid.75   
 
Scheme 3. In vitro isolated NPs derived from the photochemical interaction with DNA 
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Scopariusic acid (69) and its biosynthetically related compound 70 were recently 
isolated from the aerial parts of Isodon scoparius (Scheme 4).76  The structures were 
confirmed by spectroscopic methods, single-crystal X-ray diffraction analysis and 
chemical methods. Scopariusic acid (69) displayed weak cytotoxicity against all five cell 
lines with IC50 values within the range of 16-26 µM. Both compounds were also screened 
for immunosuppressive activity mediated through inhibition of mouse T cell proliferation 
in vitro. Again, scopariusic acid exhibited moderate immunosuppressive activity (IC50 = 
2.6 µM) while compound 70 showed no activity.  
Biosynthetically, it is proposed that scopariusic acid arises from the intermolecular 
cycloaddition between the fragment 70 and p-coumaric acid (71) esterified with (3R)-1-
octen-3-ol (72) as shown in Scheme 4. The authors note that such crossed intermolecular 
[2+2] photocycloadditions between acyclic side chains of two different molecules are rare 
among natural products and still a long standing unsolved problem in synthetic organic 
chemistry.  
 
Scheme 4. Proposed biosynthetic components of Scopariusic acid 
Another heterodimeric NP (-)-littoralisone isolated from the extracts of Verbena 
littoralis77 widely used in traditional folk remedies has been shown to promote the 
activity of nerve growth factor (NGF) in PC12D cells.78  Littoralisone is presumed to be 
  
17 
derived biosynthetically from (-)-brasoside (Scheme 5).79  Inspired by this proposed 
biosynthesis MacMillan and coworkers were successful in synthesizing littoralisone 
through an intramolecular [2+2] of these two biosynthetic fragments. This synthesis will 
be discussed in a later section. 
 
Scheme 5. Biosynthesis of (-)-littoralisone 
 
 Section Six: Noteworthy Synthetic Truxinic and Truxillic Acid Derived 
Analogues 
 
 
Figure 10. Noteworthy synthetic truxinic and truxillic acid derivatives 
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 Four truxillic acid derived analogues pyrocyclonium (73), cyclobutonium (74) 
anatruxonium (75), and truxillonium (76) were reported for use as antidepolarizing agents 
(Figure 10).80 81 82 The compounds were shown in rabbits, cats, chickens, and guinea pigs 
to have high curare-like properties. In fact, in rabbits they were shown to cause the ‘head-
drop’ effect when injected at doses of 30-50 µg/kg and are thus three to five times more 
potent than D-tubocurarine hydrochloride. Additionally, the compounds were shown to 
have low toxicity as shown by the fact that the dose required for heart arrest was at least 
three orders of magnitude higher than one that produced muscular paralysis in animals 
under artificial respiration. Some of these compounds were introduced clinically in the 
former Soviet Union as myorelaxants.83, 84 
 Although Boc-5 (77) (Figure 10) is not technically considered a truxillic amide due 
to the direct attachment of the nitrogen to the cyclobutane and thus cannot be broken down 
into a cinnamamide fragment, its similarity warrants mention due its noteworthy biological 
activity. It was serendipitously discovered through the unplanned photodimerization of 
alkene 78 during a screen for glucogon-like peptide-1 (GLP-1) agonists.85 86 GLP-1 was 
found to be an important regulator of glucose homeostasis and thus is considered to be an 
important target for the treatment of type II diabetes. More recently GLP-1 agonists have 
also emerged as molecular imaging agents of pancreatic β cells, which may be useful in 
early detection of the disease.87 Boc-5 was shown in vivo to reverse obesity in mice through 
activation of GLP-1. However, poor oral bioavailability posed a significant challenge in 
the advancement of this compound to the clinic.   
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 In a virtual screen of over 1 million compounds using DOCK for FABP 5 and 7 
agonists 48 compounds were identified, subsequently purchased and assayed for biological 
activity against purified FABP5. 88  FABP 5 and 7 have been recently identified as 
intracellular transporters of the endocannabinoid anandamide (AEA). High levels of 
endocannabinoids have been shown to have beneficial effects on stress, pain, 
inflammation, and drug withdrawal. The most potent inhibitor, identified as a novel α- 
truxillic acid 1-napthyl mono-ester, SB-FI-26 (79), was shown to have even stronger 
binding with a Ki of 0.93 µM. SB-FI-26 was also shown to have potent anti-nociceptive 
activity with mild anti-inflammatory activity in mice (Figure 10).  
 
 Section Seven: Synthetic Studies Toward Truxinic and Truxillic Acid-
Derived Scaffolds 
 
Solid State [2+2] Photocycloaddition of Cinnamic Acids 
 
 
Topochemical reactions were first defined by Kohlschutter in 1918 as reactions in 
which the products as well as their properties, are governed by the constraining influence 
of the three dimensional periodic environment.89 One of the overarching principles of 
topochemistry set forth by Kohlschutter states that reactions occurring in crystals occur 
with minimal atomic or molecular movement. But, it was not until seminal studies by 
Schmidt and coworkers on the [2+2] photocycloadditions of cinnamic acids in the 1960s 
that these principles were verified experimentally. 90,91,92  From these studies emerged four 
fundamental principles that govern reactions in the solid state:93  
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1. The packing of neighboring molecules is of greater importance than the intrinsic 
reactivity of the reactant. 
2. The orientation, distance separation, and space symmetry between the 
neighboring reactive functional groups is of crucial importance.  
3. Unlike in solution, in crystalline solids there are very few (in most cases only 
one) conformations for molecules to adopt. 
4. A vast array of polymorphs exist within molecular crystals in which a specific 
orientation, symmetry, and distance between reactive functionality prevails. 
 
 Historically, the [2+2] photocycloadditions of cinnamic acid derivatives have been 
limited solely to solid-state chemistry because UV irradiation of these substrates in solution 
has been shown to result in predominantly E/Z isomerization. The limitation of this 
chemistry to the solid state is thought to be as a result of a strong distance requirement 
between the participating olefins for the reaction to occur. Seminal studies by Schmidt and 
coworkers showed that the starting orientation of the olefins in different crystal polymorphs 
had a direct impact on whether dimerization occurred (Figure 11). The α and β crystal 
polymorphs readily produced the corresponding dimers, but the gamma form did not. 
Measurement of distances between the olefins confirmed that the polymorphs wherein the 
distance between the olefins was almost exactly 4 Å readily underwent dimerization. Even 
a slight increase in distance to 5 Å precluded reactivity, explaining the failure of the γ 
polymorph to produce the dimeric product. Since these studies, there have been several 
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follow up studies of the photodimerization of cinnamic acid derivatives in the solid 
state.94,95,96,97  
 
Figure 11. Solid state dimerization of cinnamic acid derivatives 
 
 
Other Work on [2+2] Photocycloaddition of Cinnamic Acids and Derivatives 
 
 Many groups have investigated the dimerization of cinnamate derivatives in 
solution. Certain substrates were shown to be reactive in the [2+2] photocycloaddition 
under sensitized or direct excitation conditions, including nitro cinnamates98 and electron 
rich cinnamates.99  A seminal study by Lewis, et al. showed that the use Lewis acids such 
as BF3•OEt and SnCl4 promoted dimerization of methyl cinnamate in solution but furnished 
complex mixtures of diastereomers and poor reactivity (Scheme 6).100  
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Scheme 6. Lewis acid promoted dimerization of methyl cinnamate 
 
Other methods to perform the [2+2] photocycloaddition of cinnamates utilized 
sensitizers and tethering.101 Ramamurthy and coworkers took advantage of ‘host-guest’ 
type systems such as palladium nanocages,102 γ-cyclodextrin and cucurbit-(8)-uril,103 to 
template trapped cinnamic acid derivatives and induce dimerization. The group also used 
octahedral Pd nanocage104 at a 1:2 ratio of host to guest in aqueous conditions with 3 hours 
of irradiation (Scheme 7). Under these conditions they observe 30-40% conversion of the 
starting cinnamate and one major cyclobutane diastereomer, confirmed to be the β (syn 
head-to-head) dimer, composing 20-60% of the product mixture. Selectivity is attributed 
to orientation of the monomers within the nanocage as a result of the hydrophilic ester 
moiety preferring to face outward towards the water and the hydrophobic aryl group 
preferring to remain in the hydrophobic interior of the nanocage. Other reasons cited for 
the observed selectivity include π-stacking interactions between the host and guest. A 
major limitation of this work involves use of stoichiometric amounts of a specialized host 
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system as well as absorbance of the host at similar wavelengths to the substrates potentially 
interfering with reactivity. 
 
Scheme 7. Use of Pd nanocages for the dimerization of cinnamates 
 
Ramamurthy’s group also showed that longer chain alkyl cinnamates readily 
dimerized in dilute aqueous conditions through ‘on-water’ type reactivity (Scheme 8A).105 
Interestingly, in this example, they observe predominantly the δ (anti head-to-head) 
diastereomer. More recently, Wu and coworkers in collaboration with Ramamurthy’s 
group used visible light photoredox catalysis to access various truxinic ester and amide 
derivatives (Scheme 8B).106 , 107  The catalyst system they used was found to act as a 
photosensitizer.  
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Scheme 8. On water dimerization of longer chain alkyl cinnamates and photoredox catalysis for 
the [2+2] photocycloaddition of cinnamates 
 
Other noteworthy work on the [2+2] photocycloaddition of related but non-
cinnamate substrates comes from the groups of Bach and Yoon. Bach’s group has 
published several examples of efficient and selective [2+2] photocycloadditions. 
108,109,110,111  An example from Bach’s group will be discussed in a later section. Yoon and 
coworkers recently reported a robust method for the asymmetric cross [2+2] 
photocycloaddition of enones using a dual catalysis approach with visible light (Scheme 
9).112 The methodology utilizes a Ru(bpy)3Cl2 photoredox catalyst in combination with a 
chiral Lewis acid complex to induce asymmetry.  
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Scheme 9. Dual catalysis approach to cross [2+2] photocycloaddition of enones using visible light 
 
Total Synthesis of Truxinic and Truxillic Acid Derived NPs 
 
To date there have been very few syntheses of truxinic acid derived NPs. A simple 
synthesis of caracasandiamide (61) was reported in 1999 (Scheme 10).113  The group 
showed that direct dimerization of the monomeric caracasanamide (64) did not yield the 
expected product. Instead the photodimerization of ethyl-3,4-dimethoxycinnamate (80) 
was carried out in the solid state followed by the coupling of the di-acid derivative 81 to 
yield the protected prenylagmatine (82). Deprotection yielded the desired NP in 
satisfactory yield. 
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Scheme 10. Synthesis of caracasandiamide 
 
 Incarvillateine (20) has been the most studied NP in this class with three reported 
total syntheses to date by the groups of Kibayashi in 2004,114 Bergman and Ellman in 
2008,115 and finally by Zhang’s group in 2009.116 Although each subsequent synthesis of 
incarvillateine (20) lowered the step count and increased the overall yield, all three 
syntheses relied on solid state photodimerization of the tosylated derivative of ferulic acid 
(83). Optimization of this dimerization was performed in the initial synthesis by Kibayashi, 
wherein it was shown that the tosyl derivative (83) improved both yield and 
diastereoselectivity to the desired dimer (84) (Scheme 11). Coupling to fragment 85 and 
deprotection of the tosyl group furnished incarvillateine in good yield. Incarvillateine (20) 
and various derivatives were synthesized again recently for the purpose of further probing 
the SAR. This study will be discussed in further detail in a later section.  
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Scheme 11. Kibayashi’s synthesis of (-) Incarvillateine 
 
 Kibayashi’s group later applied the optimized conditions developed for the [2+2] 
photocycloaddition of ferulic acid to the synthesis of the proposed structure of another 
truxillic acid derived NP, dipiperamide B (36). Upon synthesizing the proposed structure, 
they discovered that the spectra did not match the reported spectra of dipiperamide B but 
matched the reported spectra of dipiperamide A (35a), which had been structurally 
misassigned (Scheme 12).117 Thus, the structure of dipiperamide A has been revised to the 
structure (35) and dipiperamide B (36) is still in need of structural revision. Upon accessing 
the same core α truxillic acid utilized for the synthesis of incavillateine, a multistep process 
is used to convert this structure to the methylenedioxy di-aldehyde derivative 85. A final 
Wittig olefination using stabilized ylide 86 furnishes the revised structure of dipiperamide 
A (35) in high yield.  
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Scheme 12. Synthesis of dipiperamide A 
In 2011, Baran’s group reported the first total synthesis of the proposed structure 
piperarborenine D (56a).118 Noteworthy steps in the original synthesis included formation 
of the cyclobutane core using a methodology developed by E. J. Corey which involved a 
photochemical 4π-electrocyclic ring closure of pyrone 87 followed by a reductive opening 
of the strained photopyrone (88) (Scheme 13). Coupling of directing group 89 followed by 
two sequential stereospecific C-H functionalizations of the cyclobutane core 90 with 
epimerization allows access to the tetra-substituted truxillic pre-cursor to the proposed 
structure of piperarborenine D (56a) and piperarborenine B (52). 
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Scheme 13. Synthesis of piperarborenine B and the proposed structure of piperarborenine D 
 
The total synthesis of the proposed structure was successful but led to a structural 
revision of piperarborenine D (56). The correctly assigned natural product was synthesized 
through an intramolecular [2+2] photocycloaddition, tethering the two alkenyl fragments 
using an anhydride (91) (Scheme 14).  
 
Scheme 14. Synthesis of the revised structure of piperarborenine D 
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 A similar intramolecular [2+2] strategy was used by MacMillan and coworkers to 
synthesize (-)-littoralisone.119 Inspired by the proposed biosynthesis of (-)-littoralisone 
from (-)- brasoside described earlier in Scheme 5, the group envisioned a biomimetic 
synthesis through the intramolecular [2+2] of these two fragments. Serendipitously the 
key [2+2] photocycloaddition and subsequent deprotection of intermediate 92 furnished 
littoralisone in 84% yield as a single diastereomer with only 2 hours of irradiation 
(Scheme 15). 
 
Scheme 15. Synthesis of (-)-littoralisone 
 
Recently, a unique approach to accessing the cyclobutane core of truxinic and 
truxillic acid scaffolds was described by the group of Tang.120 The strategy they envisioned 
involved synthesis of a strained cyclopropane ring (93) followed by ring expansion to 
provide the cyclobutene ring (94) (Scheme 16). This methodology had been optimized in 
earlier publications by this group and was shown to be both stereoselective and 
regioselective. 121 , 122  The ring expansion was successfully performed using AgOTf to 
provide 94 which could be further functionalized by a rhodium(I) catalyzed addition of an 
aryl boronic acid to the enoate. Ultimately both proposed structures of 
pipercyclobtanamide A (45) and piperchabamide G (48) were achieved but led to structural 
revisions of the natural products due to mismatches of the NMR spectra to the original 
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spectra of the isolated natural products. The revised structures of pipercyclobutanamide A 
(45) and piperchabamide G (48) were revised to 46 and 49 (Figure 7).   
 
Scheme 16. Silver triflate catalyzed cyclopropane ring expansion to access cyclobutene core followed by 
Rh(I) catalyzed addition of aryl boronic acid 
 
Analog Synthesis and Structure Activity Relationship Analysis  
 
To date, only incarvillateine (20) has undergone a reasonably thorough structure 
activity relationship (SAR) analysis through the synthesis of analogues.123  This study 
relied on a modular synthesis that enabled gram scale asymmetric access to various 
simplified analogues of incarvillateine (20a, 20b, 102 – 105, Scheme 17). The key 
fragments that facilitated these syntheses (95 - 101), which include (-)incarvilline (96) and 
(-)isoincarvilline (97), are shown in Scheme 17a. Another set of further simplified 
analogues (106 - 108) were also synthesized through coupling of the tosyl protected ferulic 
acid dimer to simple boc-protected piperidine alcohols (109-111) (Scheme 17b).  
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Scheme 17. Incarvillateine analogue synthesis 
 
Incarvillateine and these nine analogues were screened in vivo in mice for the 
prevention of acetic acid-induced writhing response. This screen showed that 
incarvillateine (20) as well as two of the analogues 20a and 107 were efficacious and their 
analgesic activity further demonstrated using the formalin induced pain model. 
Furthermore, a dose of 20 or 40 mg/ kg of incarvillateine, 95, and 107 showed strong 
analgesic effects in spared nerve injury (SNI) making them much more potent than the gold 
standard, gabapentin, which is dosed at 100 mg/kg in this model.  
The only other example of the synthesis of truxinic and truxillic NP analogues is 
displayed in recent work from the Csuk group and demonstrated the synthesis of various 
piplartine A dimer (50) analogues and the screening for cytotoxicity against various human 
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cancer cell lines (Scheme 18).124 This work was inspired by the biological activity of the 
monomer piplartine (112a, also known as piperlongumine).125  Piplartine (112) and its 
analogues have been shown to possess a wide range of biological activity including 
schistosomicidal, 126  anti-leishmanial activity, 127  anxiolytic and anti-depression, 128  anti-
platelet,129 neuroprotective,130 and cytotoxic activity.131 As mentioned earlier, piplartine 
dimer A (50) has been isolated from the aerial parts of Piper rugosum but its biological 
activity had yet to be investigated and thus, this group was interested to investigate whether 
the monomer’s activity would be preserved, enhanced, or diminished in dimeric form. 
 
Scheme 18. Synthesis of piplartine dimer A analogues 
 
Dimers were synthesized using two techniques, the first in the solid state by 
irradiation of the monomers on a TLC Plate for 48 hours and the second by suspension in 
hexanes and irradiation for 17 hours (Scheme 18). Both techniques yielded the desired 
dimers albeit in very low yields and with poor selectivity. The results of the cytotoxicity 
screening in six different human cancer cell lines showed diminished activity compared 
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with piplartine in all cases except in the case of the β-truxinic derivative 113a which 
showed cytotoxicity against all screened cancer cell lines with IC50’s in the range of 1.0- 
2.2 μM. This activity is comparable if not superior in most cases to piplartine which 
displayed IC50s in the range of 0.5-8.6 μM in the same cell lines.  
 
 Section Eight: Conclusions 
 
 In conclusion, various truxinic and truxillic acid derived NPs showcase a variety of 
biological activities, but very little has been done to investigate this activity. This is as a 
result of limitations to synthetic methods to access these scaffolds. Historically this 
chemistry has been limited to the solid state which suffers from poor substrate scope, 
unpredictable selectivity, and often very long reaction times. Recently there has been a 
surge in methodology development surrounding these scaffolds but there still remain some 
key challenges including substrate scope, selectivity, and heterodimerization chemo- and 
stereoselectivity. Further development of this chemistry is crucial for the exploration of 
these NPs that possess great potential as important therapeutic agents.  
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CHAPTER TWO: Flow Photochemical Platform and  
Development of a bis-Thiourea Catalyst 
 
Section One: Introduction  
 Despite the tremendous progress and effort made towards the [2+2] 
photocycloaddition of cinnamic acid derivatives in solution, there remains a significant 
challenge. There has yet to be an efficient, general, and scalable method to access these 
cycloadducts. Our mission was to address this gap through the use of two modern 
approaches in synthetic organic chemistry, flow photochemistry and hydrogen bond 
catalysis. Performing photochemical reactions in flow has shown numerous advantages 
over traditional batch photochemistry. Furthermore, given the well-established role of 
distance between the participating olefins, we surmised that hydrogen bond-induced 
templating in solution may help overcome this barrier. 
 
Section Two: Background 
 
Benefits of Flow Photochemistry  
 
 Flow chemistry has been shown to have numerous benefits for chemical reactivity 
including enhanced mixing, improved heat transfer, infinite scalability, and enhanced 
safety by avoiding the accumulation of hazardous intermediates.132,133 One of the main 
benefits specific to photochemistry is increased surface area to volume ratio which 
enhances photon flux.134 This benefit takes advantage of the path length variable in the 
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Beer Lambert Law which describes the relationship of path length (b), molar absorption 
coefficient (ε), and molar concentration (c) to absorbance (A) (Equation 1). High 
absorbance at the surface of a vessel or reactor can lead to non-uniform inefficient 
irradiation of the reaction with less available light moving away from the surface.  
 
A= ε • b • c (Equation 1) 
 
 The enhanced mixing in flow is largely attributed to the smaller volumes flowing 
through the tubing of a flow reactor at any point in time compared to larger volumes being 
mixed in a single batch reactor. The difficulty of achieving consistent mixing in traditional 
batch reactors, especially as reactor volumes increase, is well documented.135,136,137 Flow 
patterns can be categorized into two types: laminar flow and turbulent flow. Laminar flow 
is characterized by smooth flow parallel to the tubing which is consistent throughout the 
system. There is little to no lateral mixing in this type of flow and mixing is limited to the 
rate of diffusion. Turbulent flow is characterized by more random flow patterns that 
meander and recirculate in the net flow direction. The point at which laminar flow becomes 
turbulent flow is described by the Reynold’s number (Re) which is affected by the factors: 
volumetric flow rate (Q), pipe bore (D) and kinematic viscosity (ν) (Equation 2). 
 
Re= QD/ ν (Equation 2) 
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 Improved heat transfer in flow systems is also attributed to larger surface area to 
volume ratio in flow systems which allows for more efficient cooling through either contact 
with the surrounding tubing cooled by ambient temperatures or an alternate cooling 
medium such as a water bath or cooling mantle. Heat fluctuations in chemical reactions 
can result in drastic changes in reactivity and selectivity. A pertinent example from the 
Beeler lab showed great improvements in selectivity of the intermolecular Buchner 
reaction in flow compared with batch, wherein the flow reaction reduced the exothermic 
buildup by approximately 7 oC (3 oC in flow compared 10 oC in batch). 
 The infinite scalability of flow reactions is due to the preclusion of the need to use 
larger vessels when scaling a reaction, which is a hallmark of batch reactions. As the 
volume of the batch reactor increases, it becomes more difficult to control mixing, heat 
transfer, and safety. An example from Kappe’s group demonstrated the ability to perform 
C-H arylation of heteroarenes using light-induced in situ generated highly explosive diazo 
anhydrides (121) in flow (Scheme 19).138 The intermediate is generated by pumping the 
starting materials separately into a T-mixer, thereby generating the intermediate in situ. 
The hazardous intermediate is consumed immediately which eliminates the potential for 
accumulation of large amounts.  
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Scheme 19. Safe generation of hazardous intermediates in flow 
 
 In batch, photochemical reactions suffer from the inevitable increase in path length 
of light with larger reactor volumes which drastically decreases photon flux and thereby 
the overall rate of the reaction. In flow, it is possible to keep the reactor path length 
consistent regardless of the scale by continuing to push more reaction solution through. 
This method, however, may be limited regarding maximum potential throughput (g/hr) due 
to limitation of the overall reactor volume. Increasing the reactor volume can help by 
enabling the use of higher flow rates to achieve the same residence time (tR). Residence 
time is dictated by the reactor volume and the flow rate (tR = reactor volume/ flow rate)  
In 2005 the Booker-Milburn group demonstrated the first scale up of a 
photochemical reaction to a multi-gram scale in flow (Scheme 20).139  In this seminal paper 
they built four different chemical reactors testing various parameters including both Pyrex 
and Vycor filters, tubing diameter, number of layers of tubing, and UV source. They 
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demonstrated the efficiency of their custom three layer Vycor immersion-well reactor for 
the scale up of two photochemical reactions: the intermolecular [2+2] photocycloaddition 
of maleimide 122 with alkyne 123 to furnish cyclobutene 124 and an intramolecular formal 
[3+2] photocycloaddition and rearrangement of maleimide 125 to afford dione 126 via the 
fragmentation of cyclobutane intermediate 127 (Scheme 20). Using their optimized system, 
they demonstrated throughputs of 85g and 178g per 24 hours for [2+2] and the [3+2] 
respectively. 
 
Scheme 20. Custom 3-layer Vycor reactor for the multigram scale-up of photochemical reactions 
 
In a later paper this group utilized a ‘numbering-up’ strategy to scale up another 
photoreaction by connecting three single layer reactors in parallel (Scheme 21).140,141 This 
effectively triples the reactor volume, thereby allowing for the use of much higher flow 
rates to achieve identical residence times. Using this strategy, the group was able to access 
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gram quantities of complex aziridine products (128-130) through an initial [2+2] of 
reactant 131 followed by a photochemical rearrangement of 132.  
 
 
Scheme 21. Parallel reactor strategy for scale up of photochemical reactions 
 
Hydrogen Bond Catalysis for [2+2] Photocycloadditions 
 
 In the late 1990’s to early 2000’s hydrogen bonding catalysis, especially utilizing 
thiourea moieties, emerged. 142 , 143  Advantages over more commonly used Lewis acid 
catalysis include weak complexation energy, which prevents product inhibition, a 
phenomenon by which the catalyst is sequestered by the product because of complexation 
with the Lewis basic moieties on the product. This effect often necessitates the use of 
stoichiometric or even super-stoichiometric amounts of the Lewis acid catalyst to 
effectively promote completion of the reaction. Another disadvantage of Lewis acid 
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promoted reactions includes incompatibility of these reactions in Lewis basic solvents such 
as water or DMF.144 
 The first model for hydrogen bond catalysis was proposed by Jorgensen, when it 
was observed that the Claisen rearrangement was accelerated when performed in water. It 
was proposed that two hydrogen bonds to the carbonyl functionality were needed to 
accelerate reactivity (Figure 12).145 This suggestion was later supported through crystal 
structures by the Kelly group, using biphenylenediol 133146 and the Etter group, which 
investigated the crystal structures of m-nitro diaryl ureas with several Lewis basic 
structures.147 Later, the Curran group demonstrated that dialkylurea 134 could promote a 
5-fold rate enhancement of the Claisen rearrangement (Figure 12).148  
 
Figure 12. Noteworthy examples of hydrogen bonding catalysts 
 
 Seminal studies by Schreiner and coworkers in 2003 thoroughly investigated the 
structural properties of various thiourea catalysts which identified the now widely utilized 
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3,5-bis-trifluoromethyl phenyl substituted thiourea catalyst, often referred to as 
‘Schreiner’s Catalyst’ (135). 149  Using this catalyst they showed a 1000-fold rate 
enhancement of the Diels Alder reaction compared with the uncatalyzed counterpart.150 It 
was shown that a key intramolecular ortho C-H hydrogen bond with the thiourea 
functionality increases rigidity of the catalyst and thereby increases hydrogen bonding 
reactivity (Figure 12). Thioureas were shown to have improved hydrogen bonding 
properties over ureas as a result of lower pKa of the N-H hydrogens (pKa 8.5 versus 13.8) 
as well as reduced aggregation from the lower Lewis basicity of the sulfur moiety.  
Many laboratories, most notably the Jacobsen group, have utilized thiourea 
catalysis to facilitate many transformations. 151  In one noteworthy example, the group 
showed that a homochiral Schreiner thiourea could also be used to bind anions and 
facilitate the departure of a leaving group to catalyze a cationic polycyclization in an 
asymmetric fashion (Scheme 22). 152  Upon departure of the leaving group an ion-pair 
complex (136) is formed, which facilitates selectivity (Scheme 22a). Optimization of the 
catalyst showed that larger aryl groups such as the pyrene derivative 137 promoted not 
only enantioselectivity but also reactivity (Scheme 22b). This was attributed to a 
stabilization effect caused by a cation-π interaction between the aryl group and the cationic 
species formed during the reaction.  
  
43 
 
Scheme 22. Thiourea catalyzed enantioselective polycyclization 
In photochemical reactions, Thorston Bach’s group has pioneered the use of 
hydrogen bonding catalysis to promote [2+2] photocycloaddition.153 A recent example 
employed bifunctional catalyst 138, acting as both a hydrogen-bonding catalyst and a 
sensitizer, to mediate the intermolecular [2+2] photocycloaddition of quinolones with 
vinylic esters and ketones (Scheme 23).154 The key to the effectiveness of this strategy was 
the 2-point hydrogen bond between the quinolone and the catalyst which promotes efficient 
energy transfer and high enantiofacial differentiation.  
 
Scheme 23. Bifunctional catalysis for enantioselective [2+2] photocycloaddition of quinolones 
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Another example from the Sivaguru group describes the use of a chiral 
atropisomeric thiourea catalyst 139 to facilitate the asymmetric intramolecular [2+2] 
photocycloaddition of alkene-tethered coumarins (Scheme 24). 155  The electron 
withdrawing groups on both the naphthyl groups as well as the phenyl side chain were 
shown to be of crucial importance for reactivity. Furthermore, substitution of the hydroxyl 
group for a methoxy group led to precipitous drops in both conversion and 
enantioselectivity further bolstering the importance of hydrogen bonding for reactivity. 
Detailed photophysical studies were performed, ruling out a simple triplet sensitization 
mechanism due to unfavorable energy transfer from the catalyst to the substrate.  
 
Scheme 24. Chiral thiourea induced asymmetric [2+2] photocycloaddition of alkene-tethered coumarins 
  
Section Three: Results and Discussion 
Flow Photochemical Platform 
 
 
 The flow reactor developed in the Beeler lab for the investigation of photochemical 
reactions employs a unique cone shape reactor which also allows for uniform irradiation 
by a collimated beam of light and efficient cooling through the circulation of chilled 
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ethylene glycol throughout the interior of the cone (Figure 13). The reaction mixture is 
pushed through FEP (fluorinated ethylene propylene) tubing via a syringe pump. 
 
 
Figure 13. Custom cone reactor for optimization of photochemical reactions 
 
Preliminary Uncatalyzed Studies 
 
 The absorption spectra of methyl cinnamate confirmed that the λmax of methyl 
cinnamate (140) was 270 nm with absorption tapering off to about 330 nm. Initial studies 
investigated the effects of UV filters and lamp power on percent conversion to cyclobutane 
products (141 and 142) in photodimerization. Long-pass filters resulting in wavelengths 
>370 nm, >320 nm, >305 nm, and >200 nm (no filter) were investigated and the results are 
outlined in Table 1 (entries 1-4). It was found that irradiation >305 nm was optimal filter 
for maximum conversion. The two major cyclobutane products were identified to be the 
𝛿 (𝟏𝟒𝟏)and 𝛽(𝟏𝟒𝟐)  head- to- head dimers. Varying lamp power from 200 W to the 
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maximum power, 500 W, showed a linear increase in conversion (Table 1, entries 2, 5-7). 
Finally, the effect of temperature variations from 0-40 o C (Table 1, entries 2, 8-10) was 
also examined, which proved to be negligible, although, decreasing the temperature did 
seem to improve reactivity slightly.  
 
 
Entry Temp. 
(oC) 
Power 
(W) 
Wavelength 
(nm) 
Conv.[b] d.r. 
(δ:β)[c] 
1 15 500 no filter 20% 1:1 
2 15 500 >305 24% 1:1 
3 15 500 >320 16% 1:1 
4 15 500 >370 3% 1:1 
5 15 200 >305 10% 1:1 
6 15 300 >305 18% 1:1 
7 15 400 >305 21% 1:1 
8 0 500 >305 29% 1:1 
9 5 500 >305 26% 1:1 
10 40 500 >305 21% 1:1 
      
Table 1. Uncatalyzed optimization of wavelength and power [a] Reactions were in the flow reactor with an 
8 h residence time. [b] Conversion was determined by 1H NMR of the crude reaction mixtures. [c] 
Diastereomeric ratio was determined by 1H NMR of the crude reaction mixtures. 
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Hydrogen Bond Catalysis Platform 
 
 With this photodimerization data in hand, thiourea catalysts were then investigated 
due to their well-established ability to act as hydrogen-bonding moiety as aforementioned. 
It was hypothesized that a bis-thiourea catalyst could promote the reaction through the 
hydrogen bonding to two cinnamate monomers simultaneously, mimicking the effect of 
solid-state and templating the reaction. Various bis-thiourea catalysts were synthesized by 
varying the diamine linker while maintaining the Schreiner-type aryl groups on both sides 
(Figure 14).  
Screening of a variety of cyclic and acyclic diamine linkers revealed the 1,2 ortho-
phenylenediamine linker-derived catalyst (143) to be the most effective at catalyzing the 
[2+2] photocycloaddition of methyl cinnamate providing 28% conversion to cyclobutane 
products as compared to 7% without catalyst with a 2 hour residence time (Figure 14). A 
control reaction using the classic Schreiner mono-thiourea 135 was performed to assess 
whether the bis-thiourea was necessary and indeed, the reaction was ineffective and 
comparable to the uncatalyzed reaction. This experiment supports the original hypothesis 
that the catalyst brings together two monomers to facilitate reactivity. Another control 
reaction was performed using a bis-thiourea catalyst composed of the 1,2-orthophenylene 
diamine linker-derived catalyst but lacking the 3,5-bis-trifluoromethyl substitution on the 
phenyl rings (144) to assess the effect of an identical catalyst with reduced hydrogen 
bonding capability, which also gave results comparable to the uncatalyzed reaction.  
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Figure 14. Screening of bis-thiourea catalysts for the [2+2] photocycloaddition of cinnamates 
 
Reaction Optimization and Substrate Scope 
 
Optimization of concentration, catalyst loading, residence time, and solvent 
enabled conversions of up to 75% to cyclobutane products (Scheme 25). The remainder of 
the reaction mixture consisted of a 1:1 mix of E/Z isomers of unreacted cinnamate. Solvents 
included in the screen were MeCN, THF, DCM, toluene, benzene, water, and chloroform 
but MeCN remained superior both in optimizing reactivity and ability to solubilize the 
reactants. Increasing the concentration of the reaction helped reactivity up to a certain point 
(~ 1 M) after which reactivity diminished. This is likely the result of two competing effects, 
increasing concentration promotes dimerization but also diminishes overall photon flux in 
the reaction.  The two major cyclobutane dimers were identified and characterized by 2D 
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NMR to be δ (anti head-to-head) (141), and β (syn head-to-head) (142) product, with the δ 
being the major product at a 3:1 d.r.   
 
 
Scheme 25. Optimized conditions for [2+2] photocycloaddition of methyl cinnamate using bis-thiourea 143 
and crystal structure of β 3,4,5 trimethoxy methyl cinnamate dimer  
 
 Upon arriving at the optimized conditions, the substrate scope of the reaction was 
explored (Figure 15). Cinnamates were subjected to both batch conditions and flow 
conditions with and without catalyst. Electron rich substrates such as ferulic acid methyl 
ester, the methyl 2,3,4-trimethoxy cinnamate, and methyl 3,4-methylenedioxy cinnamate 
readily performed the photocycloaddition under the optimized conditions to provide 
products 145, 148, and 149. The 3,4,5-trimethoxy methyl ester substrate also readily 
underwent the cycloaddition and a crystal structure of the β diastereomer (152) further 
confirmed the stereochemistry of this product. 
 Electron poor substrates such as methyl meta-fluoro cinnamate, para bromo ethyl 
cinnamate, and ethyl para-nitro cinnamate also were also successful in providing 
cyclobutane dimers (146, 146, 150) under the optimized conditions. Although para-nitro 
cinnamate is known to be reactive even without catalyst, a difference in selectivity with the 
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catalyst is observed (150).156 Batch reactions generally showed lower conversions and 
different selectivities, which could possibly be attributed to differences in heat transfer.  
 
             x-ray 
Figure 15. Substrate scope of optimized [2+2] photocycloaddition of cinnamates with bis-thiourea 143 
 
Progress Toward Asymmetric Catalysis  
 
 The next objective was rendering the reaction asymmetric through the use of chiral 
derivatives of our catalyst. Of note is that only one of the observed diastereomers is chiral, 
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the δ diastereomer (141), while the other (142) is a meso compound. The first strategy 
tested involved varying the diamine linker to be a chiral diamine (153-158) (Figure 16). 
Some chiral diamines that were utilized included BINAM (153), 1,2-
diphenylethylenediamine (157) and 1,2-trans-cyclohexyldiamine (158). The efficacy of the 
catalysts was tested using the optimized conditions with 8 hours residence time and 10 
mol% loading.  
 Although the unsubstituted BINAM-derived catalyst (153) gave 60% conversion to 
the two diastereomers at a 3:1 d.r., similar to the original catalyst, no enantiomeric excess 
(ee) was observed by chiral HPLC. Other variations included the reduced BINAM 
derivative 154, which also gave good conversion to the two diastereomers but once again, 
with no ee. Brominated derivatives 155 and 156 both dropped conversions to 27 and 15% 
while also providing no enantioselectivity. Photoracemization was considered as a possible 
explanation for the lack of observed enantioselectivity as BINOL moieties are known to 
undergo photoracemization through an Excited State Proton Transfer (ESPT) 
mechanism.157 ,158  However, upon thorough examination of the literature BINAM and 
atropisomeric thioureas were shown to be thermally and photochemically stable even after 
prolonged UV irradiation of 4 hours.6,159,160  Finally, the trans, 1,2-diphenyldiamine 157 
and trans-1,2-cyclohexyldiamine 158 derived catalysts gave similarly low conversions.  
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Figure 16. Chiral catalyst screening: use of chiral diamine linker 
 
 The next approach involved using Jacobsen’s so-called ‘half-Schreiner’ 
monothiourea type of catalysts (159-167). These catalysts resembled the original ortho-
phenylenediamine-derived catalyst but in place of the second Schreiner thiourea moiety 
was a chiral functionality (Figure 17). It was hoped that the amide functionality would 
participate in the desired hydrogen-bonding reaction to promote reactivity. Boc-Protected 
derivatives were used in hopes that the bulky boc group would contribute to the 
enantioselectivity. Some derivatives synthesized included the boc-protected phenyl 
alanine, alanine, t-butyl-leucine, and proline-derived catalysts. Unfortunately, none of 
these catalysts gave any enantioselectivity and all displayed very low conversions to the 
cyclobutane products, comparable to the uncatalyzed control. Low conversions were 
attributed to the loss of the second strong hydrogen bonding moiety in the original catalyst.  
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 It was postulated that conversions may be enhanced by adding additional electron 
withdrawing substituents such as fluorines and trifluoromethyl groups to the ortho-
phenylenediamine core (catalysts 163, 166, 167, Figure 17). Although slightly higher 
conversions were indeed observed (21-36%), again, no enantioselectivity was obtained. 
Another variation of these catalysts involved adding a second chiral functionality to the 
catalyst by conjugating a dipeptide as the side chain (164, 167). This strategy was also 
ineffective in promoting enantioselectivity, although fair conversions of 31 and 37% 
conversion were observed.  
 
Figure 17. Chiral catalyst screening: half-Schreiner mono-thiourea with chiral side chain 
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 The inability to achieve enantioselectivity using monothioureas strengthened the 
original hypothesis that a bis-thiourea catalyst was crucial to imparting reactivity through 
the templating of two monomers. The next strategy leveraged the projected requirement of 
a bis-thiourea catalyst but maintaining the Schreiner functionality on one side and a chiral 
thiourea on the other side. These catalysts were synthesized via chiral isothiocyanates 
(Figure 18). Phenylalanine derived isothiocyanate was successfully synthesized in good 
yield according to a known procedure. 161  Using this isothiocyanate, catalyst 168 was 
synthesized. Unfortunately, under the screening conditions a conversion of 34% was 
observed but with no enantioselectivity. With the phenylalanine-derived isothiocyanate in 
hand, bis-thiourea catalyst 169 was also synthesized, conjugated to two equivalents of the 
chiral isothiocyanate but not surprisingly, without the Schreiner functionality, conversion 
was extremely low.  
 
Figure 18. Chiral catalyst screening: chiral bis-thiourea catalysts via chiral isothiocyanates 
 
 Through a collaboration with Professor List’s group at the Max Plank Institute in 
Mulheim, Germany, a final approach toward asymmetric catalysis was tested. The group’s 
asymmetric chiral counterion directed catalysis (ACDC) approach had shown success with 
cinnamate derivatives in an asymmetric Diels Alder reaction.162 The strategy included a 
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chiral Brønsted acid component (170) that generates the chiral counterion (171) in-situ as 
well as a Lewis acid component (172) that interacts with the cinnamate substrate generating 
a silylium cation (173) which interacts with the chiral anion in the chirality generating step 
(174) to yield chiral products (175) (Scheme 26). More recently, the List group has 
published another example of this catalysis with unprotected cinnamates to perform an 
asymmetric Michael addition asymmetrically with their catalyst system.163  
 
Scheme 26. ACDC catalysis for the asymmetric Diels Alder reaction  
 
 To begin investigating the viability of this catalyst system for the reaction, 
triflimide (176), the racemic variation of the Brønsted Acid component and TMS 
allylsilane (177) the silylating reagent, were used (Scheme 27). Initial studies carried out 
in batch showed severe decomposition and reaction stalling at 35% conversion even upon 
addition of catalyst at hourly increments for 8 hours. Similar results were observed when 
triflimide was kept constant and more of the silylating reagent was used. Switching to flow 
conditions circumvented these issues and allowed for full conversion of the starting 
material in 2.5 hours (Scheme 27). Unfortunately, the reaction was messy and led to 
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unidentifiable side products. Additionally, the δ diastereomer was no longer observed 
which was concerning as only the δ diastereomer is chiral. Examination of the crude NMR 
indicated that the α diastereomer, previously observed in trace amounts, may have been 
enhanced. Attempts to isolate this product failed. 
 
Scheme 27. Optimization with achiral triflimide Brønsted acid 
 
 Although not entirely successful with the achiral model system, the chiral iDPI 
catalysts provided by the List group (178, 179) were next investigated. Two different iDPI 
catalysts were tested, one with Schreiner-type aryl side chains, (178) and one with bulkier 
9,9-dimethylfluorene side chains 179. Using catalyst 178 with TMS-allylsilane (175) as 
the silylating reagent and a 5 hour residence time we observed high conversion to 
cyclobutane products of 71% (Table 2). Interestingly, the chiral catalysts did not suppress 
δ diastereomer formation as did the triflimide. Unfortunately, no enantioselectivity was 
obtained despite efficient catalysis of the reaction. The bulkier catalyst 179 tended to give 
lower conversions to products and no enantioselectivity. 
 Next, different silylating reagents were screened in hopes that this would favorably 
change the complexation of the ion pair and facilitate enantioselectivity (Table 2). 
Unfortunately, TIPS-allylsilane, TBS-allylsilane, triphenylallylsilane, and TMS-
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methallylsilane all failed to afford enantioselectivity while also providing generally lower 
conversions.  
 
 
catalyst Silylating reagent tR (h) Conversion(%) ee 
178 TMSallylsilane  2.5 30 0 
178 TMSallylsilane 5 71 0 
179 TIPSallylsilane 3 38 0 
178 TIPSallylsilane 3 57 0 
179 Si(Ph)3allylsilane 3 25 0 
178 Si(Ph)3allylsilane 3 43 0 
178 TMSmethallylsilane 3 37 0 
178 TBSallylsilane 3 49 0 
Table 2: Screening of ACDC catalysts for the [2+2] photocycloaddition of cinnamates 
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Mechanistic Studies 
 
 
 Mechanistic studies began with experiments to define the involvement of hydrogen 
bonding between the catalyst 143 and methyl cinnamate.  An 1H NMR study was 
performed comparing the N-H peaks of the bis-thiourea catalyst with and without the 
substrate (Figure 19). In the absence of methyl cinnamate, the N-H peaks on the catalyst 
were broadened, indicating intermediate exchange of the protons. Upon addition of methyl 
cinnamate to the sample, an obvious sharpening of the N-H peaks was observed, indicating 
a slowing of the exchange of the N-H peaks which is indicative of their participation in a 
strong hydrogen bond.  
 
Figure 19. 1H NMR study in acetone d-6 comparing rate of exchange of catalyst N-H peaks 
 
Additionally, a NOESY experiment was performed on a sample containing both 
catalyst and substrate at a 1:2 stoichiometric ratio respectively (Figure 20). Indeed, 
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through-space interactions were observed between methyl cinnamate’s methoxy group and 
the N-H peaks on the catalyst, one of methyl cinnamate’s vinylic protons and both the 
catalyst N-H peaks as well an aromatic peak, and finally one of methyl cinnamate’s 
aromatic protons and an aromatic peak on the catalyst. All of these interactions indicate a 
proximity and complexation between the catalyst and the substrate which bolsters the 
proposed mechanism of hydrogen-bonding templating aiding the reactivity.  
 
 
 
Figure 20. NOESY experiment to establish substrate catalyst proximity through space 
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Computational modeling was also performed with a required parameter of the 4 Å 
distance between the two substrates to evaluate the reactive complexes that would lead to 
both the major and the minor diastereomer (Figure 21). The model suggested that that π- 
stacking effects may be contributing to the stabilization of the reactive complex leading to 
the major diastereomer.  
 
Figure 21. Computational modeling of catalyst substrate interactions leading to major (left) and minor 
products (right)  
 
 A major question regarding the function of the catalyst is whether it might function 
as a triplet sensitizer. As mentioned earlier, the absorption characteristics of both the 
catalyst and methyl cinnamate were obtained by UV-Vis Spectroscopy. Both methyl 
cinnamte and the bis-thiourea catalyst possess a λmax value of ~270 nm (Figure 22). 
However, the catalyst possesses a broader absorption peak, continuing to absorb nearly 
into the visible light region. With this knowledge, different UV filters ranging from 
>220nm up to >370 nm were tested (Table 3). Notably at >370 nm, the reactivity cuts off 
dramatically to 16% conversion compared to 76% with the >305 nm. Given that the catalyst 
still absorbs significantly at >370 nm, this is evidence against a mechanism involving 
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sensitization by the catalyst. Although, it is important to note that this could also be a result 
of decreased excitation due to a decrease in the irradiation of the absorbance band of the 
catalyst.  
 
 
Figure 22. Absorption spectra of methyl cinnamate and catalyst 
 
 
Power 
(W) 
Wavelength 
(nm) Reactor 
Conv. 
[a] d.r. (δ:β)
 [b] 
500 no filter Flow 72% 3:1 
500 >305 Flow 76% 3:1 
500 >320 Flow 59% 3:1 
500 >370 Flow 16% 1:1 
500 >305 Batch 40% 2:1 
Table 3. Catalyzed optimization of wavelength and power[a] Conversion was determined by 1H NMR of the 
crude reaction mixtures. [b] Diastereomeric ratio was determined by 1H NMR of the crude reaction 
mixtures. 
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 The possibility of a retro [2+2] was investigated as a thermodynamic equilibration 
could explain the relatively low diastereoselectivity of the catalyzed reactions. Thus, the 
cycloreversion was examined on select purified cyclobutane dimers with varying 
substituents of the aryl ring. Both diastereomers (δ and β) were subjected to the optimized 
conditions in the cone reactor with and without catalyst. The three substrates chosen to 
undergo testing were the methyl cinnamate dimers (141,142) as an electronically neutral 
substrate, the methyl m-fluoro cinnamate dimers (146a, 146b) as an electronically poor 
substrate (Scheme 28) and the methyl 3,4,5-trimethoxy cinnamate dimer (152a, 152b) as 
an electronically rich substrate (Scheme 29). Interestingly, the β-methyl-3,4,5-trimethoxy-
cinnamate dimer (152b) was the only dimer that reverted back to starting material, both 
with and without catalyst, although slightly more with catalyst.  
 
 
Scheme 28. Reversibility studies of δ and β methyl cinnamate dimers 
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Scheme 29. Reversibility studies of δ and β 3,4,5-trimethoxyc-methyl-cinnamate dimers 
 
 
Proposed Mechanism and Stereochemical Models 
 
 
 There have been conflicting statements in the literature over the mechanism of the 
[2+2] photocycloaddition of cinnamic acid derivatives. Ishigami and coworkers studied the 
photodimerization of nitro-substituted cinnamates and performed quenching studies. They 
observed selective quenching of the formation of the δ-diastereomer using triplet quenchers 
but not the β diastereomer. This led them to conclude that δ-diastereomer formation was 
triplet-state mediated and β-isomer formation was singlet state mediated.92 The 
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aforementioned study by Lewis and coworkers investigated the impact of Lewis acids on 
the photodimerization of cinnamates (Chapter 1, Scheme 6) various dimers were observed 
including those formed from the direct dimerization of Z monomers. Thus, they propose a 
singlet concerted pathway.164 Another study performed DFT calculations that predicted the 
1,4 triplet diradical intermediate leading to the δ and the β-diastereomers had the lowest 
energies.165  Another study probing the photophysical parameters of methyl cinnamate 
found that methyl cinnamate has an extremely short fluorescence lifetime through the 
lowest π-π* transition of <3 ps and that intersystem crossing to the triplet state was 
extremely inefficient which they claim explains to the lack of dimerization.166 
 With regards to the photophysical effect of the bis-thiourea catalyst on reactivity, 
Sivaguru and coworkers performed detailed photophysical studies on the reaction of 
alkenes with coumarins catalyzed by a thiourea.167 They found that a thiourea catalyst 
changed the absorption characteristics of the coumarin, promoted inter-system crossing to 
the triplet state, and prolonged the triplet lifetimes. Given the structural similarity of 
coumarins to esters, it is reasonable to extrapolate a similar effect in this system.  
 Experimentally, NMR studies described earlier provide evidence of hydrogen 
bonding of the catalyst with at least one of the monomers. Catalyst control studies and 
computational modeling also suggest templating of the two monomers. Given that dimers 
arising from the direct dimerization of the Z monomer are not observed, 
photocycloaddition is believed to occur through a stepwise triplet diradical pathway that 
allows for equilibration of the intermediates.  
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To further investigate whether a triplet mechanism was at play, triplet sensitization 
and quenching experiments were performed. An array of triplet sensitizers and quenchers 
were selected surveying a wide range of triplet energies and screened to assess whether 
sensitization or quenching was occurring (Table 4). Methyl cinnamate was irradiated under 
optimized conditions with 7 mol% of the bis-thiourea catalyst, 2 hours residence time with 
10 mol% of a quencher or sensitizer added. Of all the sensitizers and quenchers tested, only 
pyrene showed any effect, inhibiting reactivity to background uncatalyzed levels (entry 6). 
This quenching effect is consistent with the favorable energy transfer from methyl 
cinnamate which possesses a triplet energy of 54.8 kcal/mol168 to pyrene with a triplet 
energy of 48.3 kcal/mol. The quenching effect of pyrene is also seen in the change in E/Z 
isomerization, which is usually ~1:1 in most cases, to 5:1 E/Z.  
 
 
Entry Quencher/ 
Sensitizer 
tR 
(h) 
mol % 
quencher 
mol % 
bis-
thiourea 
Et 
(kcal/mol) 
% 
Conversion to 
cyclobutanes 
d.r. 
δ:β 
d.r. 
E/Z 
1 none 8 n/a 0 N/A 19% 1:1 1:1 
2 none 8 n/a 7 N/A 75% 3:1 1:1 
3 p-
dichlorobenzene 
2 10 7 80.1 21% 2:1 1:1 
4 benzophenone 2 10 7 69.3 20% 2:1 1:1 
5 2,5-dimethyl-
2,4-hexadiene 
2 10 7 59.0 19% 2:1 1:1 
6 pyrene 2 10 7 48.3 <10% 1:1 5:1 
7 anthracin 2 10 7 42.5 23% 2:1 1:1 
8 pyrene 8 10 7 48.3 19% 1:1 4:1 
9 Pyrene  8 10 0 48.3 10% 1:1 8:6 
Table 4. Triplet quenching/sensitization experiments 
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After this result, the effect pyrene had when the full 8 hour residence time was used 
both with and without the bis-thiourea catalyst was of interest (entry 8 and 9). The effect 
of quencher amount was also examined (Figure 23).  As expected, decreasing amounts of 
pyrene added resulted in a linear increase in conversion up to 60% conversion at 0.5 mol%. 
These data all provide evidence for a triplet-based diradical mechanism. 
 
 
 
 
Figure 23. Concentration dependent pyrene quenching 
 
 
Based on the experimental evidence collected and literature findings mentioned 
above, the following catalytic cycle shown in Scheme 30 was proposed.  First, two 
monomers (either E, Z, or one of each) form a hydrogen bound complex with the two 
thiourea moieties on the catalyst (180). Upon UV excitation of one of the monomers 
through the lowest π- π* transition, a 1,2 diradical (181) is formed which is stabilized by 
the catalyst, thereby prolonging the triplet lifetime. Through the extension of the triplet 
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radical lifetime and the proximity of the neighboring monomer from hydrogen bond 
templating, the radical can add to the π bond on the neighboring monomer, forming the 
more stable 1,4-diradical (182) in which both radicals reside at the resonance-stabilized 
benzylic position. At this point, the diradical undergoes a conformational equilibration to 
the two most stable stereochemical conformations, spin inversion, and C-C bond formation 
which provides the two observed products after de-complexation from the catalyst.  
 
 
Scheme 30. Proposed mechanism of the [2+2] photocycloaddition of cinnamates with bis-thiourea 143 
 
 
To explain the two major stereochemical products of the reaction, the following 
conformational models are proposed. Given the proposed involvement of a key 1,4- 
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diradical, a Curtin Hammett scenario can arise wherein the conformational isomers can 
rapidly equilibrate and the product ratio depends not only on the energy difference of the 
diradical intermediates but also the energy barrier which leads to irreversible (in most 
cases) product formation. In the case of head to head dimerization occurring via a 1,4-
diradical, there are six possible conformational isomers (141, 142, 183-186) which would 
all lead to different truxinic ester products upon radical combination and ring closure. In 
addition to the effect of the catalyst on stabilization of the isomers as mentioned earlier, 
stability of the 1,4 diradical intermediates was considered.   
All six conformations seem similarly strained, all possessing two gauche 
interactions between the methyl ester and the aryl group (Scheme 31). One could argue 
that the β- (142), ω- (183), and neo- isomers (186) are slightly more sterically strained than 
the others as a result of a slightly more significant steric effect between the neighboring 
hydrogens. However, when considering the transition state involving rotation and ring 
closure, it becomes more apparent why the β (142) and δ (141) diastereomers are favored. 
The bond rotation that occurs during the ring closure step, in all cases except the δ and β, 
results in eclipsing interactions between the largest functional groups (one interaction in 
the ζ (185) and neo (186) diastereomers or two interactions in the  (ω (183) and µ (184) 
diastereomers). In the case of the β diastereomer (142), a slight steric strain may be starting 
to develop as the two phenyl groups start to rotate towards each other in the transition state 
for ring closure, which could explain why the δ-diastereomer (141) is slightly favored in 
most cases.  
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Scheme 31. Conformational analysis of 1,4 diradical intermediates for diastereomeric selectivity 
  
 
Section Four: Conclusions 
 
In summary, an efficient methodology for the dimerization of cinnamic esters has 
been developed. Two platforms were utilized to accomplish this, a flow photochemical 
platform and a hydrogen bonding catalysis platform. A novel cone flow photochemical 
reactor enables efficient irradiation as well as control of both UV wavelength and 
temperature. A bis-thiourea catalyst was shown to enhance the efficiency and 
regioselectivity of the dimerization, most likely through templating and enhanced 
intersystem-crossing to the triplet state as well as extending of the triplet lifetime. The 
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reaction was shown to be compatible with a broad range of cinnamic ester substrates 
including electron rich and electron poor aryl groups as well as unprotected phenolic 
substrates present in various NPs. To date, attempts to achieve any level of asymmetry in 
the cycloaddition have been unsuccessful. 
 
Section Five: Experimental Methods and Analytical Data 
 
General Procedure A for Synthesis of Methyl Esters 
 
 
 
To a solution of carboxylic acid (25 g) in methanol (0.1 M), was added concentrated 
sulfuric acid (5 mol %).  The reaction was refluxed for 12 hours. Upon completion of the 
reaction by TLC, methanol was removed in vacuo and the crude mixture was dissolved in 
ethyl acetate 500 mL. The mixture was washed with a saturated sodium bicarbonate 
solution (250 mL x 3) and brine (250mL). The organic layer was dried over anhydrous 
Na2SO4 and concentrated in vacuo and was sufficiently pure to use in the next step.  
 
General Procedure of Synthesis of bis-thiourea Catalysts (143, 151-156) 
 
To a solution of diamine in ethanol (0.125M), was slowly added the appropriate 
isothiocyanate (2 eq) at room temperature. The reaction mixture was stirred at room 
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temperature until the diamine was consumed. The mixture was concentrated in vacuo and 
the resulting mixture was purified by column chromatography 
 
143: Rf = (50% EtOAc in Hexane): 0.74, IR (thin film): ν 
= 3331, 2473, 2242, 2222, 2072, 1522, 1473, 1378, 1278, 
1196, 1182, 1123, 973, 887, 848, 825, 774, 701, 682; 1H 
NMR (500 MHz, CD3OD): δ= 8.17 (s, 4H), 7.65 ( s, 2 H), 7.51 (m, 2 H), 7.40 (m, 2 H); 
13C NMR (125 MHz, CD3OD):  δ= 181.0, 141.3, 134.1, 131.2 (q), 128.4, 127.6, 126.4, 
124.3, 123.3, 122.1, 119.9, 117.4; HRMS: Calc. for: C24H14F12N4S2 [M+H]
+= 651.0547  
m/z, found: 651.0547 m/z. 
 
 
To a stirring solution of mono-boc-protected aniline in DCM at room temperature is slowly 
added 1.1 equivalents of (bis-3,5-trifluoromethyl)phenyl isothiocyanate. The reaction is 
monitored by TLC until consumption of the aniline starting material is observed (about 12 
hours). Upon completion of the reaction the reaction mixture is concentrated in vacuo and 
purified by column chromatography.  
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 187: IR (thin film): ν = 3266, 2982, 1669, 1517, 1455, 1382, 1277, 
1173, 1134, 734; 1H NMR (500 MHz, CDCl3): δ= 7.87 (s, 2H), 
7.62 (d, J= 8.3 Hz, 1H), 7.52 (s, 1 H), 7.40 (d, J= 8.3 Hz, 1H), 7.27 
(m, 1 H), 7.19 (m, 1 H), 7.10-6.99 (ovrlp, 2H), 6.79 (s, 1 H), 1.50 (s, 9 H); 13C NMR (125 
MHz, CD3OD):  δ=154.9, 153.8, 147.5, 141.6, 131.7 (q), 126.6, 125.2, 124.7, 124.5, 124.2, 
122.3, 117.9, 114.6, 110.0, 80.1, 27.2; HRMS: Calc. for: C20H19F6N3O2S [M+H]
+= 
502.1000  m/z, found: 502.1016 m/z 
 
 
Dissolve substrate in 10% TFA/DCM, monitor by TLC to consumption of starting material 
(about 1 hour). If the free amine is desired, the reaction mixture is poured into a separatory 
funnel containing ethyl acetate and saturated sodium bicarbonate and extracted with EtOAc 
(x3). The combined organic layers and washed with brine (x1) and dried over anhydrous 
Na2SO4. Product was sufficiently pure for use in the subsequent step. Note: the amine was 
characterized as the TFA salt obtained before workup. 
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188: IR (thin film): ν = 1660, 1559, 1472, 1375, 1278, 1171, 1128, 
904, ; 1H NMR (500 MHz, CD3OD): δ=8.14 (s, 2 H), 7.58 (s, 1 H), 
6.44-7.34 (ovrlp, 4 H); 13C NMR (125 MHz, CD3OD):  δ= 160.3, 
154.2, 141.3, 132.2, 131.8 (q), 129.3, 126.5, 125.7, 124.4, 123.8, 
122.3, 118.4, 115.1, ; HRMS: Calc. for:  [M+TFA]=
 402.0476  m/z, found: 402.0475 m/z 
 
General Procedure for Preparation of ‘Half-Schreiner’ Monothiourea Catalysts (157-
165) 
 
The Boc-protected amino acid was dissolved in dry Acetonitrile (0.1 M) with stirring. O-
(7-Azabenzotriazole-1-yl)-N,N,N,N’-tetramethyluronium hexafluorophosphate (HATU, 
1.1 eq) was added as a solid and the resulting clear solution was stirred for 10 min at room 
temperature. Amine 193 (1.1 eq) was injected and the resulting yellow solution was stirred 
for 20 min before diisopropylethylamine (DIEA, 2.5 eq) was added by syringe. The 
mixture was stirred for 16 h at room temperature. Upon completion of the reaction, 
acetonitrile was removed in vacuo, ethyl acetate was added, and the resulting solution was 
poured into a separatory funnel. The solution was rinsed with 1 M HCl (x2), Sodium 
Bicarbonate (x 2), and brine (x1). The combined organic layers were dried over anhydrous 
Na2SO4. and concentrated in vacuo. The crude mixture was purified by column 
chromatography.  
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160: IR (thin film): ν = 1684, 1507, 1381, 1278, 1179, 1138, 
1108, 904, 725, 649; 1H NMR (500 MHz, CDCl3): δ= 8.53-8.41 
(ovrlp, 2 H), 8.01 (s, 2 H), 7.63 (s, 1 H), 7.32-7.22 (ovrlp, 9 H), 
5.13 (br s, 1 H), 4.45 (m, 1 H), 3.15-3.01 (ovrlp, 2 H), 1.35 (s, 
9 H); 13C NMR (125 MHz, CDCl3):  δ= 180.6, 158.4, 140.0, 131.9, 131.4, 129.2, 129.0, 
128.0, 127.4, 127.2, 123.9, 118.7, 115.9, 113.2, 111.3, 110.0, 100.8, 97.0, 85.5, 47.9, 38.1, 
28.2 ; HRMS: Calc. for: C29H28F6N4O3S [M+H]
+= 627.1865  m/z, found: 627.1912m/z 
 
165: IR (thin film): ν = 3266, 2982, 1669, 1517, 1455, 1382, 
1277, 1173, 1134, 734; 1H NMR (500 MHz, CD3OD): δ= 
8.68-8.41 (ovrlp, 3 H), 8.05 (s, 2H), 7.64 (s, 1 H), 7.51-7.43, 
7.30-7.23 (ovrlp, 2H), 5.10 (br s, 1 H), 4.25 (m, 1 H), 1.43-1.39 (ovrlp, 12 H); 13C NMR 
(125 MHz, CD3OD):  δ=; HRMS: Calc. for: C23H24F6N4O3S [M+H]+= 551.1552  m/z, 
found: 551.1552 m/z 
 
166: IR (thin film): ν =3246, 2980, 1660, 1471, 1379, 1276, 1125, 
935, 732, 682; 1H NMR (500 MHz, CDCl3): δ= 9.17, 8.72-8.62 
(ovrlp, 2 H), 8.08 (s, 2 H), 7.94 (m, 1 H), 7.72-7.66 (ovrlp 2 H), 7.44 
(d, J= 9.4 Hz, 1 H), 4.40 (t, J= 6.1 Hz, 1 H) 3.56-3.51 (m, 1 H), 3.49-
3.44 (m, 1 H), 2.22-2.16 (ovrlp, 2 H), 2.05-1.9 (ovrlp, 2 H), 1.40 (s, 9 H); 13C NMR (125 
MHz, CDCl3):  δ= 180.4, 173.0, 156.0, 140.0, 134.6, 132.0, 131.7, 131.2, 127.9, 124.4, 
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124.1, 123.5, 123.2, 122.2, 121.9, 118.6, 81.6, 60.5, 47.6, 29.8, 28.3, 24.5; HRMS: Calc. 
for: C26H25F9N4O3S [M+Na]= 667.1401 m/z, found: 667.1376 m/z 
 
 
Prepared according to the referenced procedure.161 To a solution of amino acid ester salt 
(10 mmol) in DCM was added CS2 (11 mmol) followed by Et3N (40 mmol) at 0 °C; the 
mixture was stirred at this temperature for 30 min and then at r.t. for 30 min. The mixture 
was cooled to 0 °C and TsCl (13 mmol) was added. Stirring was continued for 3 h or until 
completion of the reaction (TLC analysis). Excess DCM (2 × 5 mL) was added and the 
organic layer was washed with 10% citric acid solution (2 × 15 mL), water (2 × 10 mL), 
and brine (2 × 10 mL). It was then dried over anhydrous Na2SO4, and concentrated under 
reduced pressure. The resulting crude product was subjected to column chromatography 
(10% EtOAc–hexane) to afford the pure product (87% isolated yield). All spectroscopic 
and analytical data matched the reference.  
 
 Dissolve amine 193 in DCM then slowly add isothiocyanate (1.1 eq). Stir at RT 
until consumption of the amine is observed by TLC. Upon completion of the reaction the 
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reaction mixture is concentrated in vacuo and the resulting mixture is purified by column 
chromatography.  
 
168: IR (thin film): ν =1734, 1522, 1472, 1274, 1171, 1126, 
983, 847, 700, 649, 617; 1H NMR (500 MHz, CDCl3): δ= 
8.91 (br s, 1 H), 8.76 (br s, 1 H), 8.65 (br s, 1 H), 8.04 (s, 2 
H), 7.61 (s, 1 H), 7.47 (d, J= 7.7 Hz, 1 H), 7.30 (dd, J1= 7.7, 
J2= 7.7 Hz, 1 H), 7.25-7.13 (ovrlp, 5 H), 7.01-6.97 (ovrlp, 2 H), 6.86 ( br s, 1 H), 5.19 (m, 
1 H), 3.61 (s, 3 H), 3.17 (m, 1 H), 3.01 (m, 1 H); 13C NMR (125 MHz, CDCl3):  δ= 180.8, 
180.6, 173.1, 139.9, 135.1, 133.2, 132.4, 131.8, 131.5, 129.0, 128.8, 128.6, 128.4, 127.3, 
124.1, 123.9, 121.9, 118.7, 58.5, 52.7, 37.0; HRMS: Calc. for: C26H22F6N4O2S2 [M+H]
+= 
601.1167  m/z, found: 601.1124 m/z 
 
General Experimental Procedure for [2+2] Photocycloaddition of Cinnamates 
 
A solution of cinnamate in acetonitrile (0.8 M) was prepared and 0.07 equivalents of 
catalyst was added. The solution was taken into a syringe and the reaction mixture was 
pushed through the FEP tubing reactor with a syringe pump. An acetonitrile flush was used 
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to push the sample all the way through the tubing at a constant rate (flow rate was 
determined to afford desired residence time based on reactor volume). The crude mixture 
exiting the flow system was collected and concentrated in vacuo.  The crude reaction 
mixture was purified by flash chromatography (SiO2). 
 
141: Purified by flash chromatography using a gradient of 0-20% EtOAc: 
Hexanes. Rf = (20% EtOAc/ Hexanes): 0.5; IR (thin film): 2952, 1729, 
1436, 1278, 1205, 1131, 1031, 995, 754, 698 ; 1H NMR (500 MHz, 
CDCl3):  7.34-7.24 (ovrlp, 10 H), 3.75-3.73 (ovrlp, 8 H), 3.50 (AA’BB’, JAB = 9.6 Hz, 
2H); 13C NMR (125 MHz, CDCl3)  173.0, 140.9, 128.6, 127.1, 126.8, 52.2, 47.3, 44.4.  
 
142: Purified by flash chromatography using a gradient of 0-20% EtOAc: 
Hexanes.  Rf = (20% EtOAc/ Hexanes): 0.39; IR (thin film): 2952, 1731, 
1454, 1278, 1171, 753, 647; 1H NMR (500 MHz, CDCl3):  7.10 (t, J= 
7.2 Hz, 4 H), 7.05 (d, J= 7.2  Hz, 2 H), 6.92 (d, J= 7.2 Hz, 4 H), 4.40 (AA’BB’, JAB = 6.4 
Hz, 2H), 3.85 (AA’BB’, JAB = 6.4 Hz, 2H), 3.75 (s, 6H); 13C NMR (125 MHz, CDCl3)  
172.9, 138.4, 128.0, 127.7, 126.4, 52.2, 44.9, 43.2.  
 
146a: Purified by flash chromatography using a gradient of 0-20% 
EtOAc: Hexanes. Rf = (50% EtOAc/ Hexanes): 0.88; IR (thin film): ν 
=3450, 2954, 2926, 2854, 1736, 1615, 1590, 1490, 1439, 1273, 1213, 
1153, 1036, 871, 785 cm-1, 1H NMR (500 MHz, CDCl3)  7.32-7.27 ( m, 2 H), 7.05 (dd, J 
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=7.5, 1.3 Hz, 2 H), 7.00 (ddd, J =9.8, 4.0, 1.3 Hz, 4 H), 3.76 (s, 6H), 3.70 (AA’BB’, JAB 
=9.7 Hz, 2 H), 3.46 (AA’BB’, JAB =9.7 Hz, 2 H); 13C NMR (125 MHz, CDCl3)  172.5, 
164.0, 162.0, 143.1, 130.3, 122.4, 114.3, 114.2, 113.9, 113.7, 46.8, 44.3; IR (thin 
film)max 3450, 2954, 2926, 2854, 1736, 1615, 1590, 1490, 1439, 1273, 1213, 1153, 1036, 
871, 785 cm-1 ;HRMS Calc. for C20H18F2O4 [M+H]
+= 361.1251 m/z, found: 361.1239 m/z.  
 
146b: Purified by flash chromatography using a gradient of 0-20% 
EtOAc: Hexanes. Rf = (50% EtOAc/ Hexanes): 0.79  IR (thin film): ν 
= max 3450, 2954, 2926, 2854, 1736, 1615, 1590, 1490, 1439, 1273, 
1213, 1153, 1036, 871, 785 cm-1; 1H NMR (500 MHz, CDCl3)  7.10 ( dddd, J =7.8, 5.9, 
0.9,0.4 Hz, 2 H), 6.80- 6.75 ( m, 2H), 6.71 ( dd, J =7.8, 0.4 Hz, 2 H), 6.64 ( dd, J =1.5, 9.8 
Hz, 2 H), 4.39 (AA’BB’, JAB =7.1 Hz, 2 H), 3.80 ( AA’BB’, JAB =7.1 Hz, 2 H), 3.76 ( s, 6 
H) 13C NMR (125 MHz, CDCl3)  172.6, 163.8, 140.9, 129.8, 129.7, 123.5, 114.8, 114.7, 
113.8, 113.6, 52.5, 44.8, 43.3; HRMS Calc. for C20H18F2O4 [M+H]
+= 361.1251 m/z, 
found: 361.1239 m/z.  
 
152a: Purified by flash chromatography using a gradient of 30-60% 
EtOAc: Hexanes. Rf = (50% EtOAc/Hexanes): 0.39 ; IR (thin film): ν 
= 2949, 1728, 1587, 1507, 1457, 1234, 1121, 1006, 647 cm-1; 1H 
NMR (500 MHz, CDCl3):  6.51 (s, 4 H), 3.83 (s, 12 H); 3.82 (s, 6 H), 3.76 (s, 6 H), 3.60 
(AA’BB’, JAB = 10 Hz, 2H), 3.45 (AA’BB’, JAB = 10 Hz, 2H); 13C NMR (125 MHz, 
  
79 
CDCl3):  172.9, 153.3, 137.1, 136.6, 103.8, 60.8, 56.1, 52.2, 47.9, 44.2; HRMS Calc. for 
C26H32O10 [M+H]
+= 505.2074 m/z, found 505.2076 m/z.  
 
152b: Recrystallized from isopropanol. Rf = (50% EtOAc/Hexanes): 
0.32; IR (thin film): ν = 2952, 1772, 1589, 1558, 1127, 731  cm-1; 1 
H NMR (500 MHz, CDCl3): = 6.14 (s, 4 H), 4.29 (AA’BB’, JAB = 
6.2 Hz, 2H), 3.77-3.76 (ovrlp , 8 H), 3.74 (s, 6 H), 3.67 (s, 12 H); 13 
C NMR (125 MHz, CDCl3): = 172.6, 152.9, 136.8, 134.0, 105.3, 60.8, 56.1, 52.2, 45.2, 
43.4 HRMS Calc. for C26H32O10 [M+Na]
+= 527.1853 m/z , found 527.1881 m/z.  
 
145a: Purified by flash chromatography using a gradient of 20-50% 
EtOAc: Hexanes. Rf = (50% EtOAc/Hexanes): 0.67; IR (thin film): ν = 
2951, 2255, 1737, 1505, 1403, 1444, 1357, 1280, 1042, 914, 813, 735 
cm-1; 1H NMR (500 MHz, CDCl3): = 6.78-6.73 (ovrlp, 6 H), 5.94 (s, 4 H), 3.73 (s, 6 H), 
3.54 (AA’BB’, JAB = 9.6 Hz, 2H), 3.37 (AA’BB’, JAB = 9.6 Hz, 2H); 13C NMR (125 MHz, 
CDCl3): = 172.8, 147.9, 146.7, 134.7, 120.0, 108.3, 107.2, 101.0, 52.2, 47.7, 44.6; 
HRMS: Calc. for C22H20O8 [M+H]
+= 412.1236 m/z, found: 413.1224 m/z.  
 
145b: Purified by flash chromatography using a gradient of 20-50% 
EtOAc: Hexanes. Rf = (50% EtOAc/Hexanes): 0.5; IR (thin film): ν = 
2951, 2255, 1737, 1505, 1403, 1444, 1357, 1280, 1042, 914, 813, 735 
cm-1;  1H NMR (500 MHz, CDCl3): = 6.60 (d, J = 8.0 Hz, 2H), 6.43 (dd, J = 8.0, 1.8 Hz, 
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2H), 6.41 (d, J= 1.8 Hz, 2H), 5.85 (s, 4 H), 4.25 (AA’BB’, JAB = 6.1 Hz, 2H), 3.73 (s, 6H), 
3.71 (AA’BB’, JAB = 6.1 Hz, 2H); 13C NMR (125 MHz, CDCl3): = 172.8, 147.5, 146.0, 
132.4, 120.9, 108.2, 107.9, 100.8, 52.2, 44.8, 43.6; HRMS: Calc. for C22H20O8 [M+H]
+= 
412.1236 m/z, found: 413.1220 m/z.  
 
150a: Purified by flash chromatography using a gradient of 10-30% 
EtOAc: Hexanes. Rf = (20% EtOAc/ Hexanes): 0.61; IR (thin film): ν 
= 3438, 2981, 2929, 2854, 1728, 1490, 1445, 1201, 1073, 1011, 909, 
817, 733  cm-1; 1H NMR (125 MHz, CDCl3)  7.45 (4 H, d, J = 8.5 Hz), 7.14 (4 H, d, J 
=8.5 Hz), 4.20 (4 H, q, J = 7.1 Hz), 3.61 (2 H, AA’BB’, JAB =9.6 Hz), 3.38 (2 H, AA’BB’, 
JAB = 9.6 Hz), 1.26 (6 H, t, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3)  172.1, 140.0, 131.8, 
128.5, 121.1, 61.2, 46.6, 44.6, 14.2; HRMS Calc. for C22H22Br2O4: [M+H]
+= 508.9963 
m/z, found: 508.9972 m/z.  
 
150b: Purified by flash chromatography using a gradient of 10-30% 
EtOAc: Hexanes. Rf = (20% EtOAc/ Hexanes): 0.5; IR (thin film): ν 
=3438, 2981, 2929, 2854, 1728, 1490, 1445, 1201, 1073, 1011, 909, 817, 
733  cm-1;  1H NMR (500 MHz, CDCl3)  7.24 ( d, J =8.5 Hz, 4 H), 6.79 ( d, J =8.5 Hz, 4 
H), 4.33 (AA’BB’, JAB =6.1 Hz, 2 H), 4.20 ( q, J = 7.1 Hz, 4 H), 3.73 ( AA’BB’, JAB = 6.1 
Hz, 2 H), 1.28 ( t,  J= 7.1 Hz, 6 H); 13C NMR (125 MHz, CDCl3)  172.0, 137.4, 131.3, 
129.4, 120.5, 61.2, 44.2, 43.4, 14.2; HRMS Calc. for C22H22Br2O4: [M+H]
+= 508.9963 
m/z, found: 508.9971 m/z.  
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148a: Purified by flash chromatography using a gradient of 30-60% 
EtOAc: Hexanes.  Rf = (50% EtOAc/Hexanes): 0.36; IR (thin film): 
ν = 3434, 2953, 2847, 2255, 1726, 1603, 2255, 1726, 1603, 1516, 
1436, 1368, 1206, 1125, 1033, 910, 856, 811, 730 cm-1; 1H NMR 
(500 MHz, CDCl3): δ= 6.86 (d, J= 8.0 Hz, 2H), 6.80-6.77 ( ovrlp, 4H), 5.56 (br s, 2 H), 
3.86 (s, 6 H), 3.74 (s, 6 H), 3.56 (AA’BB’, JAB =9.6 Hz, 2 H,), 3.42 (AA’BB’, JAB =9.6 Hz, 
2 H); 13C NMR (125 MHz, CDCl3): δ= 173.1, 146.5, 144.7, 133.0, 119.6, 114.4, 109.3, 
55.9, 52.2, 47.8, 44.5; HRMS: Calc. for C22H24O8 [M+Na]
+= 416.1569 m/z, found: 
439.1375 m/z.  
 
148b: Purified by flash chromatography using a gradient of 30-60% 
EtOAc: Hexanes. Rf = (50% EtOAc/Hexanes): 0.25; IR (thin film): ν 
= 3434, 2953, 2847, 2255, 1726, 1603, 2255, 1726, 1603, 1516, 1436, 
1368, 1206, 1125, 1033, 910, 856, 811, 730 cm-1; 1H NMR (500 
MHz, CDCl3): δ= 6.73 (d J=8.1 Hz, 2H), 6.56 (d, J=8.1 Hz, 2H), 6.23 (s, 2 H), 5.42 (br s, 
2 H), 4.26 (AA’BB’, JAB =6.1 Hz, 2H), 3.75-3.74 (ovrlp, 8H), 3.60 (s, 6 H); 13C NMR (125 
MHz, CDCl3): δ= 173.0, 146.1, 144.2, 130.5, 120.3, 113.8, 111.0, 55.8, 52.2, 44.8, 43.4;  
HRMS: Calc. for C22H24O8 [M+Na]
+= 416.1569 m/z, found: 439.1375 m/z.  
 
 
  
82 
149a: Purified by flash chromatography using a gradient of 30-60% 
EtOAc/ Hexanes. Rf = (50% EtOAc/Hexanes): 0.61; IR (thin film): ν 
= 2953, 2913, 2835, 1739, 1602, 1497, 1466, 1436, 1273, 1208, 1102, 
1016, 913, 798, 736 cm-1; 1H NMR (500 MHz, CDCl3): δ= 7.07 (d, 
J=8.6 Hz, 2H), 6.65 (d, J=8.6 Hz, 2H), 3.97 (AA’BB’, JAB =9.5 Hz, 2H), 3.83 (s, 6 H), 3.82 
(s, 6 H), 3.72 (ovrlp,12 H), 3.36 (AA’BB’, J=9.5 Hz, 2H), 13C NMR (125 MHz, CDCl3): 
δ= 173.3, 152.7, 151.8, 141.8, 126.8, 122.0, 107.2, 60.8, 60.7, 56.0, 51.9, 45.2, 41.3, 
HRMS: Calc. for C26H32O10  [M+Na]
+= 527.2074 m/z, found: 527.1893 m/z.  
 
149b: Purified by flash chromatography using a gradient of 30-60% 
EtOAc: Hexanes. Rf = (50% EtOAc/Hexanes): 0.5; IR (thin film): ν 
= 2953, 2913, 2835, 1739, 1602, 1497, 1466, 1436, 1273, 1208, 1102, 
1016, 913, 798, 736 cm-1;  1H NMR (500 MHz, CDCl3): δ= 6.60 (d, 
J=8.6 Hz, 2H), 6.44 (d, J=8.6 Hz, 2H), 4.55 (AA’BB’, JAB =6.5 Hz, 2H), 3.76 (s, 6 H), 
3.75-3.73 (ovrlp, 8 H), 3.70 (s, 6 H), 3.64 (s, 6 H);13C NMR (125 MHz, CDCl3): δ= 173.3, 
152.3, 141.7, 125.1, 121.9, 110.0, 106.1, 60.48, 60.46, 55.9, 52.0, 43.4, 39.2  ; HRMS: 
Calc. for C26H32O10 [M+Na]
+= 527.2074 m/z, found: 527.1893 m/z.  
 
147a: Purified by flash chromatography using a gradient of 15% 
EtOAc/ Hexanes;  1H NMR (500 MHz, CDCl3)  8.22 (4 H, d, J = 
8.8 Hz), 7.45 ( 4H, d, J =8.8 Hz), 4.24 (4 H, q, J = 7.2 Hz), 3.86 (2 
H, AA’BB’, JAB = 9.5 Hz), 3.50 (2 H, AA’BB’, JAB= 9.5 Hz), 1.29 (6 H, t, 7.2 Hz); 13C 
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NMR (125 MHz, CDCl3)  171.6, 147.4, 147.3, 127.7, 124.2, 61.6, 46.3, 44.6, 14.2; IR 
(thin film) max 3450, 2925, 2854, 1730, 1604, 1522, 1497, 1348, 1228, 1110, 1016, 913, 
855, 734 cm-1; HRMS calculated for C22H22N2O8: 442.1454. Found: 443.1454 (M+H) 
 
147b: Purified by flash chromatography using a gradient of 15% 
EtOAc/ Hexanes;  1H NMR (500 MHz) 8.01 (4 H, d, J =8.9 Hz), 
7.11 (4H, d, J =8.9 Hz), 4.57 (2 H, AA’BB’, JAB =6.1 Hz), 4.24 (4 
H, q, J =7.2 Hz), 3.86 (2 H, AA’BB’, JAB =6.1 Hz), 1.30 (6 H, t, JAB = 7.2 Hz); 13C NMR 
(100 MHz, CDCl3)  171.3, 146.7, 145.5, 128.4, 123.6, 61.5, 44.7, 43.2, 14.2; IR (thin 
film) max 3450, 2925, 2854, 1730, 1604, 1522, 1497, 1348, 1228, 1110, 1016, 913, 855, 
734 cm-1; HRMS calculated for C22H22N2O8: 443.1454. Found: 443.1440 (M+H) 
 
151a: 1H NMR Purified by flash chromatography using a gradient of 
15% EtOAc/ Hexanes;   (500 MHz, CDCl3)   7.35-7.30 (8 H ovrlp), 
7.24 (2 H, m), 5.90 (2H, m), 5.29 (2 H, d, J=  16.4 Hz), 5.22 ( 2 H, d, 
J= 10.8 H z), 4.65 (4 H, d, J= 5.6 Hz), 3.78 (2 H, AA’BB’, JAB= 9.5 Hz), 3.51 (2 H, 
AA’BB’, JAB= 9.5 Hz)  13C NMR (125 MHz, CDCl3)  172.1, 140.9, 131.8, 128.6, 127.1, 
126.8, 118.2, 65.5, 47.1, 44.7 IR (thin film) max 1380, 1159, 1127, 947, 904, 724, 648. 
HRMS calculated for C24H24O4 : 377.1753. Found: 377.1750 (M+H) 
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151b: Purified by flash chromatography using a gradient of 15% 
EtOAc/ Hexanes;   1H NMR (500 MHz, CDCl3) 7.10 (4 H, dd, 
J=7.1,7.1 Hz), 7.05 (2 H, t, J= 7.1 Hz), 6.93 (4 H, d, J=7.1 Hz), 5.92 
(2 H, m), 5.32 (2 H, d, J=16.9 Hz), 5.24 (2 H, d, J= 10.4 Hz), 4.63 (4 H, dd, J= 9.4,5.4 
Hz), 4.42 (2 H, AA’BB’, JAB= 6.3 Hz), 3.88 (2 H, AA’BB’, JAB= 6.3 Hz); 13C NMR (125 
MHz, CDCl3) 172.0, 138.5, 129.4, 128.0, 127.8, 126.3, 110.0, 65.7, 44.9, 43.4; IR (thin 
film) max 1380, 1159, 1127, 947, 904, 724, 648.; HRMS calculated for C24H24O4 : 
377.1753. Found: 377.1751 (M+H) 
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Abstract 
  
Introduction 
Experimental 
Synthesis and crystallization 
Refinement 
Crystal data, data collection and structure refinement details are summarized in Table 1. 
Results and discussion 
Computing details 
Data collection: APEX3 (Bruker, 2016); cell refinement: SAINT (Bruker, 2006); data 
reduction: SADABS (Krause, et al. 2015); program(s) used to solve structure: SHELXT 
(Sheldrick, 2015); program(s) used to refine structure: SHELXL (Sheldrick, 2015); 
molecular graphics: Olex2 (Dolomanov et al., 2009); software used to prepare material 
for publication: Olex2 (Dolomanov et al., 2009). 
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(telmesani1_0ma) 
Crystal data 
 C26H32O10 F(000) = 1072 
Mr = 504.51 Dx = 1.372 Mg m-3 
Monoclinic, P21/c Cu K radiation,  = 1.54178 Å 
a = 13.7996 (6) Å Cell parameters from 9748 reflections 
b = 20.5943 (9) Å  = 3.4–66.6° 
c = 9.0142 (4) Å  = 0.88 mm-1 
 = 107.563 (2)° T = 100 K 
V = 2442.36 (19)  Å3 Prism, colourless 
Z = 4 0.20 × 0.18 × 0.11 mm 
 
Data collection 
 Bruker X8 Proteum-R  
diffractometer 
4322 independent reflections 
Radiation source: rotating anode 4220 reflections with I > 2(I) 
Montel monochromator Rint = 0.044 
 and  scans max = 66.8°, min = 3.4° 
Absorption correction: multi-scan  
SADABS2016/2 (Bruker,2016/2) was used for 
absorption correction. wR2(int) was 0.0645 
before and 0.0562 after correction. The Ratio of 
minimum to maximum transmission is 0.8875. 
The /2 correction factor is Not present. 
h = -1616 
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Tmin = 0.668, Tmax = 0.753 k = -2420 
83190 measured reflections l = -1010 
 
Refinement 
 Refinement on F2 0 restraints 
Least-squares matrix: full Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2(F2)] = 0.035 H-atom parameters constrained 
wR(F2) = 0.084  w = 1/[2(Fo2) + (0.0362P)2 + 1.4428P]   
where P = (Fo2 + 2Fc2)/3 
S = 1.03 (/)max < 0.001 
4322 reflections max = 0.34 e Å-3 
333 parameters min = -0.24 e Å-3 
 
Special details 
 Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated 
using the full covariance matrix.  The cell esds are taken  into account individually in the 
estimation of esds in distances, angles  and torsion angles; correlations between esds in cell 
parameters are only  used when they are defined by crystal symmetry.  An approximate (isotropic)  
treatment of cell esds is used for estimating esds involving l.s. planes. 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2) for (telmesani1_0ma) 
 x y z Uiso*/Ueq 
O1 0.51832 (6) 0.55041 (4) 0.29540 (10) 0.01847 (19) 
O2 0.64520 (6) 0.46080 (4) 0.24354 (10) 0.01865 (19) 
O3 0.59371 (7) 0.33538 (4) 0.21106 (11) 0.0222 (2) 
O10 0.08978 (7) 0.55465 (5) -0.19757 (10) 0.0240 (2) 
O8 0.18496 (8) 0.64827 (4) 0.29758 (11) 0.0259 (2) 
O9 0.12808 (8) 0.65963 (5) -0.01396 (11) 0.0287 (2) 
O7 0.09096 (8) 0.29215 (5) 0.35663 (13) 0.0333 (2) 
O5 0.26577 (7) 0.36925 (5) 0.74990 (10) 0.0253 (2) 
O4 0.33779 (8) 0.29892 (5) 0.62541 (11) 0.0304 (2) 
O6 0.02566 (9) 0.34704 (6) 0.51798 (13) 0.0421 (3) 
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C6 0.37043 (9) 0.40185 (6) 0.30656 (14) 0.0172 (3) 
C8 0.48779 (9) 0.48702 (6) 0.29283 (13) 0.0160 (2) 
C9 0.55345 (9) 0.44149 (6) 0.26052 (13) 0.0159 (2) 
C4 0.52586 (9) 0.37604 (6) 0.24773 (14) 0.0172 (3) 
C10 0.27489 (9) 0.37893 (6) 0.33827 (14) 0.0178 (3) 
H10 0.2718 0.3306 0.3271 0.021* 
C22 0.11791 (9) 0.54296 (7) -0.04132 (14) 0.0192 (3) 
C11 0.25772 (9) 0.39608 (6) 0.49505 (14) 0.0178 (3) 
H11 0.2868 0.4400 0.5298 0.021* 
C5 0.43470 (9) 0.35613 (6) 0.27074 (14) 0.0180 (3) 
H5 0.4164 0.3115 0.2620 0.022* 
C20 0.16466 (9) 0.59182 (6) 0.21391 (15) 0.0194 (3) 
C19 0.17082 (9) 0.53023 (6) 0.27951 (14) 0.0189 (3) 
H19 0.1865 0.5259 0.3891 0.023* 
C18 0.15416 (9) 0.47463 (6) 0.18597 (15) 0.0182 (3) 
C23 0.12739 (9) 0.48144 (6) 0.02523 (15) 0.0190 (3) 
H23 0.1155 0.4440 -0.0393 0.023* 
C12 0.29260 (9) 0.34858 (6) 0.62760 (15) 0.0188 (3) 
C21 0.13785 (10) 0.59867 (6) 0.05200 (15) 0.0201 (3) 
C7 0.39776 (9) 0.46733 (6) 0.31813 (14) 0.0177 (3) 
H7 0.3546 0.4986 0.3434 0.021* 
C15 0.07855 (10) 0.34519 (7) 0.43434 (15) 0.0231 (3) 
C17 0.16446 (9) 0.40694 (6) 0.25347 (14) 0.0192 (3) 
H17 0.1231 0.3751 0.1762 0.023* 
C16 0.14041 (9) 0.40215 (6) 0.41091 (15) 0.0197 (3) 
H16 0.1128 0.4440 0.4374 0.024* 
C1 0.45026 (10) 0.59861 (6) 0.32004 (16) 0.0220 (3) 
H1A 0.3846 0.5950 0.2389 0.033* 
H1B 0.4789 0.6419 0.3158 0.033* 
H1C 0.4406 0.5921 0.4223 0.033* 
C2 0.63525 (10) 0.48204 (7) 0.08798 (15) 0.0225 (3) 
H2A 0.6014 0.4482 0.0140 0.034* 
H2B 0.7028 0.4905 0.0777 0.034* 
H2C 0.5947 0.5219 0.0660 0.034* 
C24 0.08672 (10) 0.50058 (7) -0.29750 (15) 0.0243 (3) 
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H24A 0.0740 0.5159 -0.4046 0.037* 
H24B 0.0321 0.4710 -0.2926 0.037* 
H24C 0.1519 0.4776 -0.2640 0.037* 
C3 0.57318 (11) 0.26745 (6) 0.20978 (17) 0.0264 (3) 
H3A 0.5100 0.2578 0.1274 0.040* 
H3B 0.5661 0.2545 0.3107 0.040* 
H3C 0.6293 0.2433 0.1904 0.040* 
C26 0.21033 (12) 0.64223 (7) 0.46311 (16) 0.0300 (3) 
H26A 0.1535 0.6222 0.4901 0.045* 
H26B 0.2239 0.6853 0.5109 0.045* 
H26C 0.2710 0.6150 0.5016 0.045* 
C25 0.20723 (13) 0.67507 (7) -0.08080 (18) 0.0330 (3) 
H25A 0.2115 0.6409 -0.1543 0.050* 
H25B 0.2722 0.6782 0.0019 0.050* 
H25C 0.1921 0.7167 -0.1357 0.050* 
C14 0.03422 (14) 0.23518 (8) 0.3768 (2) 0.0438 (4) 
H14A 0.0429 0.2005 0.3074 0.066* 
H14B -0.0380 0.2462 0.3518 0.066* 
H14C 0.0595 0.2203 0.4850 0.066* 
C13 0.29404 (13) 0.32797 (8) 0.88512 (17) 0.0365 (4) 
H13A 0.2591 0.2861 0.8598 0.055* 
H13B 0.2745 0.3487 0.9697 0.055* 
H13C 0.3677 0.3210 0.9179 0.055* 
 
Atomic displacement parameters (Å2) for (telmesani1_0ma) 
 U11 U22 U33 U12 U13 U23 
O1 0.0193 (4) 0.0137 (4) 0.0236 (5) -0.0009 (3) 0.0082 (4) 0.0001 (3) 
O2 0.0145 (4) 0.0219 (5) 0.0190 (4) -0.0008 (3) 0.0043 (3) 0.0023 (3) 
O3 0.0217 (5) 0.0166 (4) 0.0308 (5) 0.0014 (4) 0.0116 (4) -0.0029 (4) 
O10 0.0290 (5) 0.0272 (5) 0.0147 (4) 0.0028 (4) 0.0050 (4) 0.0010 (4) 
O8 0.0384 (5) 0.0194 (5) 0.0189 (5) 0.0048 (4) 0.0071 (4) -0.0009 (4) 
O9 0.0424 (6) 0.0208 (5) 0.0242 (5) 0.0115 (4) 0.0120 (4) 0.0057 (4) 
O7 0.0341 (6) 0.0243 (5) 0.0467 (6) -0.0076 (4) 0.0201 (5) 0.0015 (5) 
O5 0.0344 (5) 0.0251 (5) 0.0176 (5) 0.0066 (4) 0.0096 (4) 0.0042 (4) 
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O4 0.0382 (6) 0.0261 (5) 0.0288 (5) 0.0109 (4) 0.0129 (4) 0.0063 (4) 
O6 0.0420 (6) 0.0534 (7) 0.0398 (6) -0.0169 (5) 0.0259 (5) -0.0034 (5) 
C6 0.0183 (6) 0.0189 (6) 0.0145 (6) -0.0006 (5) 0.0051 (5) 0.0003 (5) 
C8 0.0196 (6) 0.0147 (6) 0.0129 (5) -0.0014 (5) 0.0037 (5) 0.0006 (5) 
C9 0.0149 (6) 0.0190 (6) 0.0137 (6) -0.0015 (5) 0.0041 (5) 0.0017 (5) 
C4 0.0200 (6) 0.0173 (6) 0.0144 (6) 0.0023 (5) 0.0051 (5) -0.0010 (5) 
C10 0.0183 (6) 0.0168 (6) 0.0186 (6) -0.0005 (5) 0.0060 (5) 0.0005 (5) 
C22 0.0147 (6) 0.0267 (7) 0.0166 (6) 0.0036 (5) 0.0052 (5) 0.0022 (5) 
C11 0.0165 (6) 0.0185 (6) 0.0184 (6) -0.0003 (5) 0.0054 (5) 0.0009 (5) 
C5 0.0208 (6) 0.0159 (6) 0.0174 (6) -0.0021 (5) 0.0061 (5) -0.0005 (5) 
C20 0.0175 (6) 0.0204 (6) 0.0209 (6) 0.0045 (5) 0.0066 (5) -0.0016 (5) 
C19 0.0167 (6) 0.0239 (7) 0.0163 (6) 0.0026 (5) 0.0054 (5) 0.0018 (5) 
C18 0.0137 (6) 0.0211 (6) 0.0205 (6) 0.0004 (5) 0.0061 (5) 0.0015 (5) 
C23 0.0157 (6) 0.0227 (7) 0.0188 (6) -0.0005 (5) 0.0057 (5) -0.0025 (5) 
C12 0.0146 (6) 0.0207 (7) 0.0202 (6) -0.0017 (5) 0.0041 (5) -0.0012 (5) 
C21 0.0205 (6) 0.0203 (7) 0.0200 (6) 0.0060 (5) 0.0070 (5) 0.0034 (5) 
C7 0.0195 (6) 0.0172 (6) 0.0176 (6) 0.0013 (5) 0.0074 (5) -0.0008 (5) 
C15 0.0167 (6) 0.0308 (8) 0.0199 (6) -0.0019 (5) 0.0026 (5) 0.0064 (5) 
C17 0.0182 (6) 0.0214 (7) 0.0178 (6) -0.0020 (5) 0.0051 (5) -0.0005 (5) 
C16 0.0185 (6) 0.0214 (7) 0.0198 (6) 0.0013 (5) 0.0069 (5) 0.0028 (5) 
C1 0.0232 (6) 0.0158 (6) 0.0276 (7) 0.0019 (5) 0.0085 (5) -0.0011 (5) 
C2 0.0189 (6) 0.0306 (7) 0.0198 (6) -0.0018 (5) 0.0087 (5) 0.0019 (5) 
C24 0.0242 (7) 0.0313 (7) 0.0158 (6) 0.0018 (6) 0.0034 (5) -0.0030 (5) 
C3 0.0281 (7) 0.0160 (6) 0.0368 (8) 0.0025 (5) 0.0126 (6) -0.0025 (6) 
C26 0.0441 (9) 0.0253 (7) 0.0188 (7) 0.0033 (6) 0.0065 (6) -0.0023 (5) 
C25 0.0460 (9) 0.0234 (7) 0.0307 (8) -0.0040 (6) 0.0132 (7) 0.0051 (6) 
C14 0.0454 (10) 0.0327 (9) 0.0546 (11) -0.0185 (7) 0.0172 (8) 0.0037 (8) 
C13 0.0510 (10) 0.0386 (9) 0.0197 (7) 0.0100 (7) 0.0104 (7) 0.0100 (6) 
 
Geometric parameters (Å, º) for (telmesani1_0ma) 
O1—C8 1.3697 (15) C20—C21 1.4004 (18) 
O1—C1 1.4292 (15) C19—H19 0.9500 
O2—C9 1.3790 (14) C19—C18 1.3993 (18) 
O2—C2 1.4354 (15) C18—C23 1.3901 (18) 
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O3—C4 1.3689 (15) C18—C17 1.5104 (17) 
O3—C3 1.4267 (16) C23—H23 0.9500 
O10—C22 1.3647 (15) C7—H7 0.9500 
O10—C24 1.4249 (16) C15—C16 1.5028 (18) 
O8—C20 1.3680 (16) C17—H17 1.0000 
O8—C26 1.4315 (16) C17—C16 1.5551 (17) 
O9—C21 1.3782 (16) C16—H16 1.0000 
O9—C25 1.4332 (18) C1—H1A 0.9800 
O7—C15 1.3362 (18) C1—H1B 0.9800 
O7—C14 1.4523 (18) C1—H1C 0.9800 
O5—C12 1.3342 (16) C2—H2A 0.9800 
O5—C13 1.4400 (17) C2—H2B 0.9800 
O4—C12 1.2010 (16) C2—H2C 0.9800 
O6—C15 1.1978 (17) C24—H24A 0.9800 
C6—C10 1.5066 (17) C24—H24B 0.9800 
C6—C5 1.3965 (18) C24—H24C 0.9800 
C6—C7 1.3958 (18) C3—H3A 0.9800 
C8—C9 1.3944 (18) C3—H3B 0.9800 
C8—C7 1.3895 (18) C3—H3C 0.9800 
C9—C4 1.3960 (18) C26—H26A 0.9800 
C4—C5 1.3969 (18) C26—H26B 0.9800 
C10—H10 1.0000 C26—H26C 0.9800 
C10—C11 1.5428 (17) C25—H25A 0.9800 
C10—C17 1.5926 (17) C25—H25B 0.9800 
C22—C23 1.3911 (19) C25—H25C 0.9800 
C22—C21 1.3998 (19) C14—H14A 0.9800 
C11—H11 1.0000 C14—H14B 0.9800 
C11—C12 1.5063 (17) C14—H14C 0.9800 
C11—C16 1.5717 (17) C13—H13A 0.9800 
C5—H5 0.9500 C13—H13B 0.9800 
C20—C19 1.3912 (18) C13—H13C 0.9800 
    
C8—O1—C1 116.83 (9) O6—C15—C16 122.92 (13) 
C9—O2—C2 112.08 (9) C10—C17—H17 111.1 
C4—O3—C3 116.95 (10) C18—C17—C10 119.19 (10) 
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C22—O10—C24 117.36 (10) C18—C17—H17 111.1 
C20—O8—C26 116.47 (10) C18—C17—C16 113.97 (10) 
C21—O9—C25 113.31 (10) C16—C17—C10 88.61 (9) 
C15—O7—C14 115.81 (12) C16—C17—H17 111.1 
C12—O5—C13 116.05 (11) C11—C16—H16 111.4 
C5—C6—C10 119.06 (11) C15—C16—C11 114.59 (10) 
C7—C6—C10 121.38 (11) C15—C16—C17 117.68 (11) 
C7—C6—C5 119.51 (11) C15—C16—H16 111.4 
O1—C8—C9 115.37 (11) C17—C16—C11 88.46 (9) 
O1—C8—C7 124.12 (11) C17—C16—H16 111.4 
C7—C8—C9 120.50 (11) O1—C1—H1A 109.5 
O2—C9—C8 120.37 (11) O1—C1—H1B 109.5 
O2—C9—C4 120.39 (11) O1—C1—H1C 109.5 
C8—C9—C4 119.23 (11) H1A—C1—H1B 109.5 
O3—C4—C9 114.91 (11) H1A—C1—H1C 109.5 
O3—C4—C5 124.65 (11) H1B—C1—H1C 109.5 
C9—C4—C5 120.44 (11) O2—C2—H2A 109.5 
C6—C10—H10 107.8 O2—C2—H2B 109.5 
C6—C10—C11 119.15 (10) O2—C2—H2C 109.5 
C6—C10—C17 124.11 (10) H2A—C2—H2B 109.5 
C11—C10—H10 107.8 H2A—C2—H2C 109.5 
C11—C10—C17 88.14 (9) H2B—C2—H2C 109.5 
C17—C10—H10 107.8 O10—C24—H24A 109.5 
O10—C22—C23 124.48 (12) O10—C24—H24B 109.5 
O10—C22—C21 114.76 (11) O10—C24—H24C 109.5 
C23—C22—C21 120.76 (11) H24A—C24—H24B 109.5 
C10—C11—H11 109.7 H24A—C24—H24C 109.5 
C10—C11—C16 89.81 (9) H24B—C24—H24C 109.5 
C12—C11—C10 118.51 (10) O3—C3—H3A 109.5 
C12—C11—H11 109.7 O3—C3—H3B 109.5 
C12—C11—C16 118.07 (10) O3—C3—H3C 109.5 
C16—C11—H11 109.7 H3A—C3—H3B 109.5 
C6—C5—C4 119.98 (11) H3A—C3—H3C 109.5 
C6—C5—H5 120.0 H3B—C3—H3C 109.5 
C4—C5—H5 120.0 O8—C26—H26A 109.5 
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O8—C20—C19 124.37 (11) O8—C26—H26B 109.5 
O8—C20—C21 115.77 (11) O8—C26—H26C 109.5 
C19—C20—C21 119.85 (12) H26A—C26—H26B 109.5 
C20—C19—H19 119.6 H26A—C26—H26C 109.5 
C20—C19—C18 120.81 (12) H26B—C26—H26C 109.5 
C18—C19—H19 119.6 O9—C25—H25A 109.5 
C19—C18—C17 122.28 (11) O9—C25—H25B 109.5 
C23—C18—C19 119.29 (12) O9—C25—H25C 109.5 
C23—C18—C17 118.43 (11) H25A—C25—H25B 109.5 
C22—C23—H23 119.9 H25A—C25—H25C 109.5 
C18—C23—C22 120.15 (12) H25B—C25—H25C 109.5 
C18—C23—H23 119.9 O7—C14—H14A 109.5 
O5—C12—C11 110.26 (10) O7—C14—H14B 109.5 
O4—C12—O5 124.07 (12) O7—C14—H14C 109.5 
O4—C12—C11 125.67 (12) H14A—C14—H14B 109.5 
O9—C21—C22 120.75 (11) H14A—C14—H14C 109.5 
O9—C21—C20 120.14 (11) H14B—C14—H14C 109.5 
C22—C21—C20 119.08 (12) O5—C13—H13A 109.5 
C6—C7—H7 119.8 O5—C13—H13B 109.5 
C8—C7—C6 120.30 (11) O5—C13—H13C 109.5 
C8—C7—H7 119.8 H13A—C13—H13B 109.5 
O7—C15—C16 113.34 (11) H13A—C13—H13C 109.5 
O6—C15—O7 123.71 (13) H13B—C13—H13C 109.5 
 
Document origin: publCIF [Westrip, S. P. (2010). J. Apply. Cryst., 43, 920-925]. 
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CHAPTER THREE: Scale Up and Acceleration of [2+2] Photocycloaddition of 
Cinnamates Using Liquid-Liquid Slug Flow 
 
Section One: General Introduction  
 
 As outlined in Chapter 2, one of the major advantages of flow is the ability to 
directly scale up. The major benefit flow photochemistry has over traditional batch 
photochemistry is the consistent UV path length regardless of the scale of the reaction 
(Figure 24). There are three strategies to scale up a reaction in flow: 1) continue to pump 
sample through the reactor until desired scale is reached, 2) increase the reactor volume to 
enable faster flow rates for the same residence time, and 3) use tandem reactors, effectively 
multiplying the reactor volume by the number of reactors.  Herein, is presented two 
strategies to increase the throughput of the optimized [2+2] photocycloaddition in order to 
synthesize multi-gram quantities of the cyclobutane scaffolds. The first utilizes a larger 
reactor in which faster flow rates, and thus greater throughput, can be utilized while 
maintaining the same residence time, while the second approach leverages a novel biphasic 
slug flow methodology.  
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Figure 24. Batch Photochemistry Scale Up versus Flow Photochemical Scale Up 
 
Section Two: Results and Discussion- 2nd Generation Reactor  
 
 Although it would have been possible to continue to flow more sample through the 
original cone reactor until the desired scale was reached, the small reactor volume 
drastically limits the throughput due to the slow flow rates needed to achieve the necessary 
residence time (tR =flow rate/ reactor volume). Thus, the initial strategy for scale up was to 
build a larger reactor that would enable the use of faster flow rates while maintaining the 
same residence time, resulting in a greater throughput. This larger reactor had a volume of 
~ 11 mL compared to the ~2 mL reactor volume of the original cone reactor. It was built 
from readily available materials including metal scaffolding, a computer fan, and a metal 
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halide lamp (GaI3) known to irradiate at the optimal wavelength range for the desired 
cycloaddition (>305nm) for reactivity (Figure 25).  
 
 
Figure 25. Larger photoreactor for scale up of [2+2] photocycloaddition of cinnamates 
 
 To test the effectiveness of the larger reactor, a selection of cinnamates that had 
been run in the original system (145 - 150, 152) as well as new substrates (189 and 190) 
were subjected to the optimized conditions on a 10 gram scale (Scheme 32). Yields in all 
cases were comparable to the original system and increased 24 hour total throughput by 
about 6-fold in most cases.  
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Scheme 32. Substrate scope of the scaled up [2+2] photocycloaddition using 2nd generation photoreactor.  
 
 
Section Three: Introduction and Background- Benefits of Slug Flow  
 
Although the results of the initial scale up using the 2nd generation reactor described 
above were exciting, one of the biggest challenges for increasing the throughput of the 
[2+2] photocycloaddition remained the long residence time required for conversion.  It was 
hypothesized that the reaction rate might be improved by a liquid-liquid slug flow (LLSF) 
regime. 169  Biphasic slug flow has only recently emerged as a strategy to aid photochemical 
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reactions. Most examples utilizing slug flow take advantage of gas-liquid slug flow (GLSF). 
In this strategy a gas phase and a liquid phase are pumped into a T-mixer creating 
alternating gas/ liquid segments within the tubing of a reactor.   
As an example, Seeberger and coworkers utilized GLSF to promote singlet oxygen 
reactions (Scheme 33).170 Using the catalyst TPP, the promoted ene reaction proceeded in 
88% yield. The large interfacial area and improved mass transport generated by this 
biphasic system allowed for high throughput as well as rapid and efficient reactivity due to 
better mixing. Furthermore, the safety of performing these reactions is greatly improved 
using flow chemistry compared with traditional batch chemistry by reducing the 
accumulation of unreacted oxygen.  
 
Scheme 33. Singlet oxygen generation using GLSF 
 
Another creative use of GLSF was in prevention of clogging of the reactor by the 
photodimerization products of maleic anhydride (Scheme 34).171 This photodimerization 
gives rise to cyclobutane tetracarboxylic dianhydride (CBTA), a raw material of polyimide 
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and an alignment film for liquid crystal displays (LCDs).  However, the reaction is 
challenging to scale in batch and was deemed intractable for flow due to precipitation of 
the product leading to clogging of the reactors.   In this example, nitrogen gas slugs, along 
with ultrasonication was used to transport the insoluble photoproducts preventing clogging 
of the reactor and ultimately improving efficiency of the reaction.  A similar example was 
recently reported by Seeberger and coworkers utilizing GLSF to enable heterogeneous 
catalysis.172  
 
Scheme 34. GLSF for photodimerization of maleic anhydride without clogging 
 
To our knowledge the only reports of the use of LLSF for the acceleration of a 
photochemical reaction come from the group of Kakiuchi and coworkers who reported the 
use of a LLSF strategy for improvement of the Paterno-Buchi reaction.173,174 However in 
this case, the reaction was already quite fast (on the order of seconds) and thus there was 
limited possibility for improvement and indeed they observed only a 1.2 to 1.7 fold 
acceleration compared with the single phase reaction.  
Circulatory patterns within LLSF regimes have been well characterized (Figure 
26)175,176,177,178,179 and their effect on mixing and mass transfer has been well established.180 
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Most examples have focused on promoting interphase mass transfer or performing liquid-
liquid extractions.181 It is known that the enclosed slug surrounded by the better-wetting 
solvent is divided in half, parallel to the direction of flow, by a slug axis (Figure 26). A 
stagnant zone with no net movement of solution on either side of the slug axis is surrounded 
by areas of recirculation where the solution circulates around the stagnant zone. Similar 
circulatory patterns are observed in the organic (non-enclosed) slug and these circulations 
are attributed to shearing forces between the two phases. The better-wetting solvent is the 
solvent that interacts more with the tubing, which in the case of FEP tubing (the tubing of 
choice) is the organic solvent. This wetting effect also gives rise to a thin organic film 
which fully or partially surrounds the aqueous slug.  
 
Figure 26. Circulatory patterns within LLSF regimes 
 
Section Four: Results and Discussion- Development of LLSF Methodology 
 
Initial Studies Exploring LLSF 
 
The system designed to investigate the LLSF strategy employed two syringe pumps 
to flow the substrates dissolved in ethyl acetate and; water, which were combined at a T-
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mixer creating the desired slugs (Figure 27). All other parameters such as the reactor, the 
lamp, and the fan were identical to the reactor described for the scale up of cinnamate 
substrates.  
 
 
Figure 27. LLSF setup for [2+2] photocycloaddition of cinnamates 
 
Initial results using methyl cinnamate as the prototypical substrate gave a gratifying 
26% conversion to the previously observed  (141) and  (142) cyclobutanes after only a 
55 minute residence time, compared to 6% in the absence of slugs (Table 5, entries 1 and 
2). The results were even better using the bis-thiourea catalyst (143), affording 43% 
conversion (entry 3).  
To understand the LLSF effect several important control studies were carried out.  
To understand if water was having a direct effect on the reaction, a miscible organic solvent 
solvent (MeCN) was used. Although a slight increase in conversion of 16% was observed 
compared to the non-slug reaction, conversion was still significantly lower than the slug 
flow version of the reaction (entry 4). To probe the possibility of an “on water” effect, the 
impact of substituting H2O for D2O was evaluated (entry 5) and no significant difference 
organic 
slug 
aqueous 
slug 
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was observed. This is contrary to the significant isotope effect witnessed by Sharpless in 
the seminal paper on ‘on-water‘ reactivity182  wherein it was hypothesized that D2O’s 
stronger ‘D-bonds‘ are less likely to break and engage in intermolecular ‘D-bonds‘ with 
other molecules leading to the ‘on-water‘ effect. 183  Lastly, water was replaced by a 
perfluorinated solvent, FC-70, to investigate the impact of switching the better wetting 
phase and thus eliminating the organic thin film (entry 6).184 This experiment led to a drop 
in conversion to 19% compared with 43% when water was the solvent possibly alluding to 
the importance of a thin film effect. 
 
 
Entry Slugs 
(Y/N) 
Catalyst 
(Y/N) 
Conversion 
(%) 
d.r. δ:β 
1 Y N 26 1:1 
2 Na Y 6 1.5:1 
3 Y Y 43 2:1 
4 Nb 
(MeCN) 
Y 16 1.5:1 
5 Yc (D2O) Y 46 2:1 
6 Yd (FC-
70) 
Y 19 2:1 
Table 5. Initial exploration of LLSF for the photocycloaddition of cinnamates. Reactions were run at flow 
rates of 20 μL/ min EtOAc: 180 μL/ min H2O (1:9), tR= 55 minutes unless otherwise specified. % Conversion 
was calculated by 1H NMR integration. a) Only a monophasic ethyl acetate solution was used; b) Acetonitrile, 
a water-miscible solvent was used; c) D2O was used as the aqueous phase; d) FC-70 used instead of H2O. 
 
The reaction was further optimized by evaluating parameters such as residence time 
and aqueous to organic slug size ratio. Residence time had a predictably linear effect on 
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conversion as shown in Figure 28a. Increasing the residence time while maintaining a 1:9 
organic-aqueous ratio, from 37 minutes up to 220 minutes led to conversions of up to 91%.  
However, slug ratio proved to have an even more significant impact than residence time. 
As shown in Figure 28b, as the ratio of aqueous to organic increased, conversion increased 
in a linear fashion from 23% at a 1:1 ratio up to 87% at a 1:10 ratio of organic to aqueous. 
Even doubling the residence time to 220 minutes at a 1:9 ratio (Figure 28a) provided a 
negligible improvement of conversion to 91% when compared to the 1:10 ratio at 110 
minutes which provided 87% conversion (Figure 28b).  
 
 
Figure 28. A) Effect of increasing residence time (achieved by altering total flow rate). All reactions were 
run with methyl cinnamate as substrate and 7 mol% of catalyst 143. B) Effect of changing organic slug size 
while maintaining constant residence time of 110 min. Variation of organic slug size was achieved by altering 
the flow rate ratio of aqueous to organic from 1:1 to 1:10 (50:50 µL/min EtOAc/H2O to 9:91 µL/min 
EtOAc/H2O while maintaining 100 µL/min total net flow rate to maintain consistent tR of 110 min). All 
reactions run with methyl cinnamate as substrate and 7 mol% of catalyst 143.  
 
 
Substrate Scope LLSF Variation 
 
Investigation of substrate scope compared conversions of the substrates using the 
previously described flow conditions with an 8 hour residence time to the slug flow system 
with 110 minutes residence time (Figure 29). In all cases, slug flow provided superior 
conversions in less than a quarter of the time. Both electron rich and poor substrates were 
tolerated as well as phenolic substrates (195 and 196) found in various natural product 
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scaffolds. In some cases a nearly 2-fold increase in conversion was observed as in the case 
of the caffeic acid methyl ester reaction in which we observed 60% conversion to 196 
compared with 35% conversion under previous flow conditions. It is noteworthy that 196 
δ is a natural product isolated from the leaves of Andrographis lineata that has been shown 
to have anti-diabetic properties. 185  Another noteworthy result was the ethyl p-bromo 
cinnamate (150) which showed 59% conversion under slug flow conditions compared with 
40% (8 h) without the application of slug technology.  
 
Figure 29. Substrate scope comparing original [2+2] to LLSF variation. % Isolated yields are shown in 
parentheses adjacent to % conversion determined by 1 H NMR integration 
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[2+2] Photocycloaddition of Cinnamamides using LLSF 
 
The photodimerization of cinnamamides have long been dismissed as unreactive.186 
Given the representation of cinnamamide dimers in bioactive natural products vide supra, 
efficient direct photodimerization of these substrates would be extremely useful for 
exploration of the activity of these natural products. Previous studies have demonstrated 
solid-state photodimerization of three cinnamamide dimers using dicarboxylic acids as 
non-covalent linkers to assist in the co-crystallization of the substrates.187 Another recent 
example of [2+2] photocycloaddition of cinnamamide substrates by Wu and coworkers 
was achieved in solution using an iridium photocatalyst.106 This example only displayed a 
limited scope of cinnamamide dimers all composed of unsubstituted phenyl rings (Figure 
30). Given the presence of electron rich substitution in various truxinic and truxillic amide 
derived natural products, the current methods are limited in scope and still present a 
challenge for exploration of these types of NPs.  
 
Figure 30. Substrate scope of cinnamamide [2+2] by Wu, et. al.  
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With the impressive results using LLSF in hand, photodimerzation of 
cinnamamides was investigated. Gratifyingly, under slug flow conditions, a combined 34% 
yield of the desired cyclobutane products δ- and β- 197 (2:1) was obtained (Figure 31). 
With this success, exploration of the reaction with other cinnamamide substrates was 
commenced. Electron rich substrates performed the best using this methodology. This trend 
can be observed with the methoxy substituted substrates where the trimethoxy substrate 
gave the highest yield of 60% (200) followed by the dimethoxy (199, 55%), and the 
monomethoxy substrate (198, 51%). Some less successful substrates included the 
pyrrolidine derived cinnamamide (204), the aniline derived cinnamamide (202), and the p-
bromo substituted cinnamamide (203) which all gave low conversions of under 20%.  
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Figure 31. Substrate scope of cinnamamide [2+2] using LLSF  
 
Increasing Throughput Using LLSF 
 
An overarching goal of accelerating the reaction was to increase throughput to a 
point of synthetic utility. With LLSF the rate of the reaction was significantly increased 
and higher conversions were achieved after only 110 minutes of residence time.  However, 
this comes at the cost of adding aqueous slugs which reduces the effective reactor volume.  
To overcome this obstacle it was hoped that the improved mixing in the slug flow would 
also allow an increase the overall reaction concentration.188   
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To our delight, it was found that, when using slug flow, the concentration of the 
reaction was no longer a limiting factor and proceeded equally well at much higher 
molarity. The reaction with methyl cinnamate was carried out at a range of concentrations 
from the typical 0.87 M all the way to the limit of solubility (4.3 M) (Table 6).  Calculating 
the optimal conversion versus throughput it was determined that throughputs of 360 mg/hr 
could be achieved with a lower conversion and 55 min residence time and we were able to 
get this productivity with 3 hours of steady state operation. Throughput could also be 
increased by nearly two-fold by using larger 1/8th inch outer diameter tubing but otherwise 
identical conditions (Table 6). The scalability and the potential throughputs of the reactions 
for different substrates were demonstrated by performing the reactions on gram scales 
using conditions that maximized throughput albeit providing lower conversions (Figure 
32). 
  
 
 
 
Concentration 
(M) 
Conversion 
(%) 
g/h 
cyclobutane 
4.3 43 0.36 
3.2 48 0.30 
2.1 51 0.21 
0.87 44 0.06 
0.87a 37 0.11 
Table 6. Evaluation of concentration using LLSF. Reactions were run at flow rates of 20 μL/ min EtOAc: 
180 μL/ min H2O, tR= 55 minutes with 7 mol% bis- thiourea catalyst. % Conversion was calculated by 
integration of 1H NMR integration. a) 1/8th inch tubing used. Right: Photo of slugs in 1/8th inch tubing.  
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Figure 32. Gram scale reactions with increased throughput using LLSF. Typical flow rates used 
were 30µL/min:300μL/min EtOAC/H2O (tR =33 min). All reactions were run with 7 mol% 143. 1H NMR 
conversions are shown in parentheses. 
 
 
 
Plausible Explanations for Observed Acceleration 
 
It was postulated that one of the reasons for the observed reaction acceleration by 
LLSF could be related to a thin film effect in addition to the improved mixing.  As noted 
above, when the length of the aqueous slug increased, the rate increased and, in principle, 
the length of the organic thin film surrounding would increase. This would result in a film 
formation that would decrease the UV path length (l) while the other parameters of 
concentration (c) and the molar absorption coefficient (ε) remained constant, thereby 
minimizing non-productive UV absorbance (A) (or increasing transmittance (T)) as 
described by the Beer Lambert Law (Equation 1, Figure 33).  
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Figure 33. Thin film effect in LLSF system 
 
To estimate the thin film thickness in liquid-liquid slug flow regimes, Bretherton’s 
Law was used (Equation 2), which has been shown to be reliable. 189  In this equation wall 
film thickness (h) is defined by capillary radius (R), and capillary number (Ca). Capillary 
number is a dimensionless value that incorporates the dynamic viscosity of the continuous 
phase (organic) (μ), the interfacial tension between the two solvents (σ) and the net velocity 
of the system (V) (Equation 3).  
 
A= ε • b • c (Equation 1) 
h= 1.34RCa2/3 (Equation 2)           Ca= μV /σ  (Equation 3) 
 
Using this equation, it was estimated that the film thickness is about 4 µm with the 
optimized conditions of 1:10 (ethyl acetate/ water) and a 110minute residence time in the 
standard 11 mL reactor. Using the Beer Lambert Law (Equation 1) the difference in 
absorbance with the thin film in the slug flow system versus the non-slug system was 
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calculated and found to be about 24 versus about 2375 under normal flow conditions. These 
values signify a decrease in absorbance and conversely an increase in transmittance of two 
orders of magnitude within the thin film and therefore providing a potential explanation 
for the enhancement in photon flux and reaction efficiency (Figure 31).  
To probe the effect of film thickness on reactivity two sets of experiments were 
performed. First the effect of solvents with different interfacial tension values were 
investigated to systematically modify the value of Ca in Equation 3 thereby changing the 
film thickness in Equation 2. The results of these studies are shown in Table 7 and were 
ultimately inconclusive. Although a trend correlating interfacial tension and film thickness 
to reaction efficiency was observed in the first three entries (butyl alcohol, ethyl acetate 
and diethyl ether), butyl acetate was an outlier giving the lowest conversion with the 
highest interfacial tension and thinnest calculated film. These observations be a result of 
other solvent factors such as polarity, dipole moment, refractive index, viscosity, or π- 
stacking ability. Furthermore, various potentially interesting solvents were eliminated from 
the screen due to insolubility issues including: DCM, DCE, chloroform, toluene, benzene, 
and trifluorotoluene.  
 
Entry Solvent tR (min) Interfacial 
tension with 
water (mN/m) 
Cacluclated  
film thickness 
(μm) 
% Conversion 
to CB 
1 n-butanol 33 1.8 6 27 
2 Ethyl acetate 33 6.8 4 40 
3 Diethyl ether 33 10.7 2 45 
4 Butyl acetate 33 14.5 <2 22 
 
Table 7. Investigation of solvent effect on thin film thickness. Reactions were run with methyl cinnamate as 
substrate at flow rates of 30 μL/ min organic: 300 μL/ min H2O, tR= 33 minutes with 7 mol% bis- thiourea 
catalyst. % Conversion was calculated by integration of 1H NMR integration.  
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To circumvent the need for changing the solvent to alter thin film thickness, focus 
was shifted to a different parameter in equation 3, velocity. Based on this equation, as 
velocity decreases so should thin film thickness thereby increasing reaction efficiency. This 
was achieved by keeping the solvent and rate ratios constant and varying the reactor tubing 
length allowing for different flow rates while maintaining the same residence time (Table 
8). Unfortunately, these results were also inconclusive with various velocities providing 
roughly the same conversions at the screening conditions. One possible explanation for 
these results aside from the fact that thin film may not be playing as important a role as 
previously believed or that altering thin film thickness by such small amounts as 1- 2 μm 
may not be significant enough to observe any effect. Regardless, thin film is still believed 
to play an important role in the reactivity even if the experimental evidence was not strong 
enough to prove it indisputably.  
 
Entry Organic flow 
rate (μL/min) 
Aq flow rate 
(μL/min) 
Length of 
reactor (# of 
loops) 
Calculated  
film thickness 
(μm) 
% Conversion 
to CB 
1 30 300 30 4.0 26 
2 25 250 25 3.4 26 
3 20 200 20 2.9 28 
4 15 150 15 2.4 31 
5 10 100 10 1.8 30 
6 5 50 5 1.2 31 
 
Table 8. Investigation of flow rate and reactor volume (velocity) on thin film thickness. Reactions were run 
with methyl cinnamate as substrate in ethyl acetate at combined net flow rates that gave tR= 33 minutes with 
7 mol% bis- thiourea catalyst. % Conversion was calculated by integration of 1H NMR integration.  
 
Another plausible explanation for the effect of changing the aqueous to organic slug 
ratios is the decreasing organic slug size. Measurement of organic slugs over the 10 
different ratios showed that organic slug size decreased from 7 mm at the 1:1 ratio to 1 mm 
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at the 1:10 ratio. Mixing patterns and mass transfer is known to be enhanced as slug sizes 
decrease which could explain the increase in reaction efficiency.190 
 
 
Application of Scale-Up for Synthesis and Testing of a  
Piperarborenine D- Inspired Library  
 
As described earlier, truxinic acid derived compounds have been shown to have 
various biological activities but there have been very few thorough biological studies of 
these scaffolds. This is attributed largely to the difficulty of efficiently synthesizing these 
molecules which has been thoroughly discussed in Chapter 1. To date there has only been 
one thorough SAR study of incarvillateine which has also been discussed in Chapter 1.123 
To demonstrate the utility of efficient scale up of the [2+2] photocycloaddition 
methodology described above, the methodology has been applied to the synthesis of a small 
library of truxinic acid-derived amides which has been tested in two mammalian breast 
cancer cell lines (MCF-7 and MDA-MB-231) as well as normal human breast tissue cells 
(MCF-10A) as a comparison.  
 Inspired by the anti-cancer activity of piperarborenine D, synthesis a small library 
of truxinic amides was undertaken. Given the ability to efficiently synthesize esters, 
diastereomerically pure ester dimers were used as the starting point for synthesis of the 
amide library. The esters were saponified then coupled to the desired amine to give the 
desired truxinic amide (Scheme 35). Both the δ and β diastereomers of 4 different truxinic 
esters with various methoxy substitution on the aryl ring similar to piperarborenine D as 
  
135 
well unsubstituted methyl cinnamate based dimers were used. Six different alkyl and aryl 
amine coupling partners of various sizes were chosen. Synthesis of most derivatives 
proceeded smoothly resulting in about 56 different truxinic amide derivatives which were 
submitted for screening as well as the acid and ester monomers and some miscellaneous 
cyclobutane compounds synthesized previously in the lab.  
 
Scheme 35. Synthesis of piperarborenine D inspired amide library 
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In collaboration with Boston University Medical Center, the amide library was 
tested in non-metastatic breast cancer cells MCF-7 and metastatic breast cancer cells 
MDA-MB-321 along with MCF-10A, normal breast tissue cells which were used as a non- 
neoplastic cell control. Cells were dosed at 100 µM for 24 hours. The assay was repeated 
twice (Figure 34). Gratifyingly, the results of the single dose screen seemed to indicate that 
a number of the compounds were selectively toxic against cancer cells while sparing the 
normal cell line as indicated by the heat map displaying % cell viability.  
 
Figure 34. Heat map of single dose toxicity of amide library in breast cancer cell lines 
 
 Even more interesting was that the eight most toxic compounds in the assay all 
possessed similar structural features, namely, electron rich substitution on the aryl ring (di 
or trimethoxy derivatives) and possessed bulky substituents on the amide side chain such 
as cyclohexyl, benzyl or phenyl groups (Figure 35). All eight compounds aside from one 
also possessed δ stereochemistry around the cyclobutane ring. These 8 compounds are 
currently undergoing dose-response testing. 
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Figure 35. Most active compounds from single dose amide library screen  
 
Application of Scale Up Towards the Synthesis of Eucommicin A 
 
 Efficient scale up has also enabled the first synthesis of a eucommicin A direct 
precursor. The structure of eucommicin A was intriguing due to its novel anti-cancer stem 
cell activity. Retrosynthetically, the disconnections to accessing eucommicin A can be 
made at the esters to provide the β caffeic acid dimer, which we have previously 
synthesized (196b) and quinic acid, an inexpensive commercially available acid (Scheme 
36).  A potential challenge could be the selective coupling to the trans alcohol. Fortunately, 
this challenge has been solved by a previously report on the selective protection of the syn 
diol as the acetonide (205, Scheme 37).191   Furthermore, synthesis of the monomeric 
version of eucommicin A, (–)-1,3,5-tri-O-caffeoylquinic acid, a potent RNase H inhibitor 
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and antiviral agent was reported by Brummond and coworkers providing important insights 
into potential pitfalls.192 
 
Scheme 36. Retrosynthetic analysis of eucommicin A 
 
 Synthesis of the protected quinic acid fragment proceeded smoothly according to 
the aforementioned reference.191 Truxinic ester 145b, a protected precursor of the β caffeic 
acid dimer, was synthesized using the optimized photochemical procedure in 75% yield 
(Scheme 37). After saponification to yield 206, the ester coupling reaction to two protected 
quinic acid fragments (205) was successful in furnishing the di-coupled eucommicin A 
precursor 207. Deprotection of the acetonide group followed by demethylation using 
Krapcho conditions provided the piperanyl protected eucommicin A precursor 209.  
 Unfortunately, the final deprotection step to unveil the catechol moiety proved to 
be problematic. Initial attempts using BBr3 under standard aryl demethylation conditions 
provided little to no conversion to the desired NP. Addition of pentamethylbenzene as a 
non-Lewis basic cation scavenger193 improved conversion slightly but not significantly 
enough to enable purification. Reversal of the order of the final two steps allowed access 
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to eucommicin A methyl ester (210) which was observed by UPLC. Unfortunately, 
decomposition occurred during the purification process.  
   
 
Scheme 37. First generation synthesis of eucommicin A 
 
Future work to optimize synthesis of eucommicin A include circumventing the 
problematic aryl ether deprotection step through the use of a different protection group 
such as a benzyl groups. The hydrogenation deprotection should be compatible with all the 
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other steps in the synthesis. Secondly, although preliminary studies directly dimerizing the 
eucommicin A monomer provided messy inseparable mixtures, it may be possible to 
optimize this photocycloaddition bypassing the need to use harsh deprotection conditions. 
Despite the failure to efficiently complete the final step to access eucommicin A, the above 
synthesis represents an efficient and modular strategy to access eucommicin A analogues 
to enable SAR studies which has yet to be completed for this interesting NP.  
 
Section Five: Conclusions 
 In conclusion, efficient scale up of the [2+2] photocycloaddition methodology 
presented earlier was achieved through the use of a larger reactor enabling faster flow 
rates to maintain the same residence time. However, the long 8-hour residence time 
continued to hinder productivity. Use of a LLSF strategy enabled drastic reductions in the 
required residence times of up to 4 fold in most cases while also enabling expansion of 
the substrate scope of the reaction to include substrates previously thought to be 
unreactive such as cinnamamides. LLSF is a highly under-utilized approach that may 
help improve various photochemical reactions through improved mixing and formation of 
an organic thin film to enhance photon flux.  Efficient scale up of the [2+2] 
photocycloaddition has also enabled the synthesis and testing of a piperarborenine D- 
inspired library and its testing in breast cancer cell lines. The first synthesis of a 
eucommicin A precursor was also enabled.  
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Section Six: Experimental Methods and Analytical Data 
 
General Experimental Procedure for Liquid-Liquid Slug Flow [2+2] 
Photocycloaddition Reactions 
 
 
Liquid-liquid slug flow [2+2] photocycloaddition reactions were set up according to the 
figure above. A solution of cinnamate substrate in ethyl acetate (0.1-4 M) was prepared 
and 7 mol% of catalyst was added. The solution was taken into a syringe, loaded onto a 
syringe pump, and connected to a Luer fitting inlet. A second syringe was filled with 
deionized water, loaded onto a second syringe pump, and connected to the inlet by Luer 
fitting.  Typical flow rates used were 9 μL min EtOAc: 90 μL min H2O to give a residence 
time (tR) of 110 minutes based on the 11 mL reactor volume. The rates were calculated 
based on the desired residence time and the reactor volume (tR= reactor volume/ (total flow 
rate)).  The reaction was considered to be at steady state after one residence time had 
passed. The crude biphasic mixture exiting the flow system was poured into a separatory 
funnel and extracted with ethyl acetate (x3). The combined organic layers were then dried 
over anhydrous Na2SO4 and concentrated in vacuo.  The crude reaction mixture was 
purified by flash chromatography (SiO2) unless specified otherwise. 
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Throughput Calculations 
 
Throughput calculations were calculated based on an 11 mL reactor volume and 1/16th inch 
O.D. tubing except in the case when the 1/8th inch O.D. tubing was tested in which the 
reactor volume was 19.8 mL. Flow rates were calculated based on the desired residence 
time (tR= reactor volume/ (total flow rate)). The total flow rate was sum of flow rates used 
for the aqueous phase and the organic phase. To account for the proportion of water 
contributing to this flow rate, the fraction of organic volume over total volume was 
incorporated into the calculation.  
 
Sample calculation: 
 
 
 
Section Four: Experimental Methods and Analytical Data 
 
General Procedure for Cellular Assays in MCF-10, MCF7, and MDA-MB-321 
A panel of human cell lines was selected to investigate potential toxic effects 
of specific cyclobutane scaffold compounds. MDA-MB-231 (metastatic breast 
adenocarcinoma) and MCF-7 (breast adenocarcinoma) were maintained in high-
glucose DMEM (Gibco) supplemented with 10% fetal bovine serum and 
penicillin/streptomycin. MCF-10A (non-transformed breast tissue) cells were 
maintained in MEGM (Lonza) supplemented with components of the SingleQuot 
(Lonza) supplement kit (BPE, hydrocortisone, hEGF, insulin) and 100 ng/mL cholera 
  
143 
toxin (Sigma). 7,500 cells for MDA-MB-231 and MCF-10A or 12,500 cells for MCF-
7 were seeded into each well of a 96-well plate.  
After an overnight growth period, the media was aspirated from the wells and 
replaced with the appropriate medium containing either DMSO (vehicle control, 
maximum 1%) or compound (100 uM for single dose or 1 to 300 uM for dose-response 
assays).  
Following 24 hours of incubation with compound, the media was aspirated and 
replaced with 100 uL of CellTiterGlo (Promega) diluted with medium (1:3 ratio of reagent 
to 10%FBS+DMEM) that had been equilibrated to room temperature. The 96-well plate 
was placed on an orbital shaker at 600 rpm setting for 2 minutes to allow for lysis of the 
cells. Following lysis, the volume of each well was transferred into an opaque white 96-
well plate and luminescent signal was read after a 10 minute stabilization period at room 
temperature using a BioTek Synergy H1 plate reader. The amount of cells seeded was 
titrated to assure viability readouts fell within the linear range of detection. 
 
Spectroscopic Data for Cyclobutane Compounds 
189a: Purified by flash chromatography using a gradient of 30-60% 
EtOAc/ Hexanes; Rf = (25% EtOAc/Hexanes): 0.19; IR (thin film): ν 
= 2952, 2838, 1737, 1513, 1278, 1249, 1176, 1034, 786, 539 cm-1;  1 
H NMR (500 MHz, CDCl3): = 6.83 (d, J=8.8 Hz, 4H), 6.66 (d, J=8.8 Hz, 4H), 4.29 
(AA’BB’, JAB =6.2 Hz, 2H), 3.76 (AA’BB’, JAB =6.2 Hz, 2H), 3.74 (s, 6 H), 3.71 (s, 6 H); 
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13C NMR (125 MHz, CDCl3): = 173.2, 158.0, 130.6, 128.8, 113.5, 55.2, 52.2, 44.4, 43.6;  
HRMS: Calc. for C22H24O6 [M+Na]
+= 407.1471 m/z, found 407.1483 m/z. 
 
189b: Purified by flash chromatography using a gradient of 30-60% 
EtOAc/ Hexanes; Rf = (25% EtOAc/Hexanes): 0.31; IR (thin film): ν 
= 3002, 2952, 2837, 1729, 1583, 1278, 1177, 1033, 829, 533 cm-1; 1H 
NMR (500 MHz, CDCl3): = 7.20 (d, J=8.7 Hz, 4H ), 6.85 (d, J=8.7 
Hz, 4H), 3.79 (s, 6H), 3.73 (s, 6H), 3.60  (AA’BB’, JAB =9.6 Hz, 2H), 3.42 (AA’BB’, JAB 
=9.6 Hz, 2H); 13 C NMR (125 MHz, CDCl3): = 173.0, 158.7, 133.1, 127.9, 114.0, 55.2, 
52.1, 47.4, 44.6; HRMS: Calc. for C22H24O6 [M+Na]
+= 407.1471 m/z, found 407.1483 
m/z. 
 
191a: Purified by flash chromatography using a gradient of 30-60% 
EtOAc: Hexanes.  Rf = (50% EtOAc/Hexanes): 0.43; IR (thin film): 
ν = 2925, 1652, 1457, 1263, 1026 cm-1; 1 H NMR (500 MHz, CDCl3): 
= 6.84-6.80 (ovrlp, 6 H), 3.86 (s, 6 H), 3.85 (s, 6 H), 3.74 (s, 6 H), 
3.60 (AA’BB’, JAB =9.6 Hz, 2H), 3.44 (AA’BB’, JAB =9.6 Hz, 2H); 13C NMR (125 MHz, 
CDCl3): = 173.0, 149.0, 148.2, 133.6, 118.8, 111.2, 110.0, 55.9, 55.8, 52.2, 47.6, 44.4; 
HRMS: Calc. for C24H28O8 [M+Na]
+= 467.1682 m/z, found: 467.1681 m/z.  
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191b: Purified by flash chromatography using a gradient of 30-60% 
EtOAc: Hexanes.  Rf = (50% EtOAc/Hexanes): 0.32; IR (thin film): 
ν = 2926, 1734, 1518, 1252, 1027 cm-1;  1 H NMR (500 MHz, 
CDCl3): = 6.66 (d, J= 8.3 Hz, 2H), 6.56 (dd, J1=8.3 Hz, J2= 2.1 Hz, 
2H), 6.33 (d, J=2.1 Hz, 2H), 4.30 (AA’BB’, JAB =6.3 Hz, 2H), 3.78 (s, 6H), 3.77 (AA’BB’, 
JAB =6.3 Hz, 2H),  3.75 ( s, 6 H), 3.62 ( s, 6 H);
 13C NMR (125 MHz, CDCl3): = 172.9, 
148.5, 147.6, 131.1, 119.6, 111.6, 110.6, 55.74, 55.66, 52.1, 44.6, 43.5 ; HRMS: Calc. for 
C24H28O8 [M+Na]
+= 467.1682 m/z, found: 467.1682 m/z.  
 
Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 9 μL/min EtOAc: 91 μL/min 
H2O, tR= 110 min). Purified by flash chromatography using a gradient 
of 30-60% EtOAc: Hexanes. Rf = (50% EtOAc/ Hexanes):0.48,  IR (thin film): 3450, 2924, 
2854, 1731, 1517, 1438, 1227, 1174, 909, 834, 734; 1H NMR (500 MHz, CDCl3): =  7.15 
(d, J= 8.5 Hz, 4 H), 6.78 (d, J= 8.5 Hz, 4 H), 4.72 (br s, 2H), 3.73 (s, 6H), 3.58 (AA’BB’, 
JAB = 9.6 Hz, 2H), 3.41(AA’BB’, JAB = 9.6 Hz, 2H); 13C NMR (125 MHz, CDCl3): = 
173.9, 155.1, 132.4, 128.1, 115.6, 52.6, 47.6, 44.6 HRMS Calc. for C20H20O6 [M+H]
+= 
357.1338 m/z , found 357.1351 m/z.  
 
195b: Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 9 μL/min EtOAc: 91 μL/min 
H2O, tR= 110 min). Purified by flash chromatography using a gradient 
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of 30-60% EtOAc: Hexanes. Rf = (50% EtOAc/ Hexanes): 0.3 IR (thin film): 3450, 2924, 
2854, 1731, 1517, 1438, 1227, 1174, 909, 834, 734; 1H NMR (500 MHz, CDCl3): = 6.76 
(d, J= 8.6 Hz, 4H), 6.58 (d, J= 8.6 Hz, 4H), 4.27 (AA’BB’, J= 6.3 Hz, 2H), 3.75 (AA’BB’, 
JAB= 6.3 Hz, 2H), 3.74, (s, 6H); 13C NMR (125 MHz, CDCl3): = 173.4, 154.1, 149.6, 
129.2, 115.1, 52.4, 44.5, 43.6;  HRMS Calc. for C20H20O6 [M+H]
+= 357.1338 m/z , found 
357.1351 m/z. 
 
196a: Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 9 μL/min EtOAc: 91 μL/min 
H2O, tR= 110 min). Purified by flash chromatography using a gradient 
of 2-5% MeOH: DCM. Rf = (5% MeOH/ DCM): 0.52; IR (thin film): 
3372, 1708, 1608, 1521, 1439, 1362, 1261, 1204, 1115, 810; 1H NMR (500 MHz, 
(CD3)2CO): = 7.82 (br s, 4H), 6.80 (d, J= 2.1 Hz, 2H), 6.77 (d, J= 8.0 Hz, 2H), 6.66 (dd, 
J1= 8.0 Hz, J2= 2.1 Hz, 2H), 3.68 (s, 6H), 3.46 (AA’BB’, JAB= 9.6 Hz, 2H), 3.30 (AA’BB’, 
J= 9.6 Hz, 2H). HRMS: Calc. for C20H20O8 [M+Na]
+= 411.1056 m/z, found: 411.1049 
m/z. 
 
196b: Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 9 μL/min EtOAc: 91 μL/min 
H2O, tR= 110 min). Purified by flash chromatography using a gradient 
of 2-5% MeOH: DCM. Rf = (5% MeOH/ DCM): 0.48; IR (thin film): 
3383, 1726, 1655, 1607, 1521, 1438, 1365, 1262, 1205, 1114, 805; 1H NMR (500 MHz, 
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(CD3)2CO): = 7.66 (br s, 4H), 6.58 (d, J= 8.1 Hz, 2H), 6.52 (d, J= 2.1 Hz, 2H), 6.42 (d, 
J1=8.1 Hz, J2= 2.1 Hz, 2H), 4.12 (AA’BB’, JAB= 6.2 Hz, 2H), 3.76 (AA’BB’, J= 6.2 Hz, 
2H), 3.67 (s, 6H); 13C NMR (125 MHz, (CD3)2CO): = 172.7, 144.5, 143.2, 131.0, 119.3, 
115.2, 114.6, 51.1, 44.4, 43.3; HRMS: Calc. for C20H20O8 [M+Na]
+= 411.1056 m/z, found: 
411.1049 m/z.  
 
200a: Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 5 μL/min EtOAc: 50 μL/min H2O, 
tR= 200 min). Recrystallized from DCM.  Rf = (5% MeOH/DCM): 0.45 ; IR 
(thin film): ν = 3276, 2923, 1632, 1536, 1241, 907;   1H NMR (500 MHz, 
CDCl3): δ 6.51 (s, 4 H), 6.14 (t, J= 6.4 Hz, 2 H), 3.83 (s, 12 H), 3.81 (s, 6 H), 3.54 (AA’BB’, J= 9.8 
Hz, 2 H), 3.27 (dddd, J1= Hz, J2= 13.3 Hz,  J3= 13.3 Hz,  J4= 6.4 Hz, 2H), 3.19 (dddd, J1=20.4 Hz, 
J2= 13.3 Hz,  J3=13.3 Hz,  J4= 6.4 Hz, 2H), 3.14 (AA’BB’, JAB= 9.8 Hz, 2 H), 1.52 (q, J= 7.3 Hz, 4 
H), 0.91 (t, J= 7.3 Hz, 6 H); 13C NMR (125 MHz, CDCl3): δ= 172.5, 153.5, 137.2, 136.6, 103.9, 
60.9, 56.2, 47.3, 46.9, 41.2, 22.8; HRMS Calc. for C30H42N2O8: [M+H]
+ =  559.3019 m/z, found: 
559.2996 m/z.  
 
200b: Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 5 μL/min EtOAc: 50 μL/min H2O, 
tR= 200 min). Purified by flash chromatography using a gradient of 2-5% 
MeOH: DCM.  Rf = (5% MeOH/DCM): 0.38 ; IR (thin film): ν = 3306, 2960, 
2939, 1652, 1588, 1509, 1463, 1238, 1127, 1010;   1H NMR (500 MHz, CDCl3): δ 6.16 (s, 4 H), 5.94 
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(t, J= 6.2 Hz, 2 H), 4.25 (AA’BB’, JAB= 6.2 Hz, 2 H), 3.75 (s, 6 H), 3.67 (s, 12 H), 3.64 (AA’BB’, 
JAB= 6.2 Hz, 2 H), 3.23 (m, 4 H),  1.51 (q, J= 7.4 Hz,, 4 H), 0.91 (t, J= 7.4 Hz, 6 H); 13C NMR (125 
MHz, CDCl3): δ= 171.8, 153.0, 136.8, 134.0, 105.1, 60.8, 56.1, 45.6, 45.3, 41.4, 22.8, 11.3; HRMS 
Calc. for C30H42N2O8: [M+H]
+ =  559.3019 m/z, found: 559.2989 m/z.  
 
 198a: Prepared using general liquid-liquid slug flow [2+2] 
photocycloaddition procedure (flow rates 5 μL/min EtOAc: 50 μL/min H2O) 
1H NMR (500 MHz, CDCl3): δ 7.22 (d, J= 8.7 Hz, 4 H), 6.84 (d, J= 8.7 Hz, 
4 H), 6.07, (br s, 2 H), 3.78 (s, 6 H), 3.54 (AA’BB’, JAB= 9.7 Hz, 2 H), 3.24 (m, 2 H), 3.17 (m, 2 H), 
3.11 ( AA’BB’, JAB= 9.7 Hz, 2 H), 1.50 (q, J= 7.4  Hz, 4 H), 0.89 (t, J= 7.4 Hz, 6 H) 
 
 
 
 
 
Prepared using general liquid-liquid slug flow [2+2] photocycloaddition 
procedure (flow rates 5 μL/min EtOAc: 50 μL/min H2O, tR= 200 min). 
Purified by flash chromatography using a gradient of 2-5% MeOH: DCM.  
1H NMR (500 MHz, CDCl3): δ 7.34-7.24 (ovrlp, 10 H), 6.10 (br s, 2 H), 3.68 (AA’BB’, 
JAB = Hz, 2 H), 3.27-3.14 (ovrlp, 6 H), 1.50 (q, J= 7.2 Hz, 4 H), 0.89 (t, J= 7.2 Hz, 6 H); 
13C NMR (125 MHz, CDCl3): δ= 172.6, 141.1, 128.8, 127.0, 126.9, 46.9, 46.5, 41.1, 22.8, 
11.3.  
 
General Procedure for Synthesis of Truxinic Amide Library: 
 
The carboxylic acid was dissolved in dry Acetonitrile (0.25 M) with stirring. O-(7-
Azabenzotriazole-1-yl)-N,N,N,N’-tetramethyluronium hexafluorophosphate (HATU, 2.2 
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eq) was added as a solid and the resulting clear solution was stirred for 10 min at room 
temperature. Amine (2.5 eq) was injected and the resulting yellow solution was stirred for 
20 min before of diisopropylethylamine (DIEA, 5 eq) was added by syringe. The mixture 
was stirred for 16 h at room temperature. The reaction was monitored by TLC for 
consumption of the starting acid and upon completion the reaction mixture was poured into 
a separatory mixture containing ethyl acetate and 1 M HCl. The aqueous layer was 
extracted with EtOAc (x 3), washed with brine (x1) then dried over sodium sulfate. The 
reaction mixture was purified by column chromatography.  
 
1H NMR (500 MHz, CDCl3): δ 7.33-7.32 (ovrlp, 6 H), 7.2707.23 
(ovrlp, 4 H), 6.12 (t, J= 3.9 Hz, 2 H), 3.72 (AA’BB’, JAB= 9.6 Hz, 2 
H), 3.21 (AA’BB’, JAB= 9.6 Hz, 2 H), 3.17 (m, 2 H), 3.07 (m, 2 H), 
0.93 (m, 2 H), 0.49 (m (4 H), 0.18 (m, 4 H); 13C NMR (125 MHz, CDCl3): δ=172.4, 141.2, 
128.8, 127.0, 110.0, 47.0, 46.4, 44.2, 10.7, 3.3. 
 
1H NMR (500 MHz, CDCl3): δ 7.97 (br s, 2 H), 7.52 (d, J= 9.5, Hz, 4 H), 
7.41-7.29 (ovrlp, 14 H), 7.21 (t, J= 6.3 Hz, 2 H), 3.86 (AA’BB’, JAB= 9.8 
Hz, 2 H), 3.49 (AA’BB’, JAB= 9.8 Hz, 2 H),; 13C NMR (125 MHz, 
CDCl3): δ=170.9, 140.4, 137.5, 129.1, 127.6, 127.0, 124.5, 119.8, 119.3, 47.9, 46.4 
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1H NMR (500 MHz, CDCl3): δ 7.87 (t, J= 6.0 Hz, 2 H), 7.34-7.25 
(ovrlp, 10 H), 7.13 (d, J= 8.7 Hz, 2 H), 6.67 (d, J= 8.7 Hz, 2 H), 
4.50 (dd, J1= 6.0, J2= 1.9 Hz, 2 H), 4.41 (dd, J1= 6.0, J2= 1.9 Hz, 2 
H), 3.99 (AA’BB’, JAB= 9.5 Hz, 2 H), 3.82 (s, 6 H), 3.74 (s, 6 H), 
3.61 (s, 6 H), 3.13 (AA’BB’, JAB= 9.5 Hz, 2 H); 13C NMR (125 MHz, CDCl3): δ= 173.2, 
152.5, 141.9, 138.2, 128.6, 127.8, 127.3, 127.2, 127.0, 122.3, 107.7, 60.8, 60.6, 56.0, 48.0, 
43.5, 38.7 
 
1H NMR (500 MHz, CDCl3): δ= 7.46 (t, J= 5.1 Hz, 2 H), 7.14 (d, J= 
8.7 Hz, 2 H), 6.69 (d, J= 8.7 Hz, 2 H), 3.95 (AA’BB’, JAB= 9.6 Hz, 2 
H), 3.832 (s, 6 H), 3.826 (s, 6 H), 3.76 (s, 6 H), 3.36-3.23 (ovrlp, 2 
H), 3.02 (AA’BB’, JAB= 9.6 Hz, 4 H), 1.16 (t, J= 7.3 Hz, 6 H) 13C 
NMR (125 MHz, CDCl3): δ= 173.3, 127.4, 122.3, 110.0, 107.8, 106.0, 100.1, 61.0, 60.7, 
56.0, 48.0, 38.8, 34.2, 14.6; HRMS Calc. for C28H38N2O8: [M+H]
+ = 531.2706, found: 
531.2711   m/z. 
 
1H NMR (500 MHz, CDCl3): δ= 7.54 (d, J= 8.4 Hz, 2 H), 7.14 (d, 
J= 8.8 Hz, 2 H), 6.69 (d, J= 8.8 Hz, 2 H), 3.94 (AA’BB’, JAB= 9.5 
Hz, 2 H), 3.83 (s, 6 H), 3.82 (s, 6 H), 3.77 (s, 6 H), 2.98 (AA’BB’, 
JAB= 9.5 Hz, 2 H), 1.96 (m, 2 H), 1.84 (m, 2 H), 1.76-1.67 (ovrlp, 
4 H), 1.60 (m, 2 H), 1.41-1.30 (ovrlp, 4 H), 1.23-1.11 (ovrlp 6 H)  ; 13C NMR (125 MHz, 
CDCl3): δ= 172.5, 152.4, 151.1, 141.9, 127.5, 122.4, 107.8, 60.7, 56.0, 48.4, 47.9, 38.5, 
  
151 
32.9, 29.7, 25.6, 24.8; HRMS Calc. for C36H50N2O8: [M+Na]
+ = 661.3465 , found: 
661.3412  m/z. 
 
1H NMR (500 MHz, CDCl3): δ= 6.56 (d, J= 5.7 Hz, 2 H), 6.47 (d, 
J= 5.7 Hz, 2 H), 6.25 (t, J= 5.1 Hz, 2 H), 4.56 (AA’BB’, JAB = 6.5 
Hz, 2 H), 3.79 (s, 6 H), 3.70 (s, 6 H), 3.67 (s, 6 H), 3.56 (AA’BB’, 
JAB = 6.5 Hz, 2 H), 3.16 (m, 2 H), 3.07 (m, 2 H), 0.84 (m, 2 H), 
0.47 (m, 4 H), 0.18 (m, 4 H); 13C NMR (125 MHz, CDCl3):  HRMS Calc. for C32H42N2O8: 
[M+H]+ = 583.3019 , found: 583.3021  m/z. 
 
1H NMR (500 MHz, CDCl3): δ= 6.52 (s, 4 H), 6.03 (d, J= 8.5 Hz, 
2 H), 3.84 (s, 12 H), 3.82 (6 H), 3.55 (AA’BB’, JAB =9.7 Hz, 2 H), 
3.07 (AA’BB’, JAB=9.7 Hz, 2 H); 1.93-1.85 (ovrlp, 4 H), 1.70-1.64 
(ovrlp, 6 H), 1.38-1.31 (ovrlp, 6 H), 1.21-1.11 (ovrlp, 6 H); 13C 
NMR (125 MHz, CDCl3): δ= 171.6, 153.5, 138.9, 136.7, 103.9, 60.8, 56.2, 47.3, 46.8, 
33.1, 32.9, 25.4, 24.7; HRMS Calc. for C36H50N2O8: [M+Na]
+ = 661.3465, found: 
661.3450 m/z. 
 
Prepared according to the follwing referenced procedure with an isolated 
yield of 80%: Sánchez-Abella, L.; Fernández, S.; Armesto, N.; Ferrero, M.; 
Gotor, V. Novel and Efficient Syntheses of (-)-Methyl 4-Epi-Shikimate and 
4,5-Epoxy-Quinic and -Shikimic Acid Derivatives as Key Precursors to Prepare New 
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Analogues. J. Org. Chem. 2006, 71 (14), 5396–5399. All spectroscopic and analytical 
data matched reference.  
 
Prepared according to the following referenced procedure with an isolated 
yield of 72%: Sánchez-Abella, L.; Fernández, S.; Armesto, N.; Ferrero, M.; 
Gotor, V. Novel and Efficient Syntheses of (-)-Methyl 4-Epi-Shikimate and 
4,5-Epoxy-Quinic and -Shikimic Acid Derivatives as Key Precursors to Prepare New 
Analogues. J. Org. Chem. 2006, 71 (14), 5396–5399. All spectroscopic and analytical 
data matched reference. 
 
To a stirred mixture of di-methyl ester X (266mg, 0.645 mmol) in 
methanol (2 mL) was added lithium hydroxide (46 mg, 1.94 mmol, 3 
eq). The reaction mixture was heated to 40o C and stirred until 
complete consumption of the starting material was observed by TLC (~ 4 h). The reaction 
was acidified with 1 M HCl to pH 3 and poured into a separatory funnel with water 
(10mL), extracted with ethyl acetate (10 mL x 3), washed with brine (10 ml x 1), and 
dried over sodium sulfate. The resulting material was sufficiently pure to carry to the next 
step (56%).  
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To a stirring mixture (250uL) of beta methylenedioxy 
truxinic acid (20 mg, 0.053 mmol) in DCM at 0 degrees was 
added DCC in one portion. There reaction is stirred for 10 
minutes before a solution of the diol X (2.5 eq) is added. 
Then DMAP (0.1 eq) was added. Upon addition of DMAP, 
the reaction turns from brown to yellow. The reaction is warmed to room temperature and 
is stirred for 7 h until consumption of acid is observed by TLC. The reaction mixture is 
transferred into a separatory funnel containing Et2O and saturated NH4Cl. The aqueous 
layer is separated from the organic layer and is extracted with Et2O (3X). The combined 
organic layers are washed with saturated aqueous NaHCO3 (3X), H2O (3X), and brine 
(1X) then dried over sodium sulfate. The solids are filtered off using gravity filtration and 
the filtrate is concentrated under reduced pressure by rotary evaporation. The resulting 
residue is purified on silica gel eluting with 50-100% EtOAC/hexanes to afford desired 
ester. 
A 10-mL, single-necked, round-bottomed flask equipped 
with a stir bar, rubber septum, and nitrogen line is charged 
with acetal 232 (417 mg, 0.701 mmol) and DCM (1.5mL). 
The reaction flask is cooled to 0 °C in an ice bath and 4 mL 
of a pre-mixed solution of trifluoroacetic acid / H2O (1:1, v:v) is added via syringe. 
When consumption of acetal X is seen via TLC, the reaction mixture is poured into a 
separatory funnel containing EtOAc and ice cold H2O. The aqueous layer is separated 
from the organic layer and is extracted with EtOAc (4X). The combined organic layers 
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are washed with H2O (3X), brine (1X), and are dried on MgSO4. The solids are filtered 
off using gravity filtration and the filtrate is concentrated under reduced pressure by 
rotary evaporation. The resulting residue is purified on silica gel eluting with 5%-10% 
MeOH/DCM; 1H NMR (500 MHz, CDCl3): δ= 6.59 (d, J = 8.4 Hz, 2 H), 6.43-6.40 
(ovrlp, 4 H), 5.84 (s, 4 H), 5.42 (m 2 H), 4.85 (br s, 2 H), 4.74 (br s, 2 H), 4.29 (m, 2 H), 
4.74 (m, 2 H), 3.81-3.73 (ovrlp, 8 H), 3.64 (br s, 2 H), 2.82 (m, 2 H), 2.20 (m, 2 H), 2.01 
(m, 2 H), 1.86 (m, 2 H) ; 13C NMR (125 MHz, CDCl3): δ= 174.3, 172.7, 147.5, 146.0, 
132.4, 120.9, 108.2, 107.9, 100.8, 75.7, 73.5, 71.5, 70.6, 53.1, 44.8, 43.9, 38.8, 36.8; 
HRMS Calc. for C36H40O18: [M+Na]
+ = 783.2112 , found: 783.2098  m/z. 
 
 
 
A 5 mL round bottomed flask equipped with a stir bar, 
rubber septum, and nitrogen line is charged with methyl 
ester and pyridine. To the reaction flask is then added LiI in 
one portion. The reaction is heated and stirred at reflux (90-
100 degrees). After 6 h the reaction mixture is cooled to room temperature and is 
concentrated under reduced pressure. Benzene is added to the resulting red solids and is 
evaporated under reduced pressure (3x). The solids are diluted in EtOAc and are 
transferred into a separatory funnel containing EtOAc and 1 N HCl. The aqueous layer is 
separated from the organic layer and is extracted with EtOAc; 1H NMR (500 MHz, 
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CD3OD): δ= 6.60-6.51 (ovrlp, 6 H), 5.82 (s, 4 H), 5.31 (m, 2 H), 4.31-4.10 (ovrlp, 6 H); 
3.93-3.80 (ovrlp, 4 H), 3.67 (m, 2 H), 2.28-2.02 (ovrlp, 8 H) ; 13C NMR (125 MHz, 
CDCl3): δ= HRMS Calc. for C36H36O18: [M+Na]+ = 755.1764 , found: 755.1799  m/z. 
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CHAPTER FOUR: Heterodimerization of Cinnamic Acid Derivatives 
 
Section One: Introduction and Background 
 
 Efficient intermolecular heterodimerization of cinnamic acids and derivatives is 
still elusive. Lewis and coworkers investigated the cross cycloaddition of methyl cinnamate 
with excess Z or E 2-butene using stoichiometric BF3·OEt2 (Scheme 38).
97 Although 
respectable yields could be achieved, a 20-fold excess of the butene was used, which itself 
is not prone to homodimerization.  
 
 
Scheme 38. Cross [2+2] photocycloaddition of methyl cinnanmate with E and Z 2-butene 
 
 An example mentioned in Chapter 1 from Morrison and coworkers irradiated pairs 
of cinnamic acids including sinapic, caffeic, p-coumaric, ferulic, and cinnamic acid to 
investigate the dimerization of these compounds in cell wells (Scheme 39).13 These 
cyclodimers were synthesized by dissolving 1 mg of two different acids in methanol, 
allowing the solution to evaporate under a stream of air, then capping the vial and exposing 
the mixture to sunlight for 7 days. Although heterodimers were observed by GC-MS and 
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determined to be composed mostly of α and β diastereomers, this method is neither 
practical nor scalable.  
 
Scheme 39. Heterodimerization of cinnamic acids for investigating of dimers occurring in plant cell walls 
 
 Another example from Ishigami and coworkers studied the cross [2+2] 
photocycloaddition of methyl p-nitro cinnamate with various alkenyl substrates including 
some cinnamates (Table 9, entries 8-12).194 This study found a correlation between the 
difference in ionization potential of the two reactants and the selectivity in forming 
heterodimeric products over homodimeric products. The finding led them to conclude that 
only substrates with ionization potentials lower than that of the p- nitro methyl cinnamate 
(9.3 eV) successfully underwent heterodimerization.  
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Entry R1 R2 Heterodimers Homodimers Selectivity 
Heterodimers/ 
Homodimers 
1 
  
67 8 8.2 
2 
  
55 7 7.5 
3 
  
90 12 7.8 
4 
  
53 11 5.0 
5 
  
53 12 4.7 
6 
  
8 36 0.23 
7 
  
43 27 1.6 
8 
  
55 27 2.0 
9 
  
52 15 3.4 
10 
  
59 14 4.1 
11 
  
27 41 0.66 
12 
  
18 32 0.56 
13 
  
26 20 1.3 
Table 9. Heterodimerization of p-nitro methyl cinnamate with alkenyl substrates 
 
A recent example of a cross [2+2] photocycloaddition of cinnamate derivatives and 
alkenyl substrates comes recently from the group of Wu and coworkers106 in which they 
reported the cross photocycloaddition products of cinnamic acid derivatives with alkenyl 
substrates using an iridium photocatalyst. However, the substrate scope of this 
methodology was limited to mostly 1,1-diarylethylene coupling partners and the majority 
of examples used 1,1-diphenylethylene (Figure 36).  
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Figure 36. Substrate scope of heterodimerization of cinnamate derivatives by Wu, et al 
 
 Another example of cross [2+2] photocycloadditions of cinnamic acids and 
coumarins employed a γ- cyclodextrin host-guest strategy.195 The strategy takes advantage 
of steric interactions and electronic factors to favor or disfavor the complexing of the 
monomers within the γ- cyclodextrin cavity. After complexation of the host-guest 
molecules, the complexes are irradiated in the absence of solvent for 24 hours. Using this 
method, they with 2-chloro cinnamic acid and 6-methyl coumarin, they obtained 63% yield 
of heterodimer 211, 18% of homodimer 212 and 8% of homodimer 213 (Scheme 40). 
Yields of heterodimeric products resulting from the pairing of other coumarin and cinnamic 
acid substrates ranged from 2%- 63%.  
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Scheme 40. Host-guest strategy for heterodimerization 
 
 Other noteworthy examples to obtain heterodimeric cinnamic acid derived 
cycloadducts come from the groups of Baran115 and MacMillan116 in the syntheses of 
piperarborenine D and (-)-littoralisone respectively and have been discussed in Chapter 1. 
Both synthetic strategies involve tethering the desired olefins in order to perform an 
intramolecular [2+2] photocycloaddition (Scheme 41).   
 
Scheme 41. Intramolecular approach for the heterodimerization of cinnamic acid substrates 
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Section Two: Results and Discussion 
Strategy 1: Stoichiometry and Reactivity Manipulation 
 
With an efficient method to synthesize various cinnamate and cinnamamide 
homodimers, the challenge of accessing heterodimers was undertaken. Initial efforts 
combining pairs of cinnamates resulted in complex inseparable mixtures. To overcome this 
issue of uncontrolled reactivity, it was hypothesized that combining a more reactive 
substrate with a less reactive substrate and adjusting the stoichiometric ratio may promote 
heterodimerization (Scheme 42).196,197 By increasing the stoichiometric amount of the less 
reactive substrate, it increases the likelihood that the more reactive substrate will encounter 
the less reactive substrate upon excitation, minimizing homodimerization and enriching 
heterodimerization. 
 
Scheme 42. Stoichiometry and reactivity manipulation strategy for heterodimerization 
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Over the course of the studies on the [2+2] photocycloaddition of cinnamate and 
cinnamide derivatives reactivity trends with regard to the nature of the substrate have been 
noted. For example, cinnamate esters are typically more reactive that cinnamamides and 
electron rich substrates tend to react better than electron poor substrates. This trend is 
displayed very well among the cinnamamides wherein the p-methoxy derivative afforded 
50% conversion to the desired cyclobutane products, the 3,4-dimethoxy derivative afforded 
55% conversion, and the 3,4,5-trimethoxy derivative afforded 69% conversion. 
Additionally, bulkier groups attached to the amide or ester functionality tended to 
significantly lower reactivity.  
The initial experiment utilizing this strategy combined a reactive cinnamate (methyl 
2,3,4-trimethoxy cinnamate, 214) and a less reactive amide substrate (pyrrolidine 
cinnamamide, 215) in a 1:5 stoichiometric ratio, respectively.  The reaction was carried out 
under standard LLSF conditions with a 220-minute residence time. Preliminary UPLC of 
the crude reaction mixture gratifyingly indicated a significant amount of the 
heterodimerization product 216 and only trace homodimerization products (Scheme 43). 
However, attempts to purify the mixture was challenging due to the coelution of amide 
monomer with dimeric products.  
 
Scheme 43. Initial result of heterodimerization using reactivity and stoichiometry manipulation 
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 Although the reaction was not a complete success due to purification issues, the 
results were motivating and the proof of concept was confirmed. Initial optimization of the 
approach focused on a thorough investigation of the stoichiometric ratio to determine the 
minimum amount of the less reactive substrate necessary for heterodimerization to be 
favored. The ratio was decreased from 1:5 down to 1:1 but unfortunately, in all cases a 
mixture of both homodimers, heterodimer, and both monomers was observed by UPLC, 
although the reaction performed at a 1:5 stoichiometric ratio did seem to have qualitatively 
less of the ester homodimer. 
 
Strategy 2: Photophysical Parameter Optimization 
 
In attempt to minimize unwanted amide homodimerization, the absorption 
characteristics of the amide and ester monomers were investigated and showed a significant 
difference in absorption properties. The ester monomer (214) displayed a λmax of 310 nm 
compared with the cinnamamide monomer (215) with a λmax of 280nm (Figure 37A). These 
properties suggested the potential to eliminate homodimerization of the amide monomer 
completely by selective excitation of the cinnamate using a long-pass filter with a 
wavelength cutoff of >320 nm. Unfortunately, when this experiment was performed with 
an 8-hour residence time, UPLC analysis showed very little conversion to any cyclobutane 
product, indicating that the filter was not irradiating enough of the absorbance band to 
promote reactivity. 
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Figure 37. A) Absorbance spectra of cinnamamide 215 versus cinnamates 214. B) Heterodimerization 
reaction utilizing >320 nm filter 
 
Strategy 3: Chemoselective Purification 
 
 Given the major hurdle that purification of the heterodimerization reactions 
presented, it was postulated that perhaps taking advantage of an aqueous workup of 
carboxylates could help with the purification of heterodimers from homodimers (Figure 
38). Although only methyl esters had been used as substrates in the original methodology 
investigation due to ease of solubility, there was no reason to believe that carboxylic acids 
would react very differently from the esters. It was theorized that use of a cinnamic acid as 
one of the monomers would allow for heterodimers to be easily separated from amide or 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
250 270 290 310 330 350
A
b
so
rb
an
ce
Wavelength (nm)
  
185 
ester homodimers and monomers. After a basic workup, the aqueous layer should only 
contain acid monomer, acid homodimer, and heterodimer making for a much more 
reasonable purification. Furthermore, full conversion of the acid monomer and 
optimization of stoichiometric conditions should reduce or eliminate both monomer and 
homodimer from the mixture. As an added benefit, homodimerization of the ester or amide 
partner is no longer a major concern, in fact homodimeric products can easily be isolated 
if these dimers are desired.  
 
Figure 38. Chemoselective purification of heterodimerers using acid/base workup 
 
 To confirm that the cinnamic acids exhibited similar reactivity as methyl esters, a 
control reaction was first performed using 3,4,5-trimethoxycinnamic acid under the 
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standard non-slug conditions with a 15-hour residence time. It was decided not to use LLSF 
out of concern for the solubility of acid monomers in the aqueous layer. Gratifyingly, an 
80% conversion to the δ and β diastereomer (217a, 217b) at the standard 2:1 diastereomeric 
ratio was observed (Scheme 44). 
 
Scheme 44.  [2+2] photocycloaddition of cinnamic acid under standard bis-thiourea-catalyzed conditions  
 
With this result in hand, focus was turned to the heterodimerization of imide (218) 
with 3,4,5-trimethoxycinnamic acid which had shown incomplete conversion by UPLC to 
both homodimers and heterodimer under standard reaction conditions (Scheme 45). The 
acid/base workup proved to be effective in removing both imide monomer (218) as well as 
imide homodimer (219) from the mixture. As expected, the only peaks remaining 
corresponded to the acid homodimer (217), heterodimer (220), and unconverted acid 
monomer. Purification of the heterodimer continued to be challenging as a result of the 
partial overlap of acidic monomer with the heterodimer but we confirmed the 
heterodimerization with a low isolated yield of ~20%.  
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Scheme 45. Initial result using chemoselective purification strategy 
 
 The next reaction was performed with the goal of promoting full conversion of the 
acid monomer and reducing homodimerization through more extreme stoichiometric 
manipulation and a longer residence time. With a 1:5 stoichiometric ratio of 3,4,5-
trimethoxycinnamic acid and the pyrrolidine-derived cinnamamide (215) and a 24 hour 
residence time a single major peak corresponding to the heterodimer (221) was observed 
(Scheme 46). The 1H NMR spectrum showed a diastereomeric ratio of 2:1 and the 
combined isolated yield was 93%.  These conditions were also shown to be effective with 
methyl cinnamate to provide 69% yield of heterodimers 222a/b. Furthermore, the 
uncatalyzed control reaction provided a significantly lower yield of 33%.  
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Scheme 46. Optimized heterodimerization reaction 
 
 Next, exploration of the substrate scope was commenced (Figure 39) which 
included imides, amides, and methyl esters as coupling partners with acid monomers at a 
5:1 ratio respectively. The reaction worked well with both amide and ester coupling 
partners while keeping the acid partner constant (220, 221, 222, 223). Surprisingly, the 
reaction pairing the 3,4,5-trimethoxycinnamic acid with methyl m-fluoro cinnamate 
provided a low yield of heterodimer (225) of 35% despite the reactivity of both partners. 
Not surprisingly, the reaction of methyl 2,5-dichloro cinnamate provided low yields of less 
than 20% to the heterodimer 228 most likely as a result of steric hindrance on the aryl 
group affecting dimerization.  
 Variation of the acid partner was also effective in promoting heterodimerization 
(224, 225, 226). However, it became clear that reactivity of the acid is the crucial parameter 
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for promoting heterodimerization. For example, the much less reactive cinnamic acid 229 
and ferulic acid 230 did not yield heterodimer products when paired with pyrrolidine 
cinnamamide. However, when cinnamic acid was paired with a more reactive ester (methyl 
3,4-dimethoxy cinnamate), heterodimer 226 was obtained but full conversion of the 
cinnamic acid was not obtained even after 24 hours of residence time. Another limitation 
to note is that solubility of certain acid monomers in acetonitrile can be low, making them 
unusable in the reaction.  
 
Figure 39: Substrate Scope heterodimerization of cinnamate derivatives using chemoselective purification  
 
 Interestingly, selecting which partner has the acid functionalities and the ester 
functionalities seems to have a strong impact on the success of the reaction.   For example, 
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reactions to generate heterodimers 223 and 224 would be predicted to have only modest 
difference between the potential combinations. However, when the 3,4-
dimethoxycinnamic acid was used as the limiting acid component the reaction afforded 
95% heterodimer, in contrast to 50% when the 3,4,5-trimethoxycinnamic acid was used as 
the limiting acid (Scheme 47).  This is evidence that the reaction proceeds better when the 
slightly less reactive substrate is used as the limiting reagent. A logical finding when 
considering that homodimerization of the acid fragment is the most significant byproduct 
affecting yield of heterodimerization. 
 
Scheme 47. Effect of switching acid and methyl ester on coupling partner 
   
Next, confirmation of the stereochemistry of the two observed diastereomers was 
sought. Although chemical shifts of the cyclobutyl peaks of the two major diastereomers 
seemed to suggest that they were the same as obtained in the homodimerization (δ and β), 
the lack of precedent for these products necessitated more thorough characterization. Thus, 
2D NMR analysis was performed including NOESY, HMBC, and HSQC. The two 
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diastereomers chosen to investigate were the heterodimers 222a and 222b tentatively 
assigned as the δ and β respectively. 
A key HMBC correlation between cyclobutyl peak Ha and carbonyl carbon C1 
suggests head-to-head regiochemistry of heterodimer 222a (Figure 40). Carbonyl peaks 
were confirmed by HMBC correlation of the methyl ester carbonyl with one of the methoxy 
proton peaks.  NOE interactions between cyclobutyl peak Hc and aryl protons Hb and Hc 
support the δ stereochemical assignment.  
 
 
 
Figure 40. 2D NMR interactions for characterization of δ heterodimer diastereomer 222a 
 
A key HMBC correlation between cyclobutyl peak Ha and aryl carbon C1 suggests 
head-to-head regiochemistry of heterodimer 222b (Figure 41). Once again, carbonyl peaks 
were confirmed by HMBC correlation of the methyl ester carbonyl with one of the methoxy 
proton peaks.   NOE interactions between cyclobutyl protons Ha and Hd as well as aryl 
protons Hb, and Hc support the β stereochemical assignment. 
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Figure 41: 2D NMR interactions for characterization of β heterodimer diastereomer 222b  
 
Two Step Formal Synthesis of Piperarborenine D 
 
Synthesis of piperarborenine D has previously been reported by Baran and 
coworkers and discussed in Chapter 1.118 Herein is described a short formal synthesis of 
piperarborenine D enabled by the heterodimerization methodology described above. 
Retrosynthetically, piperarborenine D can be disconnected at the imide functionality to 
provide commercially available lactam fragment 231 and truxinic acid 232 and indeed, 
this was the final step in Baran’s synthesis (Scheme 48A). Truxinic acid 232 can easily 
be accessed from heterodimer 224b, which has been successfully synthesized using the 
heterodimerization strategy in 95% yield as a mixture of diastereomers in a 1:2 d.r. A 
simple saponification of this dimer proceeded smoothly to furnish truxinic acid 232 in 
97% yield (Scheme 48B). From this point, piperarborenine D can be accessed using 
Baran’s protocol.  
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Scheme 48. Retrosynthetic analysis and formal synthesis of piperarborenine D.  
 
Section Three: Conclusions 
 
In conclusion, the first efficient general intermolecular heterodimerization of 
cinnamic acid derivatives is presented. The key to success of this methodology was 
optimization of stoichiometry and reactivity and a chemoselective purification taking 
advantage of the acid-base properties of the heterodimers compared to the undesired 
homodimer products. Although there remain some limitations to this methodology 
including substrate scope, solubility, and throughput issues, to the best of our knowledge 
it is the only methodology currently available to access these substrates with the efficiency 
with which we have shown. This methodology will be instrumental in the enabling the 
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thorough exploration of various truxinic and truxillic heterodimers commonly seen in 
bioactive natural products. 
  
Section Four: Experimental Methods and Analytical Data 
 
General Procedure for Synthesis of Heterodimers: 
 
To a solution of 3,4,5-trimethoxycinnamic acid (100 mg, 0.419 mmol, 1 equiv.) in 
acetonitrile, add cinnamate or cinnamamide substrate (5 eq) and bis-thiourea catalyst 143 
(7 mol%). Take solution up into a syringe and attach to Luer fitting of flow photoreactor. 
The reaction mixture is pumped through the reactor irradiated by UV light (>305 nm) using 
a syringe pump at a flow rate to give a 24 h residence time (typical flow rate 1.25 μL/min 
based on a 1.8 mL reactor volume). The reaction mixture collected at the end of the reactor 
is poured into a separatory funnel containing ethyl acetate (50 mL) and saturated sodium 
bicarbonate (50 mL). The organic layer is extracted with saturated sodium bicarbonate (50 
mL x 3). The combined aqueous layers are collected then acidified to pH 3 with 1 M HCl. 
This aqueous solution is extracted with ethyl acetate (100 mL x 3). The combined organic 
layers are washed with brine (50 mL x 1), dried over sodium sulfate, and concentrated in 
vacuo to yield the crude mixture containing the heterodimer products. The crude mixture 
is purified by column chromatography (gradient 5%-10% MeOH/DCM) to yield the pure 
heterodimer products.  
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IR (thin film): ν = 2996, 2943, 1734, 1589, 1516, 1463, 1420, 1328, 
1239, 1125, 1025, 912, 732;   1H NMR (500 MHz, CDCl3): δ;6.70 (d, 
J= Hz, 1 H), 6.60 (dd, J1= Hz, J2= Hz, 1 H), 6.33 (d, J= Hz, 1 H), 
6.12 (s, 2 H), 4.36-4.32 (m, 1 H), 4.28-4.25 (m, 1 H), 3.91-3.85 (ovrlp, 2H), 3.80 (s, 3 H), 
3.77 (s, 3H), 3.74 (s, 3 H), 3.65 (s, 6 H), 3.63 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ= 
177.5, 173.0, 153.0, 148.8, 148.0, 136.9, 134.1, 130.9, 119.7, 111.8, 110.9, 105.3, 61.0, 
56.3, 56.0, 55.9, 52.4, 45.4, 44.8, 43.6, 43.5; HRMS Calc. for C24H28O9: [M+Na]
+ = 
483.1631 m/z, found: 483.1625 m/z. 
 
IR (thin film): ν = 2936, 2880, 2838, 1724, 1588, 1508, 1453, 1423, 
1345, 1327, 1235, 1186, 1124, 1007, 913, 730, 700;   1H NMR (500 
MHz, CDCl3): δ;7.20-7.11 (ovrlp, 3 H), 7.01 (d, J= Hz, 2 H), 6.07 
(s, 2 H), 4.58 (t, J= Hz, 1 H), 4.07 (m, 1 H), 3.91-3.84 (ovrp, 2 H), 3.71 (s, 3H), 3.60 (s, 
6H), 3.54-3.43 (ovrlp, 3 H), 3.26-3.21 (m, 1 H), 1.91-1.83 (ovrlp, 4H); 13C NMR (125 
MHz, CDCl3): δ= 174.9, 171.8, 152.7, 139.0, 136.5, 134.4, 128.5, 128.1, 126.9, 105.2, 
60.9, 56.0, 46.5, 46.3, 45.4, 43.7, 26.1, 24.4; HRMS Calc. for C25H29NO6: [M+Na]
+ = 
462.1893, found: 462.1888  m/z. 
 
IR (thin film): ν = 2943, 1717, 1590, 1509, 1463, 1423, 1343, 1279, 
1238, 1126, 1001, 831; 1H NMR (500 MHz, CDCl3): δ 7.52 (s, 4 H), 
3.82 (ovrlp, 9 H), 3.65 (AA’BB’, JAB = 9.6 Hz, 2 H), 3.49 (AA’BB’, 
JAB = 9.6 Hz, 2 H); 13C NMR (125 MHz, CDCl3): δ= 177.0, 153.4, 136.1, 110.0, 103.7, 
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60.9, 56.1, 47.8, 44.0; HRMS Calc. for C24H28O10: [M+Na]
+ = 499.1580, found: 499.1562  
m/z.  
 
IR (thin film): ν = 2949, 1730, 1589, 1511, 1456, 1238, 1126, 1009, 
700;   1H NMR (500 MHz, CDCl3): δ 7.36-7.29 (ovrlp, 5 H), 6.51 (s, 
2 H), 3.85-3.82 (ovrlp, 10 H), 3.75 (s, 3 H), 3.67 (m, 1 H), 3.50-3.48 
(ovrlp, 2 H); 13C NMR (125 MHz, CDCl3): δ= 177.2, 172.9, 153.3, 140.7, 137.1, 136.4, 
128.7, 127.3, 126.7, 103.7, 60.8, 56.1, 52.4, 47.8, 47.3, 44.4, 43.9; HRMS Calc. for 
C22H23FO7: [M+Na]
+ = 423.1420 m/z, found: 423.1427 m/z. 
 
IR (thin film): ν = 2922, 1729, 1589, 1509, 1456, 1238, 1126, 1006, 
700;   1H NMR (500 MHz, CDCl3): δ 7.35-7.31 (ovrlp, 5 H), 6.49 (s, 
2 H), 4.44-4.37 (ovrlp, 2 H), 4.02 (m, 1 H), 3.91-3.87 (ovrlp, 7 H), 
3.83 (s, 3 H), 3.41 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ= 173.8, 172.5, 153.1, 148.1, 
145.3, 138.3, 135.3, 128.6, 127.5, 104.4, 60.9, 56.1, 51.8, 47.0, 46.2, 41.9, 41.5 ; HRMS 
Calc. for C22H23FO7: [M+Na]
+ = 423.1420 m/z, found: 423.1439 m/z. 
 
IR (thin film): ν = 2951, 1733, 1702, 1653, 1589, 1465, 1237, 1126, 
975, 745 ;   1H NMR (500 MHz, CDCl3): δ 7.13 (m, 1 H), 6.82 (m, 1 
H), 6.74 (d, J= 7.8 Hz), 6.68 (m, 1 H), 6.10 (s, 2 H), 4.35-4.34 (ovrlp, 
2 H), 3.83-3.81 (ovrlp, 2 H), 3.77 (s, 3 H), 3.74 (s, 3 H), 3.66 (s, 6 H); 
13C NMR (125 MHz, CDCl3): δ= 176.9, 172.7, 153.4, 152.8, 143.3, 137.3, 135.9, 130.3, 
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130.2, 122.4, 114.3, 114.2, 113.8, 113.6, 105.1, 104.4, 103.7, 60.8, 56.0, 52.5, 47.7, 46.8, 
44.4, 43.8; HRMS Calc. for C22H23FO7: [M+H]
+ = 419.1506 m/z, found: 419.1512 m/z. 
 
IR (thin film): ν = 2958, 1734, 1576, 1339, 1167, 1006;   1H NMR 
(500 MHz, CDCl3): δ 7.30 (m, 1H), 7.07 (m, 1 H), 7.01 (m, 1 H), 6.97 
(m, 1 H), 6.50 (s, 2 H), 3.83 (ovrlp, 9 H), 3.78 (s, 3 H), 3.73 (m, 1 H), 
3.65 (m, 1 H), 3.48-3.45 (ovrlp, 2 H); 13C NMR (125 MHz, CDCl3): 
δ= 176.6, 172.6, 163.7, 161.7, 152.8, 141.0, 140.9, 136.9, 133.4, 129.7, 129.6, 123.4, 114.8, 
114.6, 113.6, 113.4, 105.1, 60.8, 56.0, 52.4, 45.3, 44.6, 42.6, 40.2 ; HRMS Calc. for 
C22H23FO7: [M+H]
+ = 419.1506 m/z, found: 419.1512 m/z. 
 
1H NMR (500 MHz, CDCl3): δ 6.70 (d, J= Hz, 1 H), 6.60 (dd, J1= 
J2= Hz, 1 H), 6.33 (d, J= Hz, 1 H), 6.12 (s, 2 H), 4.34 (m, 1 H), 4.26 
(m, 1 H), 3.85-3.84 (ovrlp, 2 H), 3.80 (s, 3 H), 3.76 (s, 3H), 3.74 (s, 
3 H), 3.65 (s, 6 H), 3.63 (s, 3 H) 13C NMR (125 MHz, CDCl3): δ= 175.6, 172.2, 152.8, 
147.8, 136.1, 135.1, 134.0, 130.7, 124.6, 119.6, 111.6, 110.7, 110.0, 105.2, 60.8, 56.0, 55.8, 
52.3, 45.1, 44.8, 43.4;  HRMS Calc. for C22H28O9 :[M+Na]
+ = 483.1631 m/z, found 
483.1624 m/z.  
 
IR (thin film): ν = 2958, 1563, 1375, 1307, 1248, 1108, 997; 1H 
NMR (500 MHz, CDCl3): δ 7.22 (d, J= Hz, 2 H), 6.88-6.84 (ovrlp, 3 
H), 6.83-6.81 (ovrlp, 2 H), 3.86 (s, 3 H), 3.84 (s, 3 H), 3.79 (s, 3 H), 
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3.75 (s, 3 H), 3.65-3.63 (ovrlp, 2 H), 3.45-3.43 (ovrlp, 2 H); 13C NMR (125 MHz, CDCl3): 
δ=, HRMS Calc. for C22H24O7: [M+H]+ = 401.1600 m/z, found 401.1607 m/z.  
 
IR (thin film): ν = 2958, 1563, 1375, 1307, 1248, 1108, 997; 1H 
NMR (500 MHz, CDCl3): δ 6.87 (d, J= Hz, 2 H), 6.70-6.66 (ovrlp, 3 
H), 6.57 (dd, J1= 2.1, J2= 8.7 Hz, 1 H), 6.27 (d, J= 2.1 Hz, 1 H), 4.34 
(m, 1 H), 4.28 (m, 1 H), 3.87-3.85 (ovrlp, 2 H), 3.79 (s, 3 H), 3.76 (s, 3 H), 3.72 (s, 3 H), 
3.61 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ= , HRMS Calc. for C22H24O7 :[M+H]+ = 
401.1600 m/z, found 401.1607 m/z.  
 
IR (thin film): ν = 2953, 1730, 1517, 1439, 1239, 1163, 1026, 800; 
1H NMR (500 MHz, CDCl3): δ 7.38-7.29 (ovrlp, 5 H), 6.85-6.81 
(ovrlp, 3 H), 3.86 (s, 3 H), 3.85 (s, 3 H), 3.75-3.71 (ovrlp,  4H), 3.67 
(dd, J1=J2= 9.4 Hz, 1 H), 3.51 (dd, J1=J2= 9.4 Hz, 1 H), 3.45 (dd, J1=J2= 9.4 Hz, 1 H); 13C 
NMR (125 MHz, CDCl3): δ=172.9, 172.2, 148.2, 145.8, 140.6, 133.4, 128.7, 127.2, 126.7, 
118.8, 111.2, 110.1, 55.8, 52.3, 51.5, 47.4, 47.2, 44.6, 41.4 , HRMS Calc. for C21H22O6 
:[M+H]+ = m/z, found m/z.  
 
IR (thin film): ν = 2933, 1732, 1516, 1251, 1162, 1061, 911, 766, 1H 
NMR (500 MHz, CDCl3): δ 7.15 (t, J= 7.1 Hz, 2 H), 7.09 (dd, J1 = J2 
= 7.1  Hz, 1 H), 6.95 (d, J= 7.1 Hz, 2 H), 6.65 (d, J= Hz, 1 H), 6.57 
(d, J= Hz, 1 H), 6.23 (s, 1 H), 4.40-4.32 (ovrlp, 2 H), 3.88-3.85 (ovrlp, 2 H), 3.78 (s, 3 H), 
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3.75 (s, 3 H), 3.57 (s, 3 H) ; 13C NMR (125 MHz, CDCl3): δ=, HRMS Calc. for C21H22O6 
:[M+H]+ = m/z, found m/z.  
 
 
 
 
 
 
 
 
 
  
200 
 
 
  
201 
 
 
 
 
  
202 
 
 
 
  
203 
 
 
 
 
 
  
204 
  
205 
 
 
 
 
 
  
206 
 
 
  
207 
 
 
 
 
 
  
208 
 
 
 
 
 
 
  
209 
 
 
 
  
210 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
211 
 
 
 
 
 
 
 
 
  
212 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
213 
 
 
  
214 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
215 
 
  
216 
LIST OF JOURNAL ABBREIVIATIONS 
 
Acta Poloniae Pharmaceutica ................................................ Acta Poloniae Pharmaceutica 
Altern. Med. ........................................................................................ Alternative Medicine 
Am J Bot .................................................................................. American Journal of Botany 
Am Rev Soviet Med.................................................. American Review of Soviet Medicine 
Anal Quim ............................................................................................... Anales de Quimica 
Angew. Chem., Int. Ed. ................... Angewandte Chemie International Edition in English 
Arch. Pharm. Res. ............................................................. Archives of Pharmacal Research 
Aust. J. Chem  .................................................................... Australian Journal of Chemistry 
Bioorg. Med. Chem....................................................... Bioorganic & Medicinal Chemistry 
Bull. Chem. React. Eng. Catal.  ... Bulletin of Chemical Reaction Engineering & Catalysis 
Bull Chem. Soc. Jpn............................................ Bulletin of the Chemical Society of Japan 
Chem. Commun.  ....................................................................... Chemical Communications 
Chem. Eng. Sci.  .................................................................. Chemical Engineering Science 
Chem. Eur. J.  .................................................................... Chemistry—A European Journal 
ChemPhotoChem  ..................................................................................... ChemPhotoChem 
Chem. Pharm. Bull. .................................................. Chemical and Pharmaceutical Bulletin 
Chem. Rev............................................................................................... Chemical Reviews 
Cryst. Growth Des.  ................................................................... Crystal Growth and Design 
Eur. J. Pharm. Sci  .......................................... European Journal of Pharmaceutical Science 
European J. Org. Chem.  ........................................ European Journal of Organic Chemistry 
Farmakol Toksikol  ............................................................... Farmacologiia i Toksikologiia 
  
217 
Fitoterapia  ............................................................................................................. Fitoterpia 
Ind. Eng. Chem. Fundam.  .................. Industrial & Engineering  Chemistry Fundamentals 
Ind. Eng. Chem. Res.  .................................. Industrial & Engineering Chemistry Research 
Int. J. Crude Drug Res ................................. International Journal of Crude Drug Research 
Int. J. Heat Fluid Flow  .................................. International Journal of Heat and Fluid Flow 
Isr. J. Chem.  ............................................................................. Israeli Journal of Chemistry 
J. Am. Chem. Soc. ............................................ Journal of the American Chemical Society 
J. Biosci.  ............................................................................................. Journal of Bioscience 
J. Comput. Appl. Math.  ........................ Journal of Computational & Applied Mathematics 
J. Chromatogr., A ................................................................ Journal of Chromatrography, A 
J. Ethnopharmacol................................................................ Journal of Ethnopharmacology 
J. Flow Chem. .............................................................................Journal of Flow Chemistry 
J. Med. Chem  .....................................................................Journal of Medicinal Chemistry 
J. Nat. Med  .............................................................................. Journal of Natural Medicine 
J. Nat. Prod. ............................................................................... Journal of Natural Products 
J. Org. Chem. ......................................................................... Journal of Organic Chemistry 
J. Org. Process Res. Dev. .............. Journal of Organic Process Research and Development 
J. Pharm. Pharmacol  ............................................... Journal of Pharmacy & Pharmacology 
J. Photochem  .............................................................................. Journal of Photochemistry 
J. Photochem. Photobiol., A... Journal of Photochemistry and Photobiology, A: Chemistry 
J. Phys. Chem.  ...................................................................... Journal of Physical Chemistry 
J. Planar Chromatogr. .................................................... Journal of Planar Chromatography 
  
218 
Khim Farmatsev Zh  .................................................. Khimiko Farmatsevticheskii Zhurnal 
Lab Chip ......................................................................................................... Lab on a Chip 
Nature  ......................................................................................................................... Nature 
Nat. Publ. Gr.  .................................................................................... National Public Grant 
Org. Biomol. Chem. ..................................................... Organic & Biomolecular Chemistry 
Org. Lett.  ......................................................................................................Organic Letters 
Org. Process Res. Dev.  ................................. Organic Process Research and Development 
Org. Synth ................................................................................................ Organic Synthesis 
Pak. J. Pharm. Sci.  ......................................... Pakistani Journal of Pharmaceutical Science 
Photobiochem. Photobiophys.  .......................... Photobiochemistry & Photobiophysiology 
Phytochemistry. ........................................................................................... Phytochemistry 
Phytochem. Lett. ................................................................................ Phytochemical Letters 
Planta Med  .....................................................................................................Planta Medica 
PLOS ............................................................................................. Public Library of Science 
React. Chem. Eng  ............................................................. Reaction Chemical Engineering 
Science ...................................................................................................................... Science 
Sci. China Chem ...................................................................... Science in China, Chemistry 
Synlett  ....................................................................................................... Synthetic Letters 
Synth  ..................................................................................................................... Synthesis 
Tetrahedron Lett..................................................................................... Tetrahedron Letters 
Z. Anorg. Allg. Chem  .......................... Zeitschrift fur anorganische & allgemeine Chemie 
Z. Naturforsch.  ................................................................. Zeitschrift fur Naturforschung B 
  
219 
Zh Obshch Khim  ......................................................................... Zhurnal Obshchei Khimii 
 
 
  
220 
BIBLIOGRAPHY 
 
1 Sergeiko, A.; Poroikov, V. V.; Hanus, L. O.; Dembitsky, V. M. The Open Medicinal 
Chemistry Journal, 2008, 2, 26-38 
2 Krause-Baranowska, M. Truxillic and Truxinic Acids-Ocurrence in Plant Kingdom. Acta 
Poloniac Pharmaceutica. 2002, pp 403–410. 
3 Dembitsky, V. M. Bioactive Cyclobutane-Containing Alkaloids; 2008, 62. 
4  Fan, Y. Y.; Gao, X. H.; Yue, J. M. Attractive Natural Products with Strained 
Cyclopropane and/or Cyclobutane Ring Systems. Sci. China Chem. 2016, 59 (9), 1126–
1141. 
5 Lei, T.; Zhou, C.; Huang, M. Y.; Zhao, L. M.; Yang, B.; Ye, C.; Xiao, H.; Meng, Q. Y.; 
Ramamurthy, V.; Tung, C. H.; et al. General and Efficient Intermolecular [2+2] 
Photodimerization of Chalcones and Cinnamic Acid Derivatives in Solution through 
Visible-Light Catalysis. Angew. Chemie - Int. Ed. 2017, 56 (48), 15407–15410. 
6 Vallavoju, N.; Selvakumar, S.; Jockusch, S.; Sibi, M. P.; Sivaguru, J. Enantioselective 
Organo-Photocatalysis Mediated by Atropisomeric Thiourea Derivatives. Angew. Chemie 
- Int. Ed. 2014, 53 (22), 5604–5608. 
7 Du, J.; Skubi, K. L.; Schultz, D. M.; Yoon, T. P. Science, 2014, 392-396 
8 Tröster, A.; Alonso, R.; Bauer, A.; Bach, T. Enantioselective Intermolecular [2 + 2] 
Photocycloaddition Reactions of 2(1H)-Quinolones Induced by Visible Light Irradiation. 
J. Am. Chem. Soc. 2016, 138 (25), 7808–7811. 
                                                        
  
221 
                                                                                                                                                                     
9 Poplata, S.; Tro, A.; Zou, Y.; Bach, T. Recent Advances in the Synthesis of Cyclobutanes 
by Olefin [ 2 + 2] Photocycloaddition Reactions. Chem. Rev. 2016, 116, 9748-9814 
10 Telmesani, R.; Park, S. H.; Lynch-Colameta, T.; Beeler, A. B. Photocycloaddition of 
Cinnamates in Flow and Development of a Thiourea Catalyst. Angew. Chemie - Int. Ed. 
2015, 54 (39), 11521–11525. 
11  Telmesani, R.; White, J. A. H. White, Beeler, A. B. Liquid-Liquid Slug Flow 
Accelerated [2+2] Photocycloaddition of Cinnamates- ChemPhotoChem, 2018 
12 Hartley, R. D.; Morrison, W. H.; Balza, F.; Towers, G. H. N. Substituted Truxillic and 
Truxinic Acids in Cell Walls of Cynodon Dactylon. Phytochemistry 1990, 29 (12), 3699–
3703. 
13  Morrison, I. M.; Robertson, G. W.; Stewart, D.; Wightman, F. Determination and 
Characterization of Cyclodimers of Naturally Occurring Phenolic Acids. Phytochemistry 
1991, 30 (6), 2007–2011. 
14 Hanley AB, Russell WR, Chesson A. Formation of substituted truxillic and truxinic 
acids in plant-cell walls—a rationale. Phytochemistry, 1993, 33:957–960 
49. 
15 Moore, J. M.; Casale, J. F.; Cooper, D. A. Comparative Determination of Total Isomeric 
Truxillines in Illicit, Refined, South American Cocaine Hydrochloride Using Capillary Gas 
Chromatography-Electron Capture Detection. J. Chromatogr. A 1996, 756 (1–2), 193–201. 
16  Novák, M.; Salemink, C. A.; Khan, I. Biological Activity of the Alkaloids of 
Erythroxylum Coca and Erythroxylum Novogranatense. J. Ethnopharmacol. 1984, 10 (3), 
261–274. 
  
222 
                                                                                                                                                                     
17 Rahman AU, Khattak KF, Nighat F, Shabbir M, Hemalal KD, Tillekeratne LM Dimeric 
tropane alkaloids from Ery- throxylum moonii. Phytochemistry, 1998,  48, 377–383 
18 Hartmann, R.; San-Martin, A.; Munoz, O.; Breitmaier, E.; Grahamine an unusual tropane 
alkaloid from Schizanthus grahamii. Angew Chem, 1990, 102, 441–443 
19 Sudo, H.; Ide, T.; Otsuka, H.; Hirata, E.; Takushi, A.; Shinzato, T.; Takeda, Y. Chem. 
Pharm. Bull. 2000, 48, 6542 
20 Beck, A. B.; Goldspink, B. H.; Knox, J. R. A re-examination of the alkaloids of Lupinus 
cosentinii (Guss.). J Nat Prod, 1979, 42, 385–398 
21 Mashkovskii, M. D. Pharmacology of the alkaloid, thesine. Am Rev Soviet Med. 1944,  
2, 67–69 
22  Arendaruk, A. P.; Proskurnina, N. F.; Konovalova, R. A. Alka- loids of Thesium 
minkwitzianum plant. Zh Obshch Khim, 1960, (USSR) 30, 670–676 
23  Arendaruk, A. P.;  Skoldinov, A. P. Cyclobutanedicarboxylic acids. I. Structure of 
thesinic acid. Zh Obshch Khim (USSR), 1960, 30, 484–488 
24  Dimberg, L. H.; Andersson, R. E.; Gohil, S.; Bryngelsson, S.; Lundgren, L. N. 
Identification of a Sucrose Diester of a Substituted β-Truxinic Acid in Oats. 
Phytochemistry 2001, 56 (8), 843–847. 
25 Lu, Y.; Foo, L. Y. Phytochemistry, 1999, 51, 91  
26 Deng, Y.; Chin, Y. W.; Chai, H. B.; De Blanco, E. C.; Kardono, L. B. S.; Riswan, S.; 
Soejarto, D. D.; Farnsworth, N. R.; Kinghorn, A. D. Phytochemical and Bioactivity Studies 
on Constituents of the Leaves of Vitex Quinata. Phytochem. Lett. 2011, 4 (3), 213–217. 
  
223 
                                                                                                                                                                     
27 Wang J, Li P, Li B, Guo Z, Kennelly EJ, Long C. Bioactivities of Compounds from 
Elephantopus scaber, an Ethnomedicinal Plant from Southwest China. Evidence-based 
Complementary and Alternative Medicine‚ÄØ: eCAM. 2014;2014:569594. 
doi:10.1155/2014/569594. 
28 Liang, D.; Liu, Y. F.; Hao, Z. Y.; Luo, H.; Wang, Y.; Zhang, C. L.; Chen, R. Y.; Yu, D. 
Q. Acylated Flavonol Glycosides and δ-Truxinate Derivative from the Aerial Parts of 
Lysimachia Clethroides. Phytochem. Lett. 2015, 11, 116–119. 
29 Jiangsu Botanic Institute, Part II, Shanghai Science and Technology Press, Shanghai, 
1991, 364-371 
30 Lee, J.; Kim, N. H.; Nam, Y. M.;  J. W.; Lee, Y. M.; Jang, D. S.; Kim,  Y. S.;  Nam, S. 
H.; Seo, E. K.; Yang, M. S.; Kim, J. S. Arch. Pharm. Res. 2010, 33, 1317-1323  
31 Kim, J.; Kim, C. S.; Lee, Y. M.; Sohn, E.; Jo, K.; Shin, S. D.; Kim, J. S. Scopoletin 
Inhibits Rat Aldose Reductase Activity and Cataractogenesis in Galactose-Fed Rats. 
Evidence-based Complement. Altern. Med. 2013, 2013. 
32 Fujiwara, A.; Nishi, M.; Yoshida, S.; Hasegawa, M.; Yasuma, C.; Ryo, A.; Suzuki, Y. 
Eucommicin A, a β-Truxinate Lignan from Eucommia Ulmoides, Is a Selective Inhibitor 
of Cancer Stem Cells. Phytochemistry 2016, 122, 139–145. 
33  Pattabiraman, D. R.; Weinberg, R. A. Tackling the Cancer Stem Cells — What 
Challenges Do They Pose? Nat. Publ. Gr. 2014, 13 (7), 497–512. 
34  Nakamura, M.; Chi, Y. M.; Yan, W. M.; Nakasugi, Y.; Yoshizawa, T.; Irino, N.; 
Hashimoto, F.; Kinjo, J.; Nohara, T.; Sakurada, S. Strong Antinociceptive Effect of 
  
224 
                                                                                                                                                                     
Incarvillateine, a Novel Monoterpene Alkaloid from Incarvillea Sinensis. J. Nat. Prod. 
1999, 62 (9), 1293–1294. 
35 Nakamura, M.; Chi, Y.M.; Yan, W-M.; Yonezawa, A.;  Nakasugi, Y.;  Yoshizawa, T.; 
Hashimoto, F.; Kinjo, J.; Nohara, T.; Sakurada, S. Structure-antinociceptive activity 
studies of incarvil- lateine, a monoterpene alkaloid from Incarvillea sinensis. Planta Med 
2001, 67, 114–117 
36 Chi Y-C.; Hashimoto, F.; Yan, W-M.;  Nohara, T. Four monoterpene alkaloid derivatives 
from Incarvillea sinensis. Phytochemistry, 1997, 46, 763–769 
37 Chi, Y-M.; Nakamura, M.; Zhao, X-Y.;  Yoshizawa, T.;  Yan, W-M.; Hashimoto, F.;  
Kinjo, J.;  Nohara, T.; A monoterpene alkaloid from Incarvillea sinensis. Chem Pharm 
Bull. 2005,  53,1178–1179 
38 El-Ansari, M. A.; Nawwar, M. A.; Saleh, N. A. M. Phytochemistry, 1995, 40, 1543 
39 Isaza, M. J. H.; Ito, H.; Yoshida, T. Monochaetin, a Di-Hyperin Ester of Tetrahydroxy-
μ-Truxinic Acid from Monochaetum Multiflorum. Chem. Pharm. Bull. 1999, 47 (10), 
1510–1511. 
40 Krauze-Baranowska, M.; Malinowska, I.; Skwierawska, J. J. Planar Chromatogr. 2002, 
15, 437-441. 
41 Johnson, T. Ethnobotany Desk Reference. CRC Press, New York, USA, 1999 
42  Krauze-Baranowska, M.; Sowiński, P.; Kawiak, A.; Sparzak, B. Flavonoids from 
Pseudotsuga Menziesii. Zeitschrift fur Naturforsch. - Sect. C J. Biosci. 2013, 68 C (3–4), 
87–96. 
  
225 
                                                                                                                                                                     
43 Nehme M, Landa A, Ribas I (1977) Alkaloids of Papilionacea. LXII. Study of alkaloids 
of Adenocarpus complicatus (L.) Gay, subspecies Aureus (Cav.) Vicioso. An Quim 
(Brazil) 73:307– 308 
44 Faugeras G (1970) Alkaloids and polyphenols of legumes. XVIII. Adenocarpus mannii 
alkaloids. Presence of (+)-adeno- carpine, isoorensine, and santiaguine in leaves. Plant 
Med Phytotherap (Paris) 4:9–20 
45 Gonzalez AG, Gonzalez EG, Cartaya LM (1953) The alkaloids of Adenocarpus foliosus. 
Anal Real Soc Esp Fisica Quim (Madrid) 49B:783–788 
46 Ribas I, Talarid P (1950) Adenocarpine and santiaguine, two alkaloids from the broom 
of Galicia. Mon Farm Terapia (Madrid) 56:377–379 
47 Ribas I (1960) Alkaloids of species of genus Adenocarpus D.C. Rev Real Acad Ciencia. 
Exacts: Fisica Natura (Madrid) 54:405– 414 
48 Luces J, Dominguez J, Ribas I (1958) Alkaloids of the Papi- lionaceae. XXXI. The 
chemistry of orensine and santiaguine. Anal Real Soc Esp: Fisica Quim (Madrid) 54B:215–
222 
49 Ribas I (1963) The alkaloids of Adenocarpus species. Abhandl Deut Akad Wiss Geol 
Biol 4:149–157 
50  O’Donovan DG, Creedon PB (1974) Biosynthesis of santiaguine in Adenocarpus 
foliosus. II. J Chem Soc Perkin Trans 1 22:2524–2548 
51 Nehme M, Landa A, Ribas I (1975) Papilionaceae alkaloids. LXI. Structure of meso-
santiaguine. Anal Quim 71:627–628 
  
226 
                                                                                                                                                                     
52  Fitzgerald JS, Johns SR, Lamberton JA, Redcliffe AH (1972) Alkaloids of Hovea 
longipes (Leguminosae): the structure of a hypotensive alkaloid. Anal Quim 68:737–742 
53 Lamberton JA, Morton TC, Suares H (1982) Alkaloids of Hovea linearis R.Br. The 
isolation of Ormosia group alkaloids. Aust J Chem 35:2577–2582 
54 Soltis PA, Soltis DE, ChaseMW, Angiosperm phylogeny inferred from multiple genes 
as a tool for comparative biology. Nature, 1999, 402, 402–404 
55 Jaramillo MA, Manos PS (2001) Phylogeny and patterns of floral diversity in the genus 
Piper (Piperaceae). Am J Bot 88:706–716 
56 Tsukamoto, S.; Cha, B.; Ohta, T. Dipiperamides A , B , and C : Bisalkaloids from the 
White Pepper Piper Nigrum Inhibiting CYP3A4 Activity. 2002, 58, 1667–1671. 
57 Tsukamoto, S.; Tomise, K.; Miyakawa, K.; Cha, B. C.; Abe, T.; Hamada, T.; Hirota, 
H.; Ohta, T. CYP3A4 Inhibitory Activity of New Bisalkaloids, Dipiperamides D and E, 
and Cognates from White Pepper. Bioorganic Med. Chem. 2002, 10 (9), 2981–2985. 
58 Wei K, Li W, Koike K, Chen Y, Nikaido T (2005) Nigramides A–S, dimeric amide 
alkaloids from the roots of Piper nigrum. J Org Chem 70:1164–1176 
59 Fujiwara Y, Naithou K, Miyazaki T, Hashimoto K, Mori K, Yamamoto Y (2001) Two 
new alkaloids, pipercyclobutanamides A and B, from Piper nigrum. Tetrahedron Lett 
42:2497–2499 
60 Matsuda, H.; Ninomiya, K.; Morikawa, T.; Yasuda, D.; Yamaguchi, I. 
Hepatoprotective Amide Constituents from the Fruit of Piper Chaba : Structural 
Requirements , Mode of Action , and New Amides. Bioorg. Med. Chem. 2009, 17 (20), 
7313–7323. 
  
227 
                                                                                                                                                                     
61 Tewtrakul, S.; Hase, K.; Kadota, S.; Namba, T.; Komatsu, K.; Tanaka, K. J. Essent. Oil 
Res. 2000, 12, 603. 
62 Lee F-P, Chen Y-C, Chen J-J, Tsai I-L, Chen I-S Cy- clobutanoid amides from Piper 
arborescens. Helv Chim Acta 2004, 87:463–468 
63 Maxwell A, Rampersad D (1991) A new dihydropiplartine and. piplartine dimer from 
Piper rugosum. J Nat Prod 54:1150–1152 
64 Duh CY, Wu YC, Wang S K (1990) Cytotoxic pyridone alka- loids from the leaves of 
Piper aborescens. J Nat Prod 53:1575– 1577 
65 Hadom H, Jungkunz R (1951) Pepper and cubebs. Pharm Acta Helv 26:25–31 
66 Sommerwerk, S.; Kluge, R.; Ströhl, D.; Heller, L.; Kramell, A. E.; Ogiolda, S.; 
Liebing, P.; Csuk, R. Synthesis, Characterization and Cytotoxicity of New Piplartine 
Dimers. Tetrahedron 2016, 72 (11), 1447–1454. 
67 Maxwell, A.; Rampersad, D. A New Dihydropiplartine and Piplartine Dimer from 
Piper Rugosum. J. Nat. Prod. 1991, 54 (4), 1150–1152. 
68 Tsai I-L, Lee F-P, Wu C-C, Duh C-Y, Ishikawa T, Chen J-J, Chen Y-C, Seki H, Chen I-
S (2005) New cytotoxic cyclobuta- noid amides, a new furanoid lignan and anti-platelet 
aggregation constituents from Piper arborescens. Planta Med 71:535–542 
69 Dhar KL, Shah S, Prabhakar A, Sharma RL (1995) New pyrr- olidinamide dimers from 
Piper peepuloides. Fitoterapia 66:390– 392 
70 Sharma RL, Kumari M, Kumar N, Prabhakar A (1999) New piperidinamide dimers from 
Piper peepuloides. Fitoterapia 70:144–147 
  
228 
                                                                                                                                                                     
71 Delle Monache G, Botts B, Delle Monache F, Espinal R, De Bonnevaux SC, De Luca 
C, Botta M, Corelli F, Dei D, Novel hypotensive agents from Verbesina caracasana. 3. Ca- 
racasandiamide, a truxinic hypotensive agent from Verbesina caracasana. Bioorg Med 
Chem Lett, 1996, 6, 233–238 
72 Carmignani, M.; Volpe, A. R.; Delle Monache, F.; Botta, B.; Espinal, R.; De Bonnevaux, 
S. C.; De Luca, C.; Botta, M.; Corelli, F.; Tafi, A.; et al. Novel Hypotensive Agents from 
Verbesina Caracasana. 6. Synthesis and Pharmacology of Caracasandiamide. J. Med. 
Chem. 1999, 42 (16), 3116–3125. 
73 Delle Monache, G.; Botta, B.; Delle Monache, F.; Espinal, R.; De Bonnevaux, S. C.; De 
Luca, C.; Botta, M.; Corelli, F.; Carmignani, M. Novel Hypotensive Agents from 
Verbesina caracasana. 2. Synthesis and Pharmacology of Caracasanamide. J. Med. Chem. 
1993, 36, 2956-2963 
74 McGee LR, Misra R (1990) Gilvocarcin photobiology. Isolation and characterization of 
the DNA photoadduct. J Am Chem Soc 112:2386–2389 
75 Hahn BS, Joshi PC, Kan LS, Wang SY (1981) Heterodimers of psoralen and thymine 
derivatives: properties, structure and ste- reochemistry. Photobiochem Photobiophys 
3:113–124 
190. 
76 Zhou, M.; Zhang, H. B.; Wang, W. G.; Gong, N. B.; Zhan, R.; Li, X. N.; Du, X.; Li, L. 
M.; Li, Y.; Lu, Y.; et al. Scopariusic Acid, a New Meroditerpenoid with a Unique 
Cyclobutane Ring Isolated from Isodon Scoparius. Org. Lett. 2013, 15 (17), 4446–4449. 
77 Umana, E.; Castro, O. Int. J. Crude Drug Res. 1990, 28, 175. 
  
229 
                                                                                                                                                                     
78 Li, Y.-S.; Matsunaga, K.; Ishibashi, M.; Ohizumi, Y. J. Org. Chem. 2001, 
66, 2165. 
79 Schafer, B.; Rimpler, H. Z. Naturforsch. 1979, 34, 311. (b) Franke, 
A.; Rimpler, H. Phytochemistry 1987, 26, 3015. 
80  Kharkevich DA (1970) Pharmacology of the new antidepolar- izing agents, 
anatruxonium, truxillonium, cyclobutonium, and pyrocyclonium. In: Kharkevich DA (ed) 
Novue kurarepodobnye ganglioblokiruyushchie stredstava. Meditsina, Moscow, pp 41– 48 
81 Kharkevich DA, Skoldinov AP, Arendaruk AP, Kazakova TP, Muratov VK (1974) 
Anatruxonium as a new curarelike agent of nondepolarizing action. Khim Farmatsev Zh 
(USSR) 8:59–62 
82 Kharkevich DA (1965) Pharmacological properties of the new curaroid, anatruxonium. 
Farmakol Toksikol (Moscow) 28:305– 309 
83 Lysíková, M.; Fuksová, K.; Elbert, T.; Jakubík, J.; Tuček, S. Subtype-Selective 
Inhibition of [Methyl- 3 H] -N-Methylscopolamine Binding to Muscarinic Receptors by 
α-Truxillic Acid Esters. Br. J. Pharmacol. 1999, 127 (5), 1240–1246. 
84 Kharkevich, D. A.; Skoldinov, A. P.; The derivatives of carboxylic acids. In: New 
Neuromuscular Blocking Agents. ed. Handbook of Experimental Pharmacology, 1986, 
79, 323-369 
85 He, M.; Su, H.; Gao, W.; Johansson, S. M.; Liu, Q.; Wu, X.; Liao, J.; Young, A. A.; 
Bartfai, T.; Wang, M. W. Reversal of Obesity and Insulin Resistance by a Non- Peptidic 
Glucagon-like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice. PLoS One 2010, 
5 (12). 
  
230 
                                                                                                                                                                     
86 Liu, Q.; Li, N.; Yuan, Y.; Lu, H.; Wu, X.; Zhou, C.; He, M.; Su, H.; Zhang, M.; Wang, 
J.; et al. Cyclobutane Derivatives as Novel Nonpeptidic Small Molecule Agonists of 
Glucagon-like Peptide-1 Receptor. J. Med. Chem. 2012, 55 (1), 250–267. 
87  Manandhar, B.; Ahn, J.-M. Glucagon-like Peptide-1 (GLP-1) Analogs: Recent 
Advances, New Possibilities, and Therapeutic Implications. J. Med. Chem. 2015, 58 (3), 
1020–1037. 
88 Berger, W. T.; Ralph, B. P.; Kaczocha, M.; Sun, J.; Balius, T. E.; Rizzo, R. C.; Haj-
Dahmane, S.; Ojima, I.; Deutsch, D. G. PLOS, 2012, 7, 12, 1-12 
89 Kohlschutter, H. W. Z. Anorg. Allg. Chem. 1918, 105, 121 
90 Cohen, M. D.; Schmidt, G. M. J. Am. Chem. Soc.1964, 1996-2000. 
91 Cohen, M. D.; Schmidt, G. M.; Sonntag, F. I. J. Am. Chem. Soc. 1964, 2000-2013. 
92 Schmidt, G. M. J. J. Am. Chem. Soc.  1964, 2014-2021. 
93 Ramamurthy, V.; Venkatesan, K. Photochemical Reactions of Organic Crystals. Chem. 
Rev. 1987, 87 (2), 433–481. 
94  Bertmer, M.; Nieuwendaal, R. C.; Barnes, A. B.; Hayes, S. E. Solid-State 
Photodimerization Kinetics of Alpha-Trans-Cinnamic Acid to Alpha-Truxillic Acid 
Studied via Solid-State NMR. J. Phys. Chem. B 2006, 110 (12), 6270–6273. 
95  Ito, Y.; Hosomi, H.; Ohba, S. Compelled Orientational Control of the Solid-State 
Photodimerization of Trans-Cinnamamides: Dicarboxylic Acid as a Non-Covalent Linker. 
Tetrahedron 2000, 56 (36), 6833–6844. 
  
231 
                                                                                                                                                                     
96 Chowdhury, M.; Kariuki, B. M. Supramolecular Assembly in Cinnamate Structures: The 
Influence of the Ammonium Ion and Halogen Interactions. Cryst. Growth Des. 2006, 6 (3), 
774–780. 
97 Natarajan, A.; Mague, J. T.; Venkatesan, K.; Ramamurthy, V. Large Molecular 
Motions Are Tolerated in Crystals of Diamine Double Salt of Trans -Chlorocinnamic 
Acids with Trans -1,2-Diaminocyclohexane. Org. Lett. 2005, 7 (10), 1895–1898. 
98 Ishigami, T.; Murata, T.; Endo, T. Bull Chem. Soc. Jpn, 1976, 49, 12, 3578-3583. 
99 M. D’Auria, A. Vantaggi, Tetrahedron, 1992, 48, 12, 2523-2528. 
100 F. D. Lewis, S. L. Quillen, P. D. Hale, J. D. Oxman, J. Am. Chem. Soc. 1988, 110, 1261-
1267 
101 H. Yuasa, M. Nakatani, H. Hashimoto, Org. Biomol. Chem. 2006, 4, 3694-3702 
102 Karthikeyan, S.; Ramamurthy, V. J. Org. Chem. 2007, 72, 452-458 
103 Pattabiraman, M.; Natarajan, A.; Kaanumalle, L. S.; Ramamurthy, V. Org. Lett. 2005, 
7, 4, 529-532 
104 Fujita, M.; Oguro, D.; Miyazawa, M.; Oka, H.; Yamaguchi, K.; Ogura, K. Nature 
1995, 378, 469-471. 
105 Devanathan, S.; Ramamurthy, V. Journal of Photochemistry and Photobiology, A: 
Chemistry, 1987, 40, 67-77 
106 T. Lei, C. Zhou, M.-Y. Huang, L.-M. Zhao, B. Yang, C. Ye, H. Xiao, Q.-Y. Meng, V. 
Ramamurthy, C.-H. Tung, L.-Z. Wu, Angew. Chem. Int. Ed. 2017, 56, 15407-15410 
107 S. K. Pagire, A. Hossain, L. Traub, S. Kerres, O. Reiser. Chem. Commun. 2017, 53, 
12072-12075. 
  
232 
                                                                                                                                                                     
108  Kemmler, M.; Herdtweck, E.; Bach, T. Inter- and Intramolecular [2+2]-
Photocycloaddition of Tetronates - Stereoselectivity, Mechanism, Scope and Synthetic 
Applications. European J. Org. Chem. 2004, No. 22, 4582–4595. 
109 Christiane, M.; Bauer, A.; Maturi, M. M.; Cuquerella, M. C.; Miranda, M. A.; Bach, T. 
Enantioselective Intramolecular [ 2 + 2 ] -Photocycloaddition Reactions of 4-Substituted 
Quinolones Catalyzed by a Chiral Sensitizer with a Hydrogen-Bonding Motif. 2011, 
16689–16697. 
110 Coote, S. C.; Bach, T. Enantioselective Intermolecular [2+2] Photocycloadditions of 
Isoquinolone Mediated by a Chiral Hydrogen-Bonding Template. 2013, 8–11. 
111 Tröster, A.; Alonso, R.; Bauer, A.; Bach, T. Enantioselective Intermolecular [2 + 2] 
Photocycloaddition Reactions of 2(1H)-Quinolones Induced by Visible Light Irradiation. 
J. Am. Chem. Soc. 2016, 138 (25), 7808–7811. 
112 Giles, A. C.; Rankin, C. H.; Kerr, R. A.; Robie, A. A.; Bender, J.; Perona, P.; Dickinson, 
M. H.; Robie, A. A.; Branson, S.; Branson, K.; et al. A Dual-Catalysis Approach To. 
Science (80-. ). 2014, 344 (April), 392–397. 
113 Carmignani, M.; Volpe, A. R.; Delle Monache, F.; Botta, B.; Espinal, R.; De 
Bonnevaux, S. C.; De Luca, C.; Botta, M.; Corelli, F.; Tafi, A.; et al. Novel Hypotensive 
Agents from Verbesina Caracasana. 6. Synthesis and Pharmacology of 
Caracasandiamide. J. Med. Chem. 1999, 42 (16), 3116–3125. 
114  Ichikawa, M.; Takahashi, M.; Aoyagi, S.; Kibayashi, C. Total Synthesis of (-)-
Incarvilline, (+)-Incarvine C, and (-)-Incarvillateine. J. Am. Chem. Soc. 2004, 126 (50), 
16553–16558. 
  
233 
                                                                                                                                                                     
115 Tsai, A. S.; Bergman, R. G.; Ellman, J. A. Asymmetric Synthesis of (-)-Incarvillateine 
Employing an Intramolecular Alkylation via Rh-Catalyzed Olefinic C-H Bond Activation. 
J. Am. Chem. Soc. 2008, 130 (20), 6316–6317. 
116  Carmignani, M.; Volpe, A. R.; Delle Monache, F.; Botta, B.; Espinal, R.; De 
Bonnevaux, S. C.; De Luca, C.; Botta, M.; Corelli, F.; Tafi, A.; et al. Novel Hypotensive 
Agents from Verbesina Caracasana. 6. Synthesis and Pharmacology of Caracasandiamide. 
J. Med. Chem. 1999, 42 (16), 3116–3125. 
117 Takahashi, M.; Ichikawa, M.; Aoyagi, S.; Kibayashi, C. Total Synthesis of 
Dipiperamide A and Revision of Stereochemical Assignment. Tetrahedron Lett. 2005, 46 
(1), 57–59. 
118  Gutekunst, W. R.; Baran, P. S. Total Synthesis and Structural Revision of the 
Piperarborenines via Sequential Cyclobutane C-H Arylation. J. Am. Chem. Soc. 2011, 133 
(47), 19076–19079. 
119 Mangion, I. K.; MacMillan, D. W. C. Total Synthesis of Brasoside and Littoralisone. 
J. Am. Chem. Soc. 2005, 127 (11), 3696–3697. 
120 Liu, R.; Zhang, M.; Wyche, T. P.; Winston-Mcpherson, G. N.; Bugni, T. S.; Tang, W. 
Stereoselective Preparation of Cyclobutanes with Four Different Substituents: Total 
Synthesis and Structural Revision of Pipercyclobutanamide a and Piperchabamide G. 
Angew. Chemie - Int. Ed. 2012, 51 (30), 7503–7506. 
121 H. Xu, W. Zhang, D. Shu, J. B. Werness, W. Tang, Angew. Chem. 2008, 120, 9065 
122 J. M. Um, H. Xu, K. N. Houk,W. Tang, J. Am. Chem. Soc. 2009, 131, 6664. 
  
234 
                                                                                                                                                                     
123 Huang, B.; Zhang, F.; Yu, G.; Song, Y.; Wang, X.; Wang, M.; Gong, Z.; Su, R.; Jia, Y. 
Gram Scale Syntheses of (-)-Incarvillateine and Its Analogs. Discovery of Potent 
Analgesics for Neuropathic Pain. J. Med. Chem. 2016, 59 (8), 3953–3963. 
124 Sommerwerk, S.; Kluge, R.; Ströhl, D.; Heller, L.; Kramell, A. E.; Ogiolda, S.; 
Liebing, P.; Csuk, R. Synthesis, Characterization and Cytotoxicity of New Piplartine 
Dimers. Tetrahedron 2016, 72 (11), 1447–1454. 
125 Bezerra, D. P.; Pessoa, C.; De Moraes, M. O.; Saker-Neto, N.; Silveira, E. R.; Costa-
Lotufo, L. V. Overview of the Therapeutic Potential of Piplartine (Piperlongumine). Eur. 
J. Pharm. Sci. 2013, 48 (3), 453–463. 
126 de Moraes, J.; Keiser, J.; Ingram, K.; Nascimento, C.; Yamaguchi, L. F.; Bittencourt, 
C. R.; Bemquerer,M. P.; Leite, J. R.; Kato, M. J.; Nakano, E. Curr. Med. Chem. 2013, 
20,301e309. 
127 Bodiwala, H. S.; Singh, G.; Singh, R.; Dey, C. S.; Sharma, S. S.; Bhutani, K. K.; 
Singh, I. P. J. Nat. Med. 2007, 61,418e421. 
128 Felipe, F. C. B.; Souza Filho, J. T.; Souza, L. E. d. O.; Silveira, J. A.; Uchoa, D. E. d. 
A.; Silveira, E. R.; Pessoa, O. D. L.; Viana, G. S. d. B. Phytomedicine 2007, 14, 605e612. 
129 Fontenele, J. B.; Leal, L. K. A. M.; Silveira, E. R.; Felix, F. H.; Bezerra Felipe, C. F.; 
Viana, G. S. B. J. Pharm. Pharmacol. 2009, 61,511e515. 
130 Peng, S.; Zhang, B.; Meng, X.; Yao, J.; Fang, J. Synthesis of Piperlongumine 
Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) 
Activators as Potential Neuroprotective Agents. J. Med. Chem. 2015, 58 (13), 5242–
5255. 
  
235 
                                                                                                                                                                     
131  Reshmi, S. K.; Sathya, E.; Devi, P. S. J. Pharm. Res. 2010, 3, 2502e2507.  
132 Knowles, J. P.; Elliott, L. D.; Booker-Milburn, K. I. Flow Photochemistry: Old Light 
through New Windows. Beilstein J. Org. Chem. 2012, 8 (Figure 1), 2025–2052. 
133 Cambié, D.; Bottecchia, C.; Straathof, N. J. W.; Hessel, V.; Noël, T. Applications of 
Continuous-Flow Photochemistry in Organic Synthesis, Material Science, and Water 
Treatment. Chem. Rev. 2016, 116 (17), 10276–10341. 
134 Hernandez-Perez: A. C., Collins, S. K., Angew. Chem. Int. Ed. 2013, 52, 12696-12700 
135  Ehrfeld, W.; Hessel, V.; Löwe, H. Microreactors: New Technology for Modern 
Chemistry; Wiley-VCH: Weinheim, (2000). 
136  Microreactors in Organic Synthesis and Catalysis; Wirth, T., Ed.; Wiley-VCH: 
Weinheim, (2008) 
137  Chemical Reactions and Processes under Flow Conditions; Luis, S. V., Garcia-
Verdugo, E., Eds.; RSC Publishing: London, (2010) 
138 Cantillo, D.; Mateos, C.; Rincon, J. A.; Frutos, O. Kappe, C. O. Chem. Eur. J. 2015, 21, 
12894-12898. 
139 Hook, B. D. A.; Dohle, W.; Hirst, P. R.; Pickworth, M.; Berry, M. B.;Booker-Milburn, 
K. I. J. Org. Chem. (2005), 70, 7558–7564 
140 Blackman, E. E.; Knowles, J. P.; Burgess, J.; Booker-Milburn, K. I. Chem. Sci., (2016), 
7, 2302 2307. 
141 Elliott, L.; Knowles, J. P.; Koovits, P. J.; Maskill, K. G.; Ralph, M. J.; Lejeune, G.; 
Edwards, L. J.; Robinson, R. I.; Clemens, I. R.; Cox, B.; Pascoe, D. D.; Koch, G.; Fberle, 
M.; Berry, M. B. Booker-Milburn, K. I. Chem. Eur. J. (2014), 20 , 15226-15232 
  
236 
                                                                                                                                                                     
142 Kelly, T. R.; Meghani, P.; Ekkundi, V. S., Tetrahedron Lett., 1990, 31, 3381 
143 Curran, D. P.; Kuo, L. H. Tetrahedron Lett., 1995, 36, 6647. 
144 Schreiner, P. R. Chem. Soc. Rev. 2003, 32, 289-296 
145 D. L. Severance, W. L. Jorgensen, J. Am. Chem. Soc. 1992, 114, 10966 ± 10968. 
146 T. R. Kelly, P. Meghani, V. S. Ekkundi, Tetrahedron Lett. 1990, 31, 3381 ± 3384. 
147 M. C. Etter, S. M. Reutzel, J. Am. Chem. Soc. 1991, 113, 2586 ± 2598 
148 D. P. Curran, L. H. Kuo, Tetrahedron Lett. 1995, 36, 6647 ± 6650. 
149 Wittkopp, A.; Schreiner, P. R. Chem. Eur. J., 2003, 9, 407. 
150 Schreiner, P. R.; Wittkopp, A. H-Bonding Additives Act like Lewis Acid Catalysts. 
Org. Lett. 2002, 4 (2), 217–220. 
151 Taylor, M. S.; Jacobsen, E. N. Asymmetric Catalysis by Chiral Hydrogen-Bond Donors. 
Angew. Chemie - Int. Ed. 2006, 45 (10), 1520–1543. 
152 Knowles, R. R.; Lin, S.; Jacobsen, E. N. Enantioselective Thiourea-Catalyzed Cationic 
Polycyclizations. J. Am. Chem. Soc. 2010, 132 (14), 5030–5032. 
153  Photocatalysis, E.; Brimioulle, R.; Lenhart, D.; Maturi, M. M.; Bach, T. 
Enantioselective Catalysis of Photochemical Reactions Angewandte. 2015, 2–21. 
154 Tröster, A.; Alonso, R.; Bauer, A.; Bach, T. Enantioselective Intermolecular [2 + 2] 
Photocycloaddition Reactions of 2(1H)-Quinolones Induced by Visible Light Irradiation. 
J. Am. Chem. Soc. 2016, 138 (25), 7808–7811. 
155 Vallavoju, N.; Selvakumar, S.; Jockusch, S.; Sibi, M. P.; Sivaguru, J. Enantioselective 
Organo-Photocatalysis Mediated by Atropisomeric Thiourea Derivatives. Angew. Chemie 
- Int. Ed. 2014, 53 (22), 5604–5608. 
  
237 
                                                                                                                                                                     
156 Ishigami, T.; Murata, T.; Endo, T. Bull. Chem. Soc. Jap. 1976, 49, 12, 3578-3583 
157 Isr J Chem. 2009 ; 49(2): 227–233 
158 Zhang, Z.; Wang, Y.; Nakano, T. Photo Racemization and Polymerization of (R)-1,1′-
Bi(2-Naphthol). Molecules 2016, 21 (11), 1–10. 
159 Bergonzini, G.; Schindler, C. S.; Wallentin, C.-J.; Jacobsen, E. N.; Stephenson, C. R. 
J. Photoredox Activation and Anion Binding Catalysis in the Dual Catalytic 
Enantioselective Synthesis of β-Amino Esters. Chem. Sci. 2014, 5 (1), 112–116. 
160 Patel, D. C.; Woods, R. M.; Breitbach, Z. S.; Berthod, A.; Armstrong, D. W. Thermal 
Racemization of Biaryl Atropisomers. Tetrahedron Asymmetry 2017, 28 (11), 1557–
1561. 
161 Sharanabai, K. M.; Prabhu, G.; Panduranga, V.; Sureshbabu, V. V. A Facile One-Pot 
Synthesis of Selenoureidopeptides Employing Lialhseh through Staudinger Aza-Wittig-
Type Reaction. Synth. 2015, 47 (6), 801–806. 
162  Gatzenmeier, T.; Van Gemmeren, M.; Xie, Y.; Höfler, D.; Leutzsch, M.; List, B. 
Asymmetric Lewis Acid Organocatalysis of the Diels-Alder Reaction by a Silylated C-H 
Acid. Science, 2016, 351 (6276), 949–952. 
163 Gatzenmeier, T.; Kaib, P. S. J.; Lingnau, J. B.; Goddard, R.; List, B. The Catalytic 
Asymmetric Mukaiyama–Michael Reaction of Silyl Ketene Acetals with α,β-Unsaturated 
Methyl Esters. Angew. Chemie - Int. Ed. 2018, 57 (9), 2464–2468. 
164 Lewis, F. D.; Quillen, S. L.; Hale, P. D.; Oxman, J. D. Lewis Acid. J. Am. Chem. Soc. 
1988, No. 9, 1261–1267. 
  
238 
                                                                                                                                                                     
165  D’Auria, M. A DFT Study of the Photochemical Dimerization of Methyl 3-(2-
Furyl)Acrylate and Allyl Urocanate. Molecules 2014, 19 (12), 20482–20497. 
166 Lewis, D.; Quillen, L.; Elbert, E. The Singlet States Methyl Indenoate. 1989, 47, 173–
179. 
167 Vallavoju, N.; Selvakumar, S.; Pemberton, B. C.; Jockusch, S.; Sibi, M. P.; Sivaguru, 
J. Organophotocatalysis: Insights into the Mechanistic Aspects of Thiourea-Mediated 
Intermolecular [2+2]Photocycloadditions. Angew. Chemie - Int. Ed. 2016, 55 (18), 5446–
5451. 
168 J. Photochem. 1986, 35, 71-85 
169 Terao, K.; Nishiyama, Y.; Tanimoto, H.; Morimoto, T.; Oelgemoller, M.; Kakiuchi, K. 
J. Flow Chem. 2012, 2, 3, 73-76 
170 Lévesque, F.; Seeberger, P. H. Highly Efficient Continuous Flow Reactions Using 
Singlet Oxygen as a “ Green ” Reagent. Org. Lett. 2011, 13, 19, 5008-5011. 
171 Horie, T.; Sumino, M.; Tanaka, T.; Matsushita, Y.; Ichimura, T.; Yoshida, J. Org. 
Process Res. Dev. (2010), 14, 405-410 
172 Pieber, B.; Shalom, M.; Antonietti, M.; Seeberger, P. H.; Gilmore, K. Angew. Chem. 
Int. Ed. 2018, 57, 1-5. 
173 Nakano, M.; Nishiyama, Y.; Tanimoto, H.; Morimoto, T.; Kakiuchi, K. Remarkable 
Improvement of Organic Photoreaction Efficiency in the Flow Microreactor by the Slug 
Flow Condition Using Water. Org. Process Res. Dev. 2016, 20 (9), 1626–1632. 
  
239 
                                                                                                                                                                     
174 Terao, K.; Nishiyama, Y.; Kakiuchi, K. Highly Efficient Asymmetric Paternò–Büchi 
Reaction in a Microcapillary Reactor Utilizing Slug Flow. J. Flow Chem. 2015, 4 (1), 35–
39. 
175 Kashid, M. N.; Gerlach, I.; Goetz, S.; Franzke, J.; Acker, J. F.; Platte, F.; Agar, D. W.; 
Turek, S. Internal Circulation within the Liquid Slugs of a Liquid-Liquid Slug-Flow 
Capillary Microreactor. Ind. Eng. Chem. Res. 2005, 44 (14), 5003–5010. 
176 Kashid, M. N.; Platte, F.; Agar, D. W.; Turek, S. Computational Modelling of Slug 
Flow in a Capillary Microreactor. J. Comput. Appl. Math. 2007, 203 (2 SPEC. ISS.), 487–
497. 
177 Kumar, S.; Cherlo, R.; Kariveti, S.; Pushpavanam, S. Experimental and Numerical 
Investigations of Two-Phase ( Liquid - Liquid ) Flow Behavior in Rectangular 
Microchannels. Ind. Eng. Chem. Fundam. 2010, 49, 893–899. 
178 Antony, R.; Giri Nandagopal, M. S.; Sreekumar, N.; Rangabhashiyam, S.; Selvaraju, 
N. Liquid-Liquid Slug Flow in a Microchannel Reactor and Its Mass Transfer Properties - 
A Review. Bull. Chem. React. Eng. Catal. 2014, 9 (3), 207–223. 
179 Baroud, C. N.; Gallaire, F.; Dangla, R. Dynamics of Microfluidic Droplets. Lab Chip 
2010, 10 (16), 2032. 
180 Yang, L.; Nieves-Remacha, M. J.; Jensen, K. F. Simulations and Analysis of Multiphase 
Transport and Reaction in Segmented Flow Microreactors. Chem. Eng. Sci. 2017, 169, 
106–116. 
181 Wang, K.; Li, L.; Xie, P.; Luo, G. Liquid–liquid Microflow Reaction Engineering. 
React. Chem. Eng. 2017. 
  
240 
                                                                                                                                                                     
182 Narayan, S.; Muldoon, J.; Finn, M. G.; Fokin, V. V.; Kolb, H. C.; Sharpless, K. B. “On 
Water”: Unique Reactivity of Organic Compounds in Aqueous Suspension. Angew. 
Chemie - Int. Ed. 2005, 44 (21), 3275–3279. 
183  Sheu, S.-Y.; Schlag, E. W.; Selzle, H. L.; Yang, D.-Y. Molecular Dynamics of 
Hydrogen Bonds in Protein−D 2 O:  The Solvent Isotope Effect. J. Phys. Chem. A 2008, 
112 (5), 797–802. 
184 M. K. Bernett, Ind. Eng. Chem. Prod. Res. Develop. 1974, 13, 4, 250-252 
185 V. S. Deepa, K. Rajaram, P. Sureshkumar, Pak. J. Pharm. Sci. 2015, 28, 2, 443-448 
186 Sharanabai, K. M.; Prabhu, G.; Panduranga, V.; Sureshbabu, V. V. A Facile One-Pot 
Synthesis of Selenoureidopeptides Employing Lialhseh through Staudinger Aza-Wittig-
Type Reaction. Synth. 2015, 47 (6), 801–806. 
187  Ito, Y.; Hosomi, H.; Ohba, S. Compelled Orientational Control of the Solid-State 
Photodimerization of Trans-Cinnamamides: Dicarboxylic Acid as a Non-Covalent Linker. 
Tetrahedron 2000, 56 (36), 6833–6844. 
188 J. A. M. Lummiss, P. D. Morse, R. L. Beingessner, T. F. Jamison, Chem. Rev. 2017, 17, 
667-680 
189 Mac Giolla Eain, M.; Egan, V.; Punch, J. Film Thickness Measurements in Liquid-
Liquid Slug Flow Regimes. Int. J. Heat Fluid Flow 2013, 44, 515–523. 
190 Li, Y.; Reddy, R. K.; Kumar, C. S. S. R.; Nandakumar, K. Computational Investigations 
of the Mixing Performance inside Liquid Slugs Generated by a Microfluidic T-Junction. 
Biomicrofluidics 2014, 8 (5), 054125. 
  
241 
                                                                                                                                                                     
191 Sanchez-Abella, Fernandez, S.; Armesto, N.; Ferrero, M.; Goto, V. J. Org. Chem. 2006, 
71, 5396-5399 
192 Brummond, K. M.; Deforrest, J. E. Synthesis of the Naturally Occurring (-)-1,3,5-Tri-
O-Caffeoylquinic Acid. Synlett 2009, No. 9, 1517–1519. 
193 Okaya, S. Trichloroboron-Promoted Deprotection of Phenolic Benzyl Ether Using 
Pentamethylbenzene as a Non Lewis-Basic Cation Scavenger. Org. Synth. 2016, 93 (Note 
2), 63–74. 
194 Ishigami, T.; Uehara, M.; Murata, T.; Endo, T. Correlation between Selectivity in 
Photochemical Cross-Cycloaddition and Ionization Potential of the Reacting Olefins. J. 
Chem. Soc. Chem. Commun. 1978, No. 18, 786–788. 
195 Clements, A. R.; Pattabiraman, M. γ-Cyclodextrin Mediated Photo-
Heterodimerization between Cinnamic Acids and Coumarins. J. Photochem. Photobiol. A 
Chem. 2015, 297, 1–7. 
196 E. J. Corey, Rajat B. Mitra, and Hisashi. Uda J. Am. Chem. Soc., 1964, 86 (3), pp 
485–492 
197 Poplata, S.; Bach, T. Enantioselective Intermolecular [2+2] Photocycloaddition 
Reaction of Cyclic Enones and Its Application in a Synthesis of (-)-Grandisol. J. Am. 
Chem. Soc. 2018, 140 (9), 3228–3231. 
 
 
 
 
 242 
 243 
 244 
 245 
 246 
     
